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by 
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Abstract
The contributions to computer science presented in this thesis were inspired by the analysis of the 
data  generated in the early stages of drug discovery. These data  sets are generated by screening 
compounds against various biological receptors. This gives a first indication of biological activity. 
To avoid screening inactive compounds, decision rules for selecting compounds are required. Such a 
decision rule is a  mapping from a compound representation to an estimated activity. Hand-coding 
such rules is time-consuming, expensive and subjective. An alternative is to learn these rules from 
the available data. This is difficult since the compounds may be characterized by tens to thousands 
of physical, chemical, and structural descriptors and it is not known which are most relevant to 
the prediction of biological activity. Further, the activity measurements axe noisy, so the data  can 
be misleading.
The support vector machine (SVM) is a statistically well-founded learning machine th a t is not 
adversely affected by high-dimensional representations and is robust with respect to  measurement 
inaccuracies. It thus appears to  be ideally suited to the analysis of screening data. The novel 
application of the SVM to this domain highlights some shortcomings with the vanilla SVM. Three 
heuristics are developed to overcome these deficiencies: a stopping criterion, HERMES, th a t allows 
good solutions to be found in less time; an autom ated method, LAIKA, for tuning the Gaussian 
kernel SVM; and, an algorithm, STAR, th a t outputs a more compact solution.
These heuristics achieve their aims on public domain data  and are broadly successful when 
applied to  the drug discovery data. The heuristics and associated data  analysis are thus of benefit 
to both pharmacology and computer science.
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N otation
The following notation is used in this thesis, unless stated otherwise.
3? the set of reals
X  an abstract domain
In logarithm to base e
log logarithm to base 10
(x, z) inner product between two vectors x  and z
|| • || 2-norm (Euclidean distance) ||x|| =  y / (x, x)
L 2(X)  space of functions on X  square integrable w.r.t. Lebesgue measure
E(-) expectation operator
Pr{-} probability of an event
d dimensionality of input space
I number of training examples
Xj input patterns
y* target values or classes
y vector of target values
w  weight vector
b threshold (or operating point)
/  a decision function /  :3?d —>{—1,+1}
T  a family of decision functions /
\ ( l , k )  cost of misclassifying an element of class k as an element of class I
R ( f ) risk of /
Remp empirical risk of /
K  Mercer kernel
cr ‘w idth’ param eter of an RBF kernel
ai Lagrange multiplier
slack variable (margin error) 
ela£ estimator of generalization error
7Ty, 7Ty sample, true proportion of class y 6 {—1, +1}
C, C + , C~ regularization parameters 
Q Hessian of a quadratic program
e termination precision
e generalization error
k  norm on errors
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Chapter 1
Introduction
D on’t estimate the required capacity o f a bridge by the number 
o f people who swim across the river today.
A n o n
The work presented in this thesis has been motivated by the problems arising in the analysis of 
pharmaceutical data  sets. The main tool used to analyse the data, and to  make predictions, is 
the recently developed support vector machine (SVM). During the analysis of the pharmaceutical 
data, some shortcomings of the SVM are identified. Heuristics are proposed to overcome these. 
These new tools are then applied to  the problems arising in the early stages of drug discovery.
1.1 Supervised Learning
W ithout thinking about it, human beings continually process a mass of sensory data  into distinct 
objects and then put these objects into categories. Anyone of good hearing can rapidly process a 
mass of auditory data  and identify various sounds, such as ‘motorcycle engine’, ‘classical music’, 
etc. A mechanic may be able to further subdivide the former category into ‘functioning normally’ 
and ‘malfunctioning’. A musician may be able to subdivide the latter into ‘Sibelius’, ‘Mahler’, 
‘Ravel’, and so on. Although we have only a  basic understanding of how the brain performs 
this remarkable task, functionally, it can be split into two stages: object recognition and object 
classification. This is best illustrated by considering the sense of sight. Light reflected from various 
objects is incident upon the rods and cones a t the back of the eyes. Thus stimulated, these then 
convey electrical signals to  the brain. At this stage the visual cortex has a mass of structured data, 
there are no ‘objects’ in the mind as yet. The first stage is to  segment this image into ‘objects’. 
Once these ‘objects’ have been recognized they are then labelled. (The relationship between these 
labelled ‘objects’ in the mind and the objects which led to them  is a m atter for philosophers.) 
For example, a chunk of data th a t originated in the lower left portion of the visual field may be 
recognized as an ‘object’ and then labelled as ‘book’. This labelling of objects into pre-defined 
categories will be called classification. (The term  classification is not used here in the sense of 
defining the categories themselves, but the act of placing objects into pre-defined classes.) There is 
also the possibility of ‘don’t know’ or ‘novelty’. A ‘don’t know’ labelling may occur if, for example, 
the musician above was asked to classify a  motorcycle engine as ‘good’ or ‘bad’ — he may not 
have enough experience of motorcycles to distinguish the two. A ‘novelty’ labelling may occur if 
the musician was played a piece by an obscure composer he had never heard before.
The key reason th a t the classifications in the above examples did not fall into the pre-defined
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Type
nominal
binary
discrete
continuous
Object
symphony
bit
shoe
people
Attribute
composer
state
size
height
Labels
‘Sibelius’, ‘Mahler’, ‘Ravel’
‘0 \ T
3,3±,4
SR+
Table 1.1: Types of attributes, with example instantiations.
categories (that is, ‘good’, ‘bad’; ‘Sibelius’, ‘Mahler’, ‘Ravel’) was lack of experience on the part 
of the musician. Contrapositively, if classification is to be performed successfully, experience is 
required. T hat is, in order to  classify objects one must have learned what the classes are and one 
must have learned a decision strategy for placing objects into classes. The problems presented in 
this thesis are of the latter type, th a t is supervised classification. The learning is termed ‘supervised’ 
since in order to assign an object to a class, e.g. ‘Sibelius symphony’, one must have been told by 
a supervisor, or teacher, which objects are in th a t class.
In reality, things aren’t always as clear cut as described above. A car engine may be ‘functioning 
perfectly’, ‘good enough for domestic use’, ‘in need of maintenance’, ‘not working’, etc. A book 
may be ‘red’ or ‘green’ or a shade in between. A measurable attribu te associated with a set of 
objects may be: nominal, binary, discrete, or continuous. An example of each type is given in 
Table 1.1. The binary case can be thought of as a special case of the nominal case, or of the 
discrete case. It is listed separately since it is often useful to trea t the other cases as one or more 
binary problems. For example, although there is an infinite number of colours between red and 
green, it is sometimes useful to  have a boundary point. This would then allow simple classification 
of objects as ‘red’ or ‘green’. Since colours near the boundary point will be mostly yellow, the 
exact boundary point will vary from person to person.
The problem of labelling a set of objects in terms of an ordered discrete set of labels, i.e. 
ranking them according to the level of some attribute, is term ed ordinal regression. The problem 
of assigning labels to  objects from a continuous set of labels is known as regression.
A decision strategy for classification, ordinal regression or regression is a mapping
X  Y,
x  *-* y,
which maps objects x  in some set X  to labels y  in a set of labels Y .  Human beings are generally 
quite good as this, particularly when the objects x  are from their field of expertise. Human beings 
cannot, however, label the very high numbers of objects th a t businesses and research institutions 
handle on a daily basis. For example, given a set of 100 organic compounds (molecules), a  trained 
medicinal chemist may be able to label them as ‘inert’, ‘toxic’, ‘potentially therapeutic’, etc. 
However, there are potentially trillions of compounds in which a  pharmaceutical company may 
be interested, so even 1 0 0 0  medicinal chemists, examining 1 0 0  compounds a day each, would take 
hundreds of thousands of years to examine them all.
The human brain is a massively parallel computing system, which seems to make it well-suited 
for identifying objects and labelling them. However, signal transmission, and hence information 
processing, is fairly slow in the brain, in comparison to  modern computers. Computers can process 
information much faster than the human brain, but cannot easily recognize and label objects. The 
task then, is to develop a decision strategy th a t gives close to  human performance th a t can be 
implemented, rapidly, in a computer.
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One possible approach to this problem is to attem pt to encode in a computer the methodology 
of an expert. This is a very tricky problem though, as most experts find it difficult to verbalize 
exactly how they make their decisions. (How do you decide whether or not ‘sky the blue is’ is 
syntactically correct?) It is also very expensive to hire experts and skilled interrogators (known as 
knowledge engineers or elicitation experts). A more appealing alternative is to mimic the process by 
which the expert became an expert. As mentioned above, the human expert has learned a decision 
strategy based on past experience. T hat is, the expert has been trained. This training process 
essentially consists of seeing objects {xi, £ 2 , • ••,£«} and assigning labels { /(x  1), f ( x 2) , . . . ,  /(x j)} . 
A ‘teacher’ then supplies the correct labels (insofar as they can be correct) {yi ,V2i • • •, yi} and the 
trainee implicitly or explicitly adjusts her decision strategy /  accordingly. The teacher may be a 
hum an being, a textbook, nature, experience, etc.
Formally, we desire a learning machine that, given a training set
{ x i , . . .  ,xj} € X 1 (1.1)
w ith associated labels
{l/i» ■••>!«} e  Y l , (1.2)
produces a decision strategy, or hypothesis,
f : X  -  y,
/  : x •-> /(x ) ,
such th a t / (x )  is close to  y  for the m ajority of objects from X  th a t we are likely to  encounter 
in the future. Note th a t we are not demanding that /(x )  =  y  for all x £ X ,  only th a t /(x )  is 
approximately equal to y  most of the time. Demanding f ( x )  = y  for all x € X  is usually too 
stringent a requirement. We may also desire th a t /  has other properties th a t are im portant to the 
solution of the original problem. For example, that it is easy to compute in terms of memory and 
time requirements, or th a t it has a simple representation.
W hat ‘close’ means depends on the context. For classification we may desire th a t the risk
f l ( / )  =  P r { x € X | / ( x ) # y } ,  (1.3)
i.e. the probability of misclassifying an arbitrary object, is small.
In cancer diagnosis it is generally the case th a t misclassifying healthy cells as cancerous is not 
as serious as misclassifying cancerous cells as healthy. In the former case, unnecessary expense and 
stress to the patient will ensue in the form of further tests and treatm ents, which will eventually 
show th a t a mistake has been made. In the latter case, the patient may develop cancer, which is 
much more expensive to treat, is more stressful and is potentially fatal. In this case, we may desire 
th a t
R ( f )  = A(—l , + l ) P r { x  € X +1\ f (x)  =  —1}
+  A (+ l, —l)P r{ x  € X ~ 1\ f (x)  =  + 1 }
is small, where A(—1,+ 1), the cost of misclassifying cancerous cells (x  6  Af+1, y = + 1 ) as healthy 
(x  € X -1 , y = —1), is higher than  A(-i-l, —1), the cost of misclassifying healthy cells as cancerous. 
These costs may not be known beforehand, and may change with time and the opinions of different 
oncologists. Thus, it is often desirable to  have a decision strategy th a t performs well over a range
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of costs.
For regression, when the label is continuous, e.g. y  € 5R, we may desire th a t
B (/)  =  B ( | | / W - y | | , )  (1.4)
i.e. the expected deviation of the prediction from the tru th , is small, where || • ||p is a norm on the 
set Y  =  9? given by
\ \ A \ p  =  \z \p  (1.5)
and E  is the expectation operator.
A part from the risk of using a decision strategy to label objects, there are a number of other 
considerations to  be taken into account when constructing a learning machine. Which of these 
is most im portant depends upon the problem domain. Below I summarize some properties of a 
learning machine th a t have been suggested as performance criteria .1
A ccu rac y  This is an immediately obvious requirement of any predictive algorithm: we wish to 
learn an hypothesis th a t generalizes to unseen examples.
T im e  The time available for learning an hypothesis is a  key factor when constructing a learn­
ing machine. There is often a trade-off between accuracy and speed: a learning machine 
th a t outputs a less accurate decision strategy may be preferred over one outputting a more 
accurate one if the latter requires orders of magnitude more training time or prediction time.
M e m o ry  Learning machines th a t require the entire training set to be held in memory are not 
appropriate for some massive data  sets that are being generated by business and research
institutions. Memory requirements are also an issue in labelling, e.g. handw ritten digit
recognition for palm top computers.
C o n v erg en ce  A learning machine may be deterministic or stochastic. In the latter case it may 
be guaranteed to output a good decision strategy with a certain probability.
I n te rp re ta b i l i ty  D ata analysis is often autom ated owing to  the sheer size of the d ata  sets in­
volved. This can often lead to  problems of interpretability. In some countries it is a legal 
requirement of a credit refusal to have a reason, not simply “the black box says you’re a credit 
risk” . Humans are understandably wary of black boxes, e.g. in medical decision making.
R o b u s tn e s s  Many real-world data  sets are corrupted by noise, either in the description of the 
objects or in their labels. How a learning machine is affected by this will determine its 
suitability in such domains.
F le x ib ility  Is the learning machine to  be used on one problem only, or a class of similar prob­
lems? In real world applications the objects of interest may vary in their form and in their 
descriptions.
P e rfo rm a n c e  over a  ra n g e  o f  co sts  The misclassification costs may not be equal, may be vari­
able or may not be known at all beforehand.
D a ta  h an d lin g  Objects may be described by various types of attributes, as listed in Table 1.1. 
Many learning machines, in particular those from statistics, are designed only to handle 
continuous attributes, which could be a shortcoming in some domains.
1 With thanks to Peter Bentley.
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T u n a b ility  This can be a boon or a burden. The ability to  change the settings to suit the problem 
is desirable, but having free param eters means th a t they need to be set, which can take a 
considerable amount of time and human effort. Ideally, a learning machine should have an 
autom ated method to  set its param eters, w ith user intervention allowed if desired.
In the next section the requirements of a learning machine for labelling compounds during the early 
stages of drug discovery are discussed. In Section 1.3 the support vector machine is introduced, 
and its suitability for the pharmaceutical problems posed with respect to the above performance 
criteria is discussed.
1.2 Drug Discovery
Supervised learning would be confined to the realms of theoretical computer science without ap­
plications. The application of supervised learning presented in this thesis is to the problem of 
drug discovery. Specifically, to the early stages of drug discovery where it is necessary to  whittle 
down the the trillions of potential (i.e. as yet unsynthesized) therapeutic agents to  a handful of 
compounds th a t can be investigated in detail by chemists, phaxmacologists, biochemists and so on 
in order to  develop a useful, marketable, effective drug.
In the early stages of drug discovery, pharmaceuticals companies physically screen tens to hun­
dreds of thousands of compounds against therapeutic targets in order to identify those exhibiting 
desirable biological activity. This process, known as high throughput screening (HTS) has become 
possible due to  advances in assay technology, robotics and information processing. A new field, 
chemoinformatics, has been developed to  cope with the subsequent processing of the massive vol­
ume of data generated by HTS. Even though millions of compounds axe screened annually, this 
is not sufficient to exhaust the trillions of possible ‘drug-like’ compounds. One goal, therefore, is 
to preferentially order compounds for screening. If a learning machine can be developed to order 
compounds such th a t those a t the top of the list are more likely to  exhibit appropriate biological 
activity then the number of active compounds, or hits, discovered by HTS will be increased. This 
is one way to  avoid the problem of screening everything. This is an ordinal regression problem 
and as such can be tackled by classification or regression. The classification approach is to  learn 
a decision strategy for identifying hits, that outputs a confidence in its labelling. The compounds 
can then be ranked in terms of ‘confidence of h it’. The regression approach would be to learn a 
mapping from the compounds to their real-valued activity. As there is a huge volume of screening 
data, there axe plenty of training data  for learning such a decision strategy. By the same token, 
human analysis of the raw data  is impossible, necessitating autom ated summaxization and learning 
techniques.
Activity estim ates from HTS are subject to  variation due to  experimental conditions and the 
small amounts of compounds used. Compounds determined as hits on an initial screen axe subjected 
to further screens in order to obtain more accurate estimates of their activity. At each successive 
stage the number of compounds is reduced, and their bioactivities better chaxacterized. D ata from 
these later, more accurate, screens can be used to  learn further decision strategies for compound 
selection and for prediction of activity. At each stage the d a ta  have particular chaxacteristics which 
must be taken into account when learning each new decision strategy.
An absolutely vital aspect of supervised learning, which up to now has not been made explicit, 
is the description of the object to be labelled. In the case of drug discovery, we cannot physically 
input compounds into a computer. Instead, we must input a collection of numbers, perhaps with 
some structure, th a t describe th a t compound. For the purpose of labelling compounds as ‘drug’ or
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‘non-drug’, these may be such things as: molecular weight, solubility, polarizability, etc. It is an 
open problem in most applications as to what description is optimal. This topic, in the context of 
drug discovery, is dealt w ith in more detail in Chapters 2  and 5, but remains, ultimately, insoluble. 
It may seem sensible to input all available information about an object in a learning machine, but 
this is frequently misleading. Certain attributes of the object may be irrelevant for classification. 
Some attributes may be poorly measured and do more harm  than  good, even if they are relevant.
In Section 1.1 above, some desirable properties of a learning machine were outlined. In the 
application of supervised learning to drug discovery the following are required of a learning machine.
A ccu racy  over a  ra n g e  o f  co s ts  The cost of a missed potential drug is unknowable; the cost of 
predicting useless compounds as hits is the cost of subsequent screening and processing; these 
costs vary over time, on different projects, and according to different chemists’ viewpoints.
A b ility  to  h a n d le  u n b a la n c e d  d a ta  There axe typically many more inactive compounds than 
active compounds for any screen, thus a learning machine th a t always predicts a compound 
to be inactive will have a high overall accuracy, but will be useless in practice. Assigning a 
higher cost to  misclassifying hits (see previous point) can alleviate this.
F a s t c lassifica tion  The number of compounds whose activity we may desire to predict is very 
large, hence a short classification time is desired.
In te rp re ta b il i ty  The popularity of rule-based systems, such as decision trees, among chemists is 
due to their readability. If a learning machine can provide a  short description of its strategy, 
then an expert can potentially work out what the strategy is and improve it, as well as 
contribute to  domain knowledge.
R o b u s tn e ss  Activity measurements are variable, and compound attributes axe frequently calcu­
lated as opposed to measured. A learning machine must be robust to  such variations and 
inaccuracies.
A b ility  to  h a n d le  h ig h -d im en s io n a l d a ta  Descriptions of compounds can have tens to  thou­
sands of attributes and it is often not known which axe useful for prediction. If we avoid the 
problem of attribu te selection then we require a technique th a t can handle many attributes, 
that may or may not be relevant.
B io logical a n d  ch em ica l sen se  The learning machine must somehow embody biological and 
chemical sense, although this is difficult to evaluate, especially if the learned strategy is hard 
to interpret.
The following properties are obviously desirable, but not essential for the applications considered 
in this work.
F as t tra in in g  The training set sizes are generally 102-10 4 (although they could potentially be 
~  1 0 6), which is not particularly laxge in the context of supervised learning.
E conom y o f sp ace  Many learning machines explicitly or implicitly perform m atrix operations 
o n l x l  matrices (I is the number of training examples), if I =  104 then 1 Gb of memory would 
be required to store such a m atrix, which is likely to  be impractical. For very large d ata  sets 
with many examples or descriptors, it may not even be practical to store the training data 
in memory.
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R o b u s tn e s s  to  m issin g n ess  Compound properties are usually calculated and so are rarely miss­
ing. W hen predicting bioactivity from other bioactivities there may be missing data  since 
not all compounds have been screened on all assays (these compounds would normally be 
removed from the training data, even though they do contain some information).
The support vector machine, introduced in the next section, fulfils most of these requirements to 
a reasonable degree, and is the learning machine of choice used in the work presented here. There 
are some problems when using support vector machines for pharmaceutical d ata  analysis (and in 
other applications) th a t are discussed in Section 1.4.
1.3 The Idea of Structural Risk M inim ization
W hen learning a classification rule in drug discovery, there are essentially two classes of compounds: 
those th a t have been screened on an assay and those th a t haven’t. This division ignores the fact 
th a t screens are not mutually exclusive, and th a t compounds may have been screened against 
the same target at different times and under different conditions. The work presented in this 
thesis aims to  predict activity of the unscreened compounds from the activities of the screened 
compounds, using some common set of descriptors. For a given task, a risk functional is specified 
and the aim is to  minimize the risk of making predictions about unscreened compounds.
The concept of minimizing the risk incurred in using a learned decision strategy is core to 
supervised learning, even though it may not always be the most im portant consideration. An 
obvious approach to minimizing the true risk R  is to  minimize the risk on the available training 
d a ta  (the empirical risk Remp). This is easily calculable since the true labels are provided for the 
training set (i.e. the screened compounds). Learning consists of choosing an hypothesis /  from 
some set of hypotheses. An initial problem then is: which set of hypotheses? If we assume that all 
hypotheses are equally likely then we are doomed to failure since learning is impossible without 
some form of inductive bias (Mitchell, 1997; Popper, 1968; Vapnik, 1998). If the hypothesis space 
is too small then there may not be an hypothesis which accurately captures the properties of 
the underlying d ata  generating process. If the hypothesis space is too large then there will be 
hypotheses th a t capture the idiosyncracies of the particular training d a ta  th a t are available, and 
thus have a low empirical risk. Such an hypothesis is unlikely to  have low true risk though, since 
the specific idiosyncracies of the training data  will be rare in the general population of unseen 
data. W hat is required is an hypothesis th a t captures the general properties of the training data 
th a t are repeated in the general population. Equivalently, we need to  choose the right hypothesis 
space and then choose th a t hypothesis minimizing the empirical risk.
The problem of choosing the hypothesis space is termed model order selection. One approach 
to this problem is structural risk minimization (SRM). Statistical learning theory provides bounds 
on the true risk of using an hypothesis /  of the form
R { f )  < R e mp ( f )  +  $ { h ,  I , rj). (1.6)
T hat is, the true risk is upper bounded (with probability 1 — rj) by the empirical risk plus a penalty 
term  dependent on the ‘size’ h of the hypothesis space and the number of training examples I (and 
on the required probability 77). The ‘size’ of an hypothesis space is formalized in Chapter 3. The 
SRM approach is then:
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1. Form a sequence of hypothesis spaces
i C H 2 C . . .
with increasing ‘size’
h i  <  h*2 < • •  •
2. For each Hi find th a t /* minimizing i?emp-
3. From the set choose th a t hypothesis minimizing the upper bound on the true 
risk (1 .6 ).
In practice, this is approximated by minimizing
( / )  +  A P (/), (1.7)
where P  is a regularization operator and A is a regularization constant. P  is an operator chosen 
to capture the dominant term s in the penalty term  $  and to  make the minimization tractable. 
(It is often the case th a t minimizing (1.6) directly is intractable.) The constant A controls the 
trade-off between minimizing the empirical risk and ensuring th a t the implicit hypothesis space is 
not too large. The problem of determining the hypothesis space has been transformed into one of 
determining the optimal value of A.
The support vector machine (SVM) implements SRM by minimizing a  quantity of the form (1.7). 
The SVM is discussed in more detail in Chapter 3. Some of its properties are as follows.
A ccu racy  In term s of misclassification rate, or squared loss for regression, the SVM has been 
shown to be competitive with the state  of the art in many applications. It can also be 
trained with unequal misclassificaton costs and unbalanced data.
T ra in in g  t im e  This is roughly quadratic in the number of training examples. This is not as 
fast as many statistical and rule-induction techniques, but is generally better than other 
sophisticated learning machines such as neural networks and Bayesian networks.
C lassifica tion  t im e  This is linear in the ‘size’ of the decision strategy. Often the decision strategy 
has a short description, enabling rapid labelling of objects, but in some cases the description 
of the decision strategy includes most of the training data, which can lead to the SVM being 
‘abysmally slow in classification mode’ (Burges, 1998).
In te rp re ta b il i ty  The decision strategy is a weighted vote of comparisons between the new object 
to be classified and ‘borderline’ objects from the training data  (known as support vectors). 
If there are few support vectors then it may be possible to  gain an understanding of the 
decision strategy, or to construct a readable set of rules (although the meaningfulness of the 
support vectors is open to question).
M em o ry  re q u ire m e n ts  The algorithms used to implement the SVM in the work presented here 
have memory requirements linear in the number of training examples. For these algorithms it 
is necessary to  hold the entire training set in memory. O ther algorithms are available which 
do not require this (although they have correspondingly longer training times).
R o b u s tn e ss  Owing to  their theoretical foundations, SVMs are highly robust to noise in the 
attributes and in the training labels. The SVM is not affected as much as other learning
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machines by irrelevant or correlated attributes. The SVM can learn hypotheses in very high 
dimensional spaces without deterioration in performance.
The SVM then, seems well suited to the problems encountered in the early stages of drug discovery.
There axe some shortcomings however, and these are discussed in the next section.
1.4 H euristics for Support Vector Classification
There axe three main labelling problems tackled in the work presented in this thesis. Briefly, these
are as follows.
H T S  These d a ta  axe proprietary to GlaxoSmithKline (GSK). Once a target has been identified, 
thousands to tens of thousands of compounds are screened against the target in a primary 
HTS assay. A percentage inhibition is reported for each compound. These data  axe coarse, 
one common procedure is to threshold the real-valued activities as ‘h it’ or ‘miss’. Thresholds 
for these assays were provided by the screening group a t GSK.
The aim of the experiments presented here is to  use these labelled data  to select for screening 
those (unscreened) compounds which axe likely to be hits. This is done in two ways. The 
regression approach is to learn a relationship between descriptive attributes and the real- 
valued activity. The classification approach is to learn a rule th a t accurately predicts a 
compound to be a hit or a miss.
p K i  These d a ta  are proprietary to GSK. Once a  compound has been determined active in a HTS 
screen, its activity is confirmed in a secondary screen. Those compounds that are active 
and are deemed satisfactory in pharmacological terms, are then screened over a range of 
concentrations to obtain an IC50 value. These data  are more refined than those from the 
prim ary HTS screen: the aim is to  determine the quality of known hits. The IC50 is a 
measure of concentration, thus a low IC50 is good. Analogues of compounds having low 
IC50 may also be studied further, often across related assays, e.g. to  determine selectivity 
across a particular class of targets (such as histamines).
A pKi value can then be determined, either by a functional assay, or calculated from the 
IC50 value. A pKi value for a compound against a particular target is essentially a constant. 
The effect of assay variables, principally ligand concentration, has been removed. They thus 
allow more direct comparison across assays done a t different times, or across assays with 
related receptors. This la tter allows for selectivity screening: it may be desired to hit one or 
more related receptors, or only a specific example from a class.
These data  are left and right censored. To avoid throwing away useful data they were 
converted to  a semi-quantitative ranking. Thresholds were provided for these data, for the 
purpose of labelling a compound as active or inactive. A classification approach was taken 
to predict which (unscreened) compounds would be active.
Q S A R  These d a ta  axe available from the UCI Machine Learning Repository (Blake and Merz, 
1998). This is a small focussed set of compounds, typical of those found in the traditional 
QSAR problems th a t axise in the latex stages of dxug discovexy. The aim is to rank the 
compounds in terms of their inhibition of dihydrofolate reductase (reported as log(l/K j)). 
This is an ordinal regression problem. It is tackled by learning a ranking function great(), 
such th a t great(n ,m ) =  +1 if drug n has activity higher than drug m. Thus the problem is
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reformulated as one of classification. Note th a t this approach to ordinal regression becomes 
unfeasible when there are many compounds, since for I compounds there are 1(1 — 1) instances 
of great(n, m).
The compounds in these d a ta  sets can be characterized by a variety of attribu te sets, as described 
in the relevant sections of this thesis. These three problems have been chosen as representative of 
the sort of problems typically encountered during the drug discovery process.
The objective of learning a decision rule from such data  sets is to  make predictions about 
unscreened compounds. For the purpose of validating the decision rules, some of the available data 
are treated  as unscreened. As yet, GSK have not used the developed tools to select compounds 
for screening.
On the last of these problems, the standard support vector machine outperforms a range of 
machine learning techniques commonly used by the QSAR community.
On the second problem, th a t of predicting the activity of competitive antagonists, an SVM 
does not outperform a decision tree. Two problems are identified with the SVM.
S o lu tio n  C o m p le x ity  One of the oft-cited advantages of the SVM is the sparseness of the solu­
tion: the solution is an expansion on a subset of the training data, known as support vectors 
(SVs). For the competitive antagonist data, 55%-85% of the training data become SVs. 
This is undesirable from the point of view of model interpretability and classification speed. 
Further, it suggests th a t the SVM is overfitting the training data, and this is borne out by 
observing the discrepancy between training and test error. The complexity of the solution 
could also be interpreted as the complexity of the problem. Thus an alternative is to change 
the problem, by changing the training data, or the descriptive attributes.
K e rn e l T u n in g  In the absence of domain knowledge, the kernel of an SVM should be chosen to 
be flexible and easily computable. The Gaussian kernel K (x , z) =  exp(—||x  — z ||2 /2cr2) is 
often used. This projects the data  into a countably-infinite dimensional feature space. The 
performance of the SVM is sensitive to  the setting of a. There are various heuristics for 
setting a, or for searching for the optimal value. Although these are practical for the size of 
the d ata  sets presented here, a preferable approach is to adaptively tune a  during training 
to reduce run-time.
These two problems axe interrelated since setting a  too small will lead to  a large number of support 
vectors and the SVM will overfit the training data.
Even when there are not many training data, it is desirable to  have a  fast autom ated method 
for tuning a  for the purposes of exploratory data  analysis. For example, for the pKi data, although 
there are only 395 compounds in the training set, there axe activity d a ta  for 11 assays and a t least 
four possible compound representations. In to tal there are 44 classification problems, removing 
one free param eter can thus save a lot of time as well as human effort. Also, if there are few SVs, 
there may be some interpretative value to  be gained from examining the 44 sets of SVs.
A further characteristic of SVMs is th a t there is a global optimum. W hilst this is extremely 
appealing in compaxison to other machine learning techniques, an observation should be made. It is 
often the case th a t an acceptable test error, or its minimum, can be achieved in far fewer iterations 
than  it takes to atta in  the global optimum. Thus it is desirable to  have a stopping criterion based on 
predicted error. Such a stopping criterion is also desirable when other heuristics axe incorporated 
into the SVM training algorithm, since these may no longer guarantee the existence of a global 
optimum.
The following three heuristics axe thus introduced and evaluated.
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H E R M E S  A heuristic stopping criterion based on predicted error. An estim ator of the error is 
used to  track the progress during training. Although this estim ator is strictly only valid at 
the global optimum, its behaviour is empirically the same as the test error. Training is halted 
if the estim ator is unchanged for a fixed number, say 100, of iterations.
L A IK A  A heuristic for setting the param eter a  in a Gaussian kernel. This heuristic is applied 
online and subsequently refined in order to reduce training time.
S T A R  A heuristic for removing noisy points during training. In the standard SVM these points 
become SVs, i.e. they form part of the solution, this is intuitively undesirable. Removing 
them  results in a cleaner model w ith fewer SVs, with little or no loss in performance.
These heuristics are described in Chapter 4 and evaluated on some publicly available data  sets. In 
Chapter 5 these heuristics are applied to the classification of the 44 pKi data  sets.
To summarize, the application of a state-of-the-art learning machine, the SVM, to  a difficult 
practical application has led to the development of heuristics. These heuristics trade-off various 
performance characteristics in order to obtain a learning machine more suited to pharmaceuti­
cal classification problems. The heuristics are general purpose and directly transferable to  the 
application of the SVM in other domains.
1.5 Synopsis
The layout of this thesis and the main contributions (italicized) presented are as follows.
D ru g  D isco v e ry  In which the modern drug discovery process is sketched out and certain prob­
lems are highlighted, particularly focussing on the problem of representing compounds in 
silico and learning predictive functions from in vitro data.
T h e  D ru g  D iscovery  P ro c e s s  The early stages of drug discovery consist of designing com­
pound libraries, selecting compounds from these libraries for screening, and progressing 
lead compounds to the next stage. D ata generated at all stages can and should be 
utilized to improve process efficiency.
H ig h  T h ro u g h p u t  S creen in g  In the early stages of drug discovery many compounds 
are screened in the hope of identifying active ones.
S c reen in g  S e t S e lec tio n  Since there are potentially trillions of drug-like compounds, 
an intelligent selection process is required to save time and money.
L ib ra ry  D esig n  Compound libraries may be diverse, to  ensure good coverage of chem­
ical space, or focussed, for a particular pharmacological target. Intelligent filters 
may also be used to  optimize pharmacological properties.
R e p re s e n tin g  C o m p o u n d s  The performance of any predictive tool learned from pharma­
ceutical data  depends on the representation of compounds in silico.
Id e n tify in g  D e sc rip tiv e  F e a tu re s  This is an impossible problem without domain 
knowledge and is not explicitly addressed in this work.
S tru c tu ra l  K ey s The presence of predefined sub-structures is indicated by a bitmap. 
These were developed for database searching, but have proved useful in building 
predictive tools.
F in g e rp r in ts  Structural keys are limited in the amount of information th a t they 
enocode. Fingerprints have been developed to overcome these limitations.
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A ffin ity  F in g e rp r in ts  Physicochemical and structural descriptors do not directly en­
code biological information. Affinity fingerprints attem pt to directly encode relevant 
biological information.
R ev iew  o f  C u r re n t  A p p ro a ch es  The traditional QSAR approach is not well-suited to 
the analysis of the large, noisy, heterogeneous d ata  sets th a t are being generated during 
drug discovery. Other approaches include those based on similarity metrics. Machine 
learning techniques are also becoming popular.
Q S A R  —  R a tio n a l  D esig n  For a focussed group of compounds one can construct a 
simple regression equation to describe the relationship between activity and physico­
chemical properties.
S im ila rity  M e a su re s  The similar property principle states th a t structurally similar 
compounds will have similar physicochemical and biological properties. 
C lu s te r in g  Clustering aims to partition compounds into homogeneous groups, such 
th a t the groups are distinct. Compounds within a cluster may be assumed to  have 
similar physicochemical and biological properties.
D ec is io n  T rees  Compounds can be recursively partitioned into homogeneous subsets.
Predictive tools can be constructed based on the labelling of these subsets.
N e u ra l  N e tw o rk s  Standard QSAR used linear regression, occasionally with interac­
tion terms. Neural networks learn more complex non-linear relationships. However, 
they are prone to overfitting and are labour-intensive.
P h a rm a c e u tic a l  D a ta  A n a ly sis  Two problems are presented: one from the very early 
stages of drug discovery, the other from the later stages.
P re d ic t in g  th e  In h ib it io n  o f  D ih y d ro fo la te  R e d u c ta se  A small scale ordinal re­
gression problem, typical of QSAR problems encountered in the later stages of drug 
discovery, is converted into a classification problem. A manually tuned neural net­
work exhibits the best predictive performance, but requires labour- and time-intensive 
model tuning.
A n a ly s is  o f  H T S  D a ta  D ata from the early stages of drug discovery are used to  rank 
unscreened compounds to learn a predictive tool for selecting unscreened compounds 
for HTS screening. Performance is reported as the global enhancement of active 
compounds selected over random selection. The standard linear QSAR approaches 
of logistic and linear regression are shown to outperform an automatically tuned 
neural network. The classification approach outperforms the regression approach. 
A 2-d representation tends to give the best results. No one combination o f repre­
sentation and technique is best overall.
S u p p o r t  V e c to r C lass ifica tio n  In which the support vector machine for classification is intro­
duced, together with some estimators and measures of performance, and applied to  a variety 
of representative pharmaceutical problems.
T h e  S u p p o r t  V e c to r M ach in e  The SVM is a  powerful recent addition to the machine 
learning toolbox. It has shown good performance on a  range of problems.
B in a ry  C lassifica tio n  Supervised learning is doomed to  failure without capacity con­
trol. Capacity control can be achieved by maximizing the separation of the classes 
(the margin), this is equivalent to limiting the ‘size’ of the hypothesis space.
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M a rg in  M a x im iz a tio n  as a  Q u a d ra tic  P ro g ra m  The SVM solution is found by 
solving a QP with linear constraints. Hence, there is a global optimum, and pa­
rameters affecting training time do not affect the quality of the solution. 
Im p le m e n ta tio n  The QP is solved by a decomposition routine. Empirically, training 
time is quadratic in the number of training points (and linear in the number of 
dimensions).
V a riab le  M isc la ss ifica tio n  C o s ts  A simple adjustm ent allows the analyst to specify 
misclassification costs. This is im portant in many domains, including drug discov­
ery.
B o u n d s  o n  th e  E x p e c te d  E r ro r  As the SVM has a strong theoretical underpinning 
it is possible to construct estimators of its performance without using costly val­
idation data. A risk functional is introduced that is a more useful indicator o f 
performance when there are few positive examples. The ela  ^ estimator is shown 
empirically to be a useful indicator o f performance, although care must be taken in 
certain situations.
P e rfo rm a n c e  M e a su re s  The number of misclassifications made by a classifier is not nec­
essarily a useful measure of its performance.
R ece iv e r O p e ra t in g  C h a ra c te r is t ic  C u rv es  W hen the costs of misclassification are 
variable, it is useful to plot an ROC curve to show the class-specific misclassification 
rates and to  set the optimal operating point.
R e la tiv e  A d v a n ta g e  The relative advantage is the proportion of positives found by 
the classifier, compared to random selection. This is a useful measure when the aim 
is to identify the small number of active compounds in a set.
A p p lic a tio n s  The SVM is applied to  three problems typical of those encountered during 
drug discovery. Some advantages and disadvantages are highlighted.
P re d ic t in g  th e  In h ib i t io n  o f  D ih y d ro fo la te  R e d u c ta se  The SV M  is shown to have 
performance as good as the best neural network. The main advantage is the reduc­
tion in manual effort and computational time during parameter selection. 
P re d ic t in g  A c tiv ity  o f  C o m p e titiv e  A n ta g o n is ts  The SV M  does not outperform 
a decision tree. No improvement is obtained by using domain knowledge to select 
the training set, or by reweighting the misclassification costs.
A n aly sis  o f  H T S  D a ta  A state o f the art SV M  does not outperform logistic regression 
in preferentially ranking compounds for screeening.
H e u ris tic s  fo r S u p p o r t  V e c to r C lassifica tio n  In which the results of the previous chapter 
motivate the development of heuristics for: term inating training early, tuning a Gaussian 
kernel, and removing noisy training points.
S to p p in g  C r i te r ia  The term ination criteria for an SVM are usually defined in terms of the 
optimization problem. In practical data  mining situations it is often desired to  have 
stopping criteria based on time and estimated accuracy.
P e rs is te n c e  The estimator is shown empirically to behave qualitatively as the test 
error during training. This motivates a heuristic (HERMES) for early stopping of 
SVM training.
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R e s u lts  a n d  D iscu ssio n  On some benchmark data sets, the performance o f HERM ES  
is shown to be the same as the standard SVM. The number o f iterations is reduced 
substantially.
A u to m a te d  M o d e l O rd e r  S e lec tio n  The SVM with Gaussian kernel is very sensitive to 
the width cr of the kernel. A heuristic for setting cr, or tuning it, would save time and 
effort.
In c re m e n ta l  T u n in g  A line search on cr, or gradient descent in param eter space, leads 
to a good value of cr, but roughly doubles the training time.
H e u r is tic  A p p ro a ch es  Heuristics from radial basis function networks suggest setting 
a  to  be on the scale of the separation of basis function centres.
A p p ro x im a tin g  th e  S u p p o r t  V e c to r S e t The basis function centres are the sup­
port vectors, which are not known in advance. A number o f heuristics (LA IK A ) for  
estimating the eventual support vector set and tuning a according to their separation 
are shown to find the optimal a  under the circumstances considered.
R e d u c in g  T ra in in g  T im e  The heuristics are modified to  reduce training time. 
S to p p in g  C r ite r io n  Since LAIKA is not guaranteed to converge an alternative stop­
ping criterion is required. HERM ES is shown to be compatible with LAIK A. 
R e s u lts  a n d  D iscu ssio n  On data sets not used in its development, LAIK A is shown 
to have improved performance compared to the initial heuristic on which it is based. 
The solutions are sparser. The training time is increased.
In d u c in g  S p a rs ity  The sparseness of the SVM solution is often stated  as one of its advan­
tages. On noisy or complex d ata  sets however, this sparsity can be lost.
D a ta  C lean in g  A heuristic (STA R ) is introduced for automatically removing noisy 
points during training. Noisy points become support vectors and, counter-intuitively, 
contribute to the decision function.
R e s u lts  a n d  D iscu ssio n  On a number of data sets, ST A R  is shown to produce sparser 
solutions than the standard SV M  with little or no loss in performance. The training 
time is increased, the classification time is reduced.
A p p lic a tio n  to  pKi D a ta  In which the heuristics introduced in the previous chapter are applied 
to  the pKi da ta  sets discussed above. D ata mining strategies and alternative compound 
representations are also assessed.
S om e D a ta  M in in g  C o n s id e ra tio n s  Before considering modifications to the SVM, some 
general techniques from d ata  mining are used to  attem pt to improve the performance.
T ra in in g  D a ta  S e lec tio n  Selecting the training data by clustering offers some advan­
tages and disadvantages.
M isc lass ifica tio n  C o s ts  Altering the misclassification costs to maximize the relative 
advantage over randomly sampling is unsuccessful.
M eta -A n a ly s is  The performance with respect to two useful measures can be maxi­
mized indirectly by minimizing loss functionals. The a£  estimator is not a reliable 
indicator of performance.
E v a lu a tio n  o f H e u ris tic s  The heuristics overcome some of the deficiencies of the SVM, 
but sometimes at a cost elsewhere.
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S T A R  ST A R  reduces the solution complexity without loss in performance.
L A IK A  LA IK A  offers little gain on these data.
A lte rn a t iv e  C o m p o u n d  R e p re s e n ta tio n s  The SVM is trained with three other com­
pound representations.
P re d ic t in g  fro m  S tru c tu ra l  K ey s Structural keys lead to less complex and more ac­
curate solutions at the expense o f longer training time.
P re d ic t in g  fro m  R e d u c e d  G ra p h s  Reduced graphs offer similar advantages to the 
structural keys, without the increase in training time.
P re d ic t in g  fro m  B io a c tiv ity  A novel representation is described and shown to pro­
vide simple solutions with higher accuracy that are quicker to find.
Finally, a discussion of the main points, critical analysis of the key contributions and results, and 
suggestions for future work are presented.
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Chapter 2
Drug Discovery
Throughout history, certain plants, as well as virtually every 
anatomical component o f animals and humans, have been ascribed 
some curative property: earthworms rolled in honey for the treat­
m ent o f gastritis; owl brain for headache; sheep brain for insomnia; 
deer heart for heart disease; fox lung for tuberculosis; goat Uver 
for jaundice; powdered human skull or the fresh blood o f a dying 
Christian gladiator for epilepsy; rabbit testicles for bladder disease 
and, o f course, for impotence; and cow dung for eye infections, to 
name but a few.
Manfred A. Hollinger, Introduction to P harmacology
A drug is a chemical substance th a t th a t can alter or influence the responsiveness of a biological 
system (Hollinger, 1997). A drug either mimics, facilitates, or antagonizes a normally occurring 
phenomenon. According to the US Food and Drug Administration (FDA) a drug is
a chemical which is utilized for the diagnosis, prevention, cure or amelioration of an 
unwanted health condition.
There axe various ways of classifying drugs: physical, pharmacological, chemical, legal, and psy­
chological depending on one’s point of view. A useful categorization from a therapeutic point of 
view is provided by Hollinger (1997).
D ru g s  u se d  to  c o m b a t in fec tio n  These can actually cure an illness, e.g. penicillin which in­
hibits bacterial cell wall synthesis but has no effect on mammalian cell membrane synthesis.
D ru g s  u se d  to  re p la c e  in ad eq u ac ies  o f  n a tu ra l ly  o c c u rr in g  s u b s ta n c e s  These include in­
sulin for the treatm ent of diabetes mellitus.
D ru g s  th a t  ch an g e  re g u la tio n  This is the largest class, concerned with treating symptoms, e.g. 
sedatives and birth  control pills.
D ru g s  to  a l te r  m o o d  o r  b e h a v io u r  This class includes both licit drugs such as alcohol, caf­
feine and tranquilizers, and illicit ones such as cocaine and tetrahydrocannabinol (the active 
ingredient in marijuana).
The effect of a drug is generally caused by its interaction with a target. Although not all known 
drugs interact with a target, e.g. antacids such as bicarbonate of soda, the vast majority do. The
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site of interaction may be part of a cellular constituent such as DNA, a mitochondrial enzyme, or 
the cell membranes.
In the context of receptor binding, the binding compound is term ed a ligand. A compound 
binding to a receptor may be an agonist or an antagonist. An agonist is a ligand that binds to 
a receptor and promotes a physiological effect. An antagonist binds to a receptor but does not 
directly promote a physiological effect. Thus it may impede the action of an agonist. Note th a t the 
term s agonist and antagonist axe context dependent: an agonist may be behaving antagonistically 
if it is reducing the binding of another agonist. The site of interaction of a  drug need not be the site 
of binding. The drug may interact elsewhere and cause a conformational change in the receptor, 
impeding its function.
The effect of a compound on a target may be quantified by the strength of binding relative 
to a known ligand in a competitive binding assay. Alternatively, if the target is, for example, an 
enzyme, then the effect may be measured by the inhibition of its activity in a functional assay. 
The term  ‘percentage inhibition’ is used in both cases. Ligands th a t are similar to each other in 
some sense axe termed congeners and may be expected to  have similar affinity for a given receptor 
(although ‘similar’ can typically be two or three units on a logarithmic scale).
The search for and subsequent optimization of ligands has grown from a handful per chemist 
per year to autom ated synthesis and screening of millions of compounds per year. Increasingly, 
statistical and artificial intelligence methods are being used to  quantify and qualify the action of 
compounds. The need for autom ated modelling and decision making is now particularly acute in 
the early stages of drug discovery as there axe too many compounds being tested for a chemist to 
interpret the raw data being generated.
The remainder of this chapter is organized as follows. Some historical perspectives on drug 
design axe presented in Section 2.1, followed by a more detailed description of contemporary ap­
proaches to the early stages of drug design. In Section 2.2, vaxious representations of compounds 
for building predictive models are presented and discussed. In Section 2 .3 ,1 review some statistical 
and artificial intelligence techniques currently used to analyse pharmaceutical data. In Section 2.4, 
I present some results from applying existing statistical and machine learning techniques to  the 
analysis of pharmaceutical data. In Section 2 .5 ,1 summarize the key points and conclusions of the 
chapter.
2.1 The Drug Discovery Process
The approach to  drug discovery through the mid-nineteenth century to the late twentieth century 
took as its starting point naturally occurring compounds. The initial step was the discovery of some 
pharmacological effect produced by a source material, occurring either in the human body or in 
other animals and plants. Once the active ingredient had been isolated and identified, congeners of 
it were synthesized and assayed. A structure-activity relationship (SAR) could then be determined. 
A SAR relates the biological activity of a group of related compounds to their structural features. 
This enables the chemist to characterize congeners of the active ingredient.
This traditional approach to  drug discovery often began with the identification of a lead com­
pound, followed by trial and error synthesis of congeners. The lead compound may be inspired 
by nature, knowledge of biochemical mechanisms in the body, or by the assay itself (Hollinger, 
1997). The bioactive compound was first identified and this suggested a specific receptor or bind­
ing site. The pharmacological properties of the compound would then be optimized in a laborious 
process by synthesis and testing of variants. The traditional path  of rational drug discovery can
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be summarized as in Table 2.1 (Howard et al., 2001).
Modern drug discovery is taking advantage of autom ated, robotic in vitro (outside of the 
organism) assays to broaden the search. An advantage of in vitro assays is th a t they can be 
adapted to  allow for screening of compounds on a  mass scale, known as high throughput screening 
(HTS). HTS facilitates the screening of millions of compounds per year against many targets.
Increased screening capacity and rational drug design have led to the situation where the drug 
target is first identified and then a search for suitable compounds is undertaken. For example, 
the human genome project is now generating many potential therapeutic targets. This ‘reverse 
pharmacology’ is summarized in Table 2.2,
These and other approaches to drug discovery are not m utually exclusive. Any of them may be 
employed to some extent in the various stages of drug discovery and they may contribute to  each 
other.
Predictive techniques can help to streamline the early stages of the drug discovery process 
by selecting compounds for screening and by identifying false positives and false negatives in 
HTS. Discriminatory techniques are also useful for filtering out compounds th a t are likely to have 
poor absorption, distribution, metabolism, excretion (ADME) and toxicological properties. Such 
techniques axe, in addition, useful further downstream to  characterize groups of related compounds 
and to identify which physico-chemical features are responsible for various desirable properties.
2.1.1 H igh Throughput Screening
The early stages of the drug discovery process today are concerned with identification of potential 
drugs (leads) and the elucidation of their mechanism of action. The lead discovery process is largely 
as follows (Curran, 2001). A biological target is identified by biologists working on elucidating 
possible disease mechanisms, e.g. an enzyme or receptor associated with a possible therapy. The 
first step is to  identify a natural ligand. For example, the natural ligand for a 5-hydroxytryptophan 
(5-HT) receptor would be 5-HT itself (also known as serotonin). If a  natural ligand is not known 
then a ligand fishing exercise is undertaken to identify one. In this case it is referred to  as a tool 
ligand. It is then possible to set up a prim ary in vitro assay. Typically the compounds screened 
would be chosen to be as diverse as possible, in order to  cover a large amount of chemical space. 
Compounds showing some initial activity are termed hits. Chemists take these initial hits and 
search a  company’s compound archives for similar molecules th a t could have a similar or better 
response. Promising molecular classes are identified and initial SARs are determined. The primary 
assay results may be confirmed for these compounds in subsequent screens. Substructural moieties 
of these molecules axe then mixed and matched by the combinatorial chemists to optimize the lead 
compound’s action.
An advantage of in vitro assays is th a t they axe amenable to  rapid screening of thousands of 
compounds. Advances in technology now enable the screening of millions of compounds a year, a 
process called high throughput screening (HTS). HTS is used to search through compound space
1. Choose a disease state.
2. Identify the active principle (natural ligand).
3. Identify the receptor or biological response.
4. Synthesize analogues to the natural ligand (drug candidates).
Table 2.1: The traditional path  of rational drug discovery.
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1. Choose a receptor (this may be an orphan receptor, i.e. its mechanism is unknown).
2. Identify the endogenous active principle, for orphan receptors this may be achieved by: 
testing ligands of related receptors; analysing gene expression patterns of the receptor 
and putative ligands; using functional assays; or, testing against families of known 
ligands (a HTS ‘ligand fishing’ exercise).
3. Elucidate the biological response mechanism and disease state.
4. Identify drug candidates for optimization.
Table 2.2: A ‘reverse pharmacology’ facilitated by advances in HTS and genomics.
in the hope of finding active compounds. The motivation behind this strategy is the serendipity 
principle — if we look everywhere, hopefully we’ll find something. This serendipity principle is 
now an accepted paradigm in the pharmaceutical industry.
The goal of HTS is to  find lead compounds to pass to  the lead optimization phase. HTS is also 
used to provide an initial SAR for a lead group.
This ability to  screen large numbers of compounds requires large numbers of compounds to 
screen. Pharm aceuticals companies have overcome the once rate-limiting step of compound syn­
thesis by screening the vast supplies of marine and plant resources (Stead, 2000), buying compound 
libraries from specialist suppliers, and by combinatorial chemistry (Hijfte et al., 1999).
HTS can generate thousands of hits. A hit is a molecule showing activity above a given 
threshold in a prim ary screen. The threshold is a pragm atic one, it may be varied according to 
the assay results in order to  ensure th a t a reasonable number of compounds are progressed. The 
hits from a HTS assay are subsequently screened over a range of concentrations to determine the 
7(750 value. The 7(750 is a  higher quality measurement of activity. It is the concentration of test 
compound required to  inhibit the binding of the competing tool ligand by 50%. It is dependent 
on the tool ligand used, and the concentration thereof. Compounds with a low enough 7(750 axe 
then progressed to the next stage. (Increasingly, functional assays are being used to determine an 
£(750, the concentration of compound required to give 50% of its maximal response.)
Compounds which axe isolated in chemical space axe not considered progressible, since it is 
not possible to generate a reliable SAR. A group of related compounds th a t all have robust 
concentration-response activity is termed progressible. Progressible hits are modified to  optimize 
the phaxmacokinetics, ADME, toxicity and other properties. A progressible hit with sufficient 
potential and novelty is term ed a lead. A lead is a sound basis for further optimization.
At this stage, the physical and pharmacodynamic chaxacteristics of the drug axe improved. 
Typically, solubility is increased, as is bioavailability and duration of action. The compound’s 
ability to  move through the different body fluids to  the site of action is also improved, as well as 
increasing its potency and selectivity.
Idealized, the modern drug discovery process is designed to s ta rt from the set of ‘drug-like’ 
compounds and successively refine the search until a lead compound is found which can be opti­
mized. There are numerous practical difficulties. The search space is vast: the lowest estimate 
of the number of drug-like compounds is ten trillion (Valler and Green, 2000). High-throughput 
synthesis and screening cannot possibly cope with this volume of compounds. When there is some 
prior knowledge virtual screening can be used to select compounds for screening. Virtual screening, 
also known as in silico screening, refers to using a computer program to seaxch and evaluate very 
large compound libraries (Terstappen and Reggiani, 2001; W alters et al., 1998).
Even though HTS cannot possibly be used to screen everything, the volume of compounds that
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are being produced by HTS is causing bottlenecks downstream. Too many potential drugs are 
being identified by HTS and must be filtered out a t later stages owing to poor ADME and other 
properties. The large volume of data  now being generated is also causing problems. The new field 
of chemoinformatics has arisen to  handle the logistics of screening management and the process of 
extracting information and knowledge from the data  (Hann and Green, 1999).
2.1.2 Screening Set Selection
In general, the development of a new drug requires the synthesis and evaluation of thousands of 
compounds (Eglen et al., 2000). A recurring problem in HTS is deciding which compounds to 
screen. This is especially true when considering new targets. Companies now have vast libraries of 
compounds. However, it is not economically feasible to screen all of these compounds against all 
targets. Compounds should be chosen for screening so as to maximize the probability of generating 
hits. To do this requires analysis of structure-activity relationships, either for the target of interest, 
if data  are available, or for related targets if no screening data  are available for the novel target. 
One simple process th a t is used to  improve HTS is to screen a diverse set of compounds, analyse 
the data, and produce a decision function th a t indicates in what area of chemical space to look for 
potential hits. T hat is, a  predictor of activity is learned for the assay and used to predict in silico 
the activity of the library compounds. Compounds predicted to  have some activity can then be 
selected for synthesis. Building such a predictor can be treated as a classification problem: identify 
compounds th a t are more likely to be screening hits; or, as a regression problem: estimate the real­
valued activity of a compound. E ither approach requires th a t there axe descriptive attributes of 
the compounds available th a t can be used in making a prediction. The goal of such an analysis 
would be to  enrich the set of compounds chosen for screening, such th a t the hit rate is higher than 
would be obtained by random selection (Gillet et al., 1998; Dixon and Villar, 1998).
2.1.3 Library D esign
As a broad definition, a chemical library is any collection of chemicals. For instance, the entire 
compound collection of a phaxmaceutical company, a catalogue of compounds from a retailer, 
or a collection of hypothetical compounds existing in compound space. The last of these three 
is typically referred to as a virtual library since the compounds have not yet been synthesized. 
Library design is required in many stages of lead discovery. The process has been facilitated by the 
introduction of combinatorial chemistry (Hijfte et al., 1999), which allows for the rapid synthesis 
of thousands of closely related compounds, and by chemoinformatics (Hann and Green, 1999), 
which has axisen to  handle the large number of compounds (whether synthesized or virtual) that 
axe commonly dealt with in drug discovery.
2 .1.3.1 D iv erse  L ib ra r ie s
When initially investigating a new target there may be little prior knowledge of the mechanism of 
action. For example, consider a protein suggested as a target by analysis of the human genome. 
It may be necessary to identify compounds th a t bind strongly to the protein before its role in the 
body can be elucidated. In such cases, the ideal approach would be to test everything (Valler and 
Green, 2000). This is not practical, even if ‘everything’ is considered only to refer to a company’s 
entire compound collection. (The entire compound collection may be screened against a particular 
target, but this approach is too expensive to apply it to all possible targets.) The accepted 
approach is to screen as diverse a set of compounds as possible (Dixon and Villar, 1998; McGregor
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and Pallai, 1997). W hat exactly ‘diverse’ means is debatable, some commonly used (dis)similarity 
measures are given in Section 2.3.2. Once a measure of diversity has been chosen, it is necessary 
to maximize this criterion. This can be difficult. Clustering techniques (see Section 2.3.3) can be 
used to segregate the compound set into homogenous subsets th a t are dissimilar to each each other. 
Talcing one member of each cluster then generates a reasonably diverse subset for screening. Dixon 
and Villar (1998) show th a t more diverse subsets can be achieved by using a stochastic search 
over compound space th a t attem pts to maximize directly some measure of diversity. A diverse 
subset is not necessarily representative, it may consist of many outliers. An approach to  selecting 
a representative screening set, based on clustering, is given by Menard et al. (1998).
2 .1 .3 .2  L ead  L ib ra r ie s
If some knowledge is available about the target then it is desirable to incorporate this into the 
design of a screening library (Valler and Green, 2000). Such a library is described as focussed on 
the target of interest. Knowledge of the target may have been extracted from the results of previous 
(diverse or random) screening of compounds against th a t target. If there are known ligands for 
the target then these can be used to  construct a three-dimensional molecular model of the part of 
the ligand active in binding (known as the pharmacophore). A search for this pharmacophore in 
compound databases may then be undertaken. If structural information about the target is known 
then docking algorithms can be used to select compounds from available databases and compound 
libraries (Walters et al., 1998).
An alternative approach is to take the lead compounds and generate hundreds or thousands of 
congeners of these. This approach is based on the principle th a t similar compounds have similar 
activity profiles. Again, the meaning of the term  ‘similar’ may vary. Dixon and Villar (1998) give 
an example of screening compounds to measure binding affinity for human serum albumin. They 
present a set of nine compounds th a t are highly structurally diverse, yet have high binding affinity 
(7(750 in the range 16nM-81nM; a low 7(750 indicates high binding affinity). For one of these 
compounds they select five congeners, which all have low binding affinity (7(750 >  2.5m M  about 
four to  five orders of magnitude less).
2 .1 .3 .3  C o m b in a to r ia l L ib ra r ie s
An ongoing process in pharmaceuticals companies is maintaining a diverse and representative 
compound bank. As noted above, the concepts of ‘diversity’ and ‘representativeness’ are rather 
fluid. If a region of chemical space is considered to  be under-represented in a company’s compound 
bank, then it may be possible to  ‘fill in the gaps’. If there are a handful of known compounds in the 
region of interest then combinatorial chemistry can be used to  generate thousands of structurally 
similar compounds. There is no guarantee th a t these new compounds will be close to  the original 
ones in property space however. It is possible to use predictive techniques to estimate the location 
of virtual compounds in property space (Walters et al., 1998). Compounds predicted to  be in the 
region of interest can then be synthesized. A similar approach could be used to  select for synthesis 
compounds with specific predicted bioactivity profiles.
2 .1 .3 .4  O p tim iz in g  A D M E  p ro p e r t ie s
A lead compound may fail to  become a marketable drug due to problems with absorption, dis­
tribution, metabolism and excretion (ADME) and toxicity. The absorbtion and distribution of a 
drug refer to its uptake and subsequent distribution throughout the body and to  the site of action.
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The metabolism and subsequent excretion of the drug refer to how the body processes the drug 
and eliminates it from the body (note th a t most drugs are xenobiotic and are hence removed from 
the body).
Filters can be developed to  screen compounds for desirable ADME and toxicity properties. 
One early example is the ‘rule of five’ proposed by Lipinski et al. (1997). This states th a t poor 
absorption or permeation are more likely when:
•  there are more than  5 H-bond donors;
•  the molecular weight is over 500;
•  log P  >  5, where P  is the partition coefficient of the compound in an octanol-water mixture; 
or,
•  there are more than 10 H-bond acceptors.
Certain compound classes are known to be exceptions, e.g. those th a t are actively absorbed into 
the cell. A filter for new compounds consisted of raising a ‘poor absorption or permeability is 
possible’ alert for compounds with two of the above param eters out of range. More sophisiticated 
techniques can be used to learn similar filters, alhough ease of interpretability is likely to be lost. 
Such filters can then be used to  analyse compound libraries for purchase or synthesis in order to 
enhance the proportion of ‘drug-like’ compounds in a company’s collection. It is im portant to 
note th a t there will be exceptions to any such filter. When the number of alerts is high, it is not 
possible for a human chemist to examine all of the suspect compounds. A filter should ideally 
also provide a measure of confidence in the alert, and be robust to  changes in the costs of false 
negatives (missed opportunities) and false positives (unnecessary junk).
2.2 Representing Compounds
The way in which a compound is represented ultimately limits the success of all subsequent pro­
cedures (Kauvar et al., 1995). Dixon and Villar (1998) state the following.
It is very difficult to  conceive of structural descriptors th a t can reliably predict activity 
for a given target across the range of compounds present in a typical corporate library.
If there were such descriptors, then HTS would not be nearly so widespread as it is.
In the remainder of this section, I describe the problem of selecting descriptors for the purpose 
of prediction. This is followed by a brief review of some descriptors th a t have been shown to be 
useful for predicting biological activity.
2.2.1 Identifying D escriptive Features
In real life applications, databases may be poorly maintained and contain irrelevant information. 
Not all of this can be removed by data  cleaning and pre-processing. This leads to noise in the 
descriptors and in the target value. In pharmaceutical d ata  analysis, the noise may vary over 
chemical space. For example, many descriptors are calculated by in-house or commercial software. 
The formulae are constructed from finite compound libraries. Such formulae may not be accurate 
when used to calculate descriptors of compound classes th a t were under-represented in the library 
used for constructing the formulae (see Section 2.3.1 below). There may be some compounds for 
which the algorithms used to compute descriptors do not provide a value. Pre-processing techniques
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are thus used to clean the data, fill in missing values (if possible) and remove irrelevant features 
before learning a decision function from the data. Features may also be correlated or redundant, 
thus unnecessarily increasing the dimensionality of the input space and exacerbating the ‘curse of 
dimensionality’ (Bellman, 1961). In principle, more relevant features should increase generalization 
accuracy, in practice increasing the number of features may lead to a deterioration since a classifier 
may then model the idiosyncracies in the training data. The purpose of feature selection is to 
choose the optimal feature set for the learning task. The problem of feature selection may also 
be of direct interest itself. For example, identification of predictive physico-chemical descriptors 
is necessary for building predictive models and constructing SARs. When choosing a compound 
representation there are vast numbers of potential features. Selection of a handful of the most 
predictive ones can aid understanding of the prediction and modelling processes.
In the absence of domain knowledge, identifying which set of descriptors is optimal for a given 
task is known to be an NP-Complete problem. Ripley (1996) states ‘this is an impossible problem’ 
and is ‘being supplanted by model selection m ethods’. T hat is, all of the features are used in 
building a model, and by controlling the expressivity of the algorithm it is hoped th a t irrelevant 
features will not contribute significantly to the model. This approach is implicit in the support 
vector machine (see Chapter 3).
2.2.2 Structural K eys
Structural keys were developed for high-speed searching of chemical databases (James et al., 2000). 
The purpose of searching chemical databases is to  identify compounds with certain substructures. 
(Note th a t the term  screening is often used in this context. The term  searching will be used 
here to avoid confusion w ith in vitro, in vivo and in silico screening to  measure or predict various 
biological or physico-chemical properties.) A structural key is a bitm ap in which each bit represents 
the presence or absence of a specific structural feature. Examples of such structural features 
given by Jam es et al. (2000) include: the presence of an element, or its frequency; im portant or 
unusual electronic configurations, such as ‘triple-bonded nitrogen’; rings and ring systems; common 
functional groups, such as amines; and, im portant functional groups. A single bit may be used to 
indicate the presence of any of a group of rare features, to  avoid excessive numbers of bits which 
are usually zero. Structural keys may be generic, such as MACCS keys (MACCS-II, 1994), or 
generated for a particular set of compounds. For example, a database of organometallics may have 
specific bits for metal-containing functional groups (James et al., 2000). Structural keys vary in 
length from a few tens to  several thousands of bits. There is an obvious trade-off between specificity 
and length.
When learning a decision function to predict biological activity from structural keys it is im­
portant to  ensure th a t the structural features encoded are biologically relevant. S tructural keys 
are usually high-dimensional, sparse, binary representations. Care should be taken to ensure that 
an algorithm does not overfit the data  or make invalid assumptions about the underlying distri­
butions of the individual bits. Some algorithms actually seem to perform better in this kind of 
sparse high-dimensional space. Joachims (2001) presents theoretical reasons to support the case 
for using a  support vector machine on such data.
Brown and M artin (1996) reported the relative ability of several structural descriptors and 
clustering methods to distinguish active from inactive compounds. They found th a t 2D descrip­
tors gave a better separation than  3D descriptors and th a t the best overall was a subset of 153 
descriptors from the MACCS structural key (MACCS-II, 1994). The publicly available MACCS 
key records the occurrence of 166 small generic and specific fragments including atom counts, ring
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types and counts, augmented atoms and short linear sequences. These were chosen for substruc­
ture searching, not to reflect biological or physical properties. In subsequent work, Brown and 
M artin (1997) show th a t this ability to distinguish active from inactive compounds appears to be 
due to the encoding of information about the properties of a ligand relevant to receptor binding. 
T hat is, MACCS keys could be used to predict the values of properties known to be relevant to 
binding. The advantages of using two-dimensional structural descriptors to  predict ligand bind­
ing, compared to using calculated physico-chemical properties, are two-fold. Firstly, not all of the 
properties may be calculable for every compound and, secondly, structural descriptors are faster 
to calculate (Brown and M artin, 1997).
2.2.3 Fingerprints
Structural keys suffer from a lack of generality in describing compounds. A structural key developed 
to represent one group of compounds, e.g. congeners of a progressible hit, may be almost useless 
for another group of compounds (James et al., 2000). Fingerprints address this deficiency by 
eliminating the idea of pre-defined patterns. The following description is adapted from James 
et al. (2000). A substructure’s fingerprint characterizes that substructure, but the meaning of an 
individual bit is not well-defined (hence the name, in analogy with human fingerprints). Every 
substructure in a molecule is included in the fingerprint. Since the number of substructures is 
huge, it is not possible to have one bit for each substructure. Instead, each substructure serves 
as a seed to a pseudo-random number generator to produce a set of four or five bits. These are 
logically OR’d with the fingerprint of the molecule. Thus, every bit th a t is set in the substructure’s 
fingerprint will be set in the molecule’s fingerprint. A fingerprint doesn’t indicate with certainty 
th a t a particular substructure is present, but it contains far more substructures than  a structural 
key. Thus it is possible to  do a more sophisticated search for particular desirable, or undesirable, 
substructures in a database of molecules.
The advantages of fingerprints over structural keys include: one fingerprinting system serves all 
databases and all queries; more effective use is made of the bitmap, so fingerprints are relatively 
dense (20%-40% of bits are on), hence a fingerprint can be much smaller than a structural key 
with the same discriminatory power; and, the more complex a molecule gets, the more accurately 
its fingerprint characterizes it. Fingerprints constructed for a particular compound collection are 
optimal, with about 50% of bits on. Although fingerprints were developed for substructure search­
ing, they have been used to predict bioactivity (Brown and M artin, 1996) and physicochemical 
properties (Brown and Maxtin, 1997).
2.2.4 Affinity Fingerprinting
The descriptors described so far relate to physico-chemical or structural properties of a ligand. 
These contain chemical information relevant to the ligand-receptor binding (Brown and M artin,
1997) and thus may be used to  predict binding affinity. However, it is often the case th a t compounds 
which are structurally similar, according to some description and similarity measure, may have 
quite different affinities for a given target (Dixon and Villar, 1998). To overcome this difficulty it 
is possible to encode directly information relevant to  biological activity. Dixon and Villar (1998) 
give the following motivation, which should be kept in mind whenever undertaking a data mining 
exercise (see also Bishop (1995); Duda and Hart (1973); Fukunaga (1972); Devijer and Kittler 
(1982)).
W ithout proper selection of descriptors, simply increasing the number of dimensions
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may tend to obscure information provided by the biologically relevant subset. . . .  The 
goal is to  minimize the number of dimensions and maximize the amount of bioactively 
relevant information provided.
They argue th a t the information relevant to predicting binding is binding affinity itself. To this end 
they assemble a panel of about 20 functionally dissimilar proteins, so th a t the respective binding 
affinities have low correlation. An affinity fingerprint for a compound is the corresponding 20 
affinity measurements, as determined by a high-throughput competitive binding assay (Kauvar 
et al., 1995). If there are no activity data  for the target of interest then the affinity fingerprints 
can be used to select a bioactively diverse set of compounds for screening, in order to increase 
the chance of obtaining hits. If activity data  are available then a focussed library can be selected 
for screening, based on correlations between the protein binding affinities and the affinity to the 
target.
2.3 Review  of Current Approaches
The traditional approach to  modelling properties of potential drugs has been quantitative structure- 
activity relationship (QSAR) analysis (Section 2.3.1). This aimed to  generate simple equations in 
a few variables, in order to predict the values of physicochemical properties and biological activity. 
The variables were typically one-dimensional descriptors such as: number of hydrogen bond donors 
and acceptors, solubility, permeability, molecular weight, etc. There has also been increasing use of 
two- and three-dimensional descriptors, e.g. th a t describe the molecular surface, or the topology of a 
compound. M ethods based on similarity measures (Section 2.3.2) and clustering (Section 2.3.3) aim 
to make predictions about a compound based on other compounds which are in some sense nearby 
in compound space. Techniques from artificial intelligence, such as decision trees (Section 2.3.4) 
and neural networks (Section 2.3.5), are similar to QSAR in th a t the aim is to learn a relationship 
between the target variable (e.g. biological activity) and the measured (or calculated) variables. 
They differ in th a t the relationship learned is often highly non-linear, this flexibility can often lead 
to improved predictive performance, but at the loss of interpretability.
2.3.1 Q SA R  —  R ational D esign
There is a widely-held assumption in pharmacology th a t the structural and chemical properties of 
a molecule are im portant in determining its biological activity (Bravi et al., 2000). Quantitative 
structure-activity relationships (QSAR) represent an attem pt to  predict activity from these proper­
ties. The properties of interest include binding affinities for particular receptors, ADME properties 
and general concepts of ‘drug-likeness’. The descriptors used to  characterize the compound may 
include one-dimensional descriptors such as molecular weight and hydrophobicity (lack of affinity 
for water), two-dimensional descriptors such as sub-structural fragments, and three-dimensional 
descriptors such as those th a t describe the molecular surface (considered to  be key to binding of 
ligand to receptor). QSAR models are generally regression models in a few variables, e.g. the 
relationship between growth inhibition of E. coli by sulfonamides and sigma effect can be written 
as (Seydel, 1966):
log ( ^ )  =  1.05<r -  1.28, (2.1)
where C  is the minimum concentration of the sulfonamide th a t inhibited the growth of E. coli and 
cr measures the relative strength of electron-withdrawing or -donating properties of a substituent.
40
An early example of a structure-activity relationship (SAR) was the observation by Cros, in 
1863, th a t toxicity of alcohols to mammals increased as the water solubility of the alcohols de­
creased (Borman, 1990). In the 1890s, Meyer and Overton independently observed th a t the tox­
icity of organic compounds depended on their solubility in fats and oils ( lipophilicity) (Borman, 
1990; Lipnick, 1986). Louis Hammett correlated electronic properties of organic acids and weak 
bases with their equilibrium constants and reactivity (Hammett, 1970). The breakthrough in 
QSAR analysis came when Robert Muir, a  botanist, attem pted to correlate H am m ett’s electronic 
descriptors of a class of plant growth regulators w ith their biological activity. This did not lead 
to meaningful results until Hansch recognized the importance of lipophilicity in biological activity 
(Hansch, 1969).
Lipophilicity affects the bioavailability of a drug since a compound must be lipid soluble to pass 
through the gastro-intestinal (GI) lining. The GI trac t is considered to  be roughly approximated 
by an octanol-water partition. Hence, lipophilicity of a compound is represented by the logarithm 
of the partition coefficient, P , of the compound in an octanol-water mixture. Early analyses used 
the measured value of log P  when deriving QSARs. W ith the increasing number of compounds 
available there have been numerous attem pts to  calculate log P  from either sub-structural fragments 
or molecular properties (Morris and Bruneau, 2000). One of the most commonly used methods 
is CLOGP, based on proprietary Daylight fingerprints which encode sub-structural fragments of 
compounds (Leo and Weininger, 2000).
There are two factors here th a t may limit the predictive ability of a QSAR using CLOGP as 
a descriptor. Firstly, there is no reason to expect the partition coefficient in octanol-water to out­
perform any other solvent-water mixture in relating to processes in vivo (in the organism) (Morris 
and Bruneau, 2000). Abraham (2001) has dem onstrated th a t for certain classes of compounds the 
octanol-water partition does not mimic their uptake in the GI tract, possibly owing to  active up­
take and other effects. Secondly, the predicted value of log P  can only be expected to be accurate 
on compounds th a t were represented in the model building. Bevan et al. (2001) have patented a 
method for measuring lo g P  robotically for thousands of compounds. For the 18000 compounds 
evaluated the measured value and the computed value had a low correlation (Spearman’s p ~  0.6). 
Gillet et al. (1998) give an example of data  sets where accurate values of CLOGP could not be 
obtained.
Lipophilicity is just one descriptor commonly used in QSAR analyses. Many other calculated 
descriptors are also used, and these may suffer from similar problems. It is often stated th a t the 
main challenge for QSAR analysts today is developing new features and identifying useful ones 
(Manallack and Livingstone, 1999). The number of available descriptors has been increasing in an 
attem pt to  meet this challenge (Morris and Bruneau, 2000). The increasing number of features 
does not mean th a t new, useful (from a data  m iner’s point of view) information has been encoded. 
This is particularly relevant when considering new techniques for the analysis of drug discovery 
data, as the process of mining data  for useful information relies on their being useful information 
in the data  to begin with.
The original aim of QSAR analysis was to model the structure-activity relationship on a small 
group of related compounds, e.g. congeners of a lead compound. The focus has shifted to the 
prediction of biological activity of new compounds. The vast m ajority of published work on QSAR 
analysis has used very small d ata  sets of focussed compounds. These are typical of the groups of 
compounds of interest downstream in the drug discovery process, e.g. in lead optimization. When 
using such small data  sets there are problems with model validation. Many authors do not provide 
unbiased estimates of predictive ability since the same data  are used for feature selection, model
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selection and building, and reporting error rates. Some recent reviews have stressed the need for 
proper model validation (Kovesdi et al., 1999; Eriksson and Johansson, 1996). Another aspect 
of using small data  sets is th a t it is possible to measure or calculate more predictive descriptors. 
For example, aligned three-dimensional descriptors provide a lot of useful information but their 
application is quite time-consuming and they axe usually restricted to datasets of less than 100 
compounds (Morris and Bruneau, 2000).
In the framework of traditional drug design, QSAR analysis came to  be an accepted paradigm. 
An active compound is identified first, and then its mediation of the receptor is investigated, 
together w ith similar compounds. The increasing demand for drugs has lead to the mass screening 
of compounds. QSAR analysis is still useful downstream, but must be adapted to  cope with the 
different goals and the nature of the data  now being generated in the eaxly stages of the drug 
discovery process.
2.3.2 Sim ilarity M easures
The similar property principle states th a t structurally similar molecules will exhibit similar physic­
ochemical and biological properties (Brown and M artin, 1996). This concept can be employed to 
select compounds for synthesis, and subsequent screening. If no screening d a ta  are available then 
similarity measures can be used to  identify a diverse subset of compounds for an initial screening 
run (see Section 2.1.2). The similar property principle can also be used for prediction of properties 
in the following manner. The pairwise similarity of a compound is calculated with every other 
compound in a dataset. The predicted value of a property for a new compound is then taken as 
the mean of th a t property for all compounds th a t exhibit more than  a given threshold similarity to 
the new compound (Brown and M artin, 1997). This approach is akin to  A;-nearest neighbour pre­
diction (Mitchell, 1997). To apply the similar property principle it is necessary to have a definition 
of similarity, or conversely of dissimilarity (e.g. distance).
Compounds are often represented as bitmaps, such as structural keys (Section 2.2.2) and fin­
gerprints (Section 2.2.3), as described above. An obvious distance between two bitmaps A  and B  
is the Hamming distance (Ash, 1990). This is the number of bits set to  one for which two bitmaps 
differ, i.e.:
Hamming(A, B ) =  # (A  XOR B ). (2.2)
where # (•) counts the number of bits th a t axe 1 in a bitmap. It is equivalent to the square of the
Euclidean distance. It is normalized to  remove the effect of fingerprint size to give:
Euclidean (A, B ) = ^ A X°R B) . (2.3)
1^1
(This is not a true Euclidean distance, but this definition is used in the literature (James et al., 
2000).) This distance (2.3), however, can be misleading when the bitmaps are mostly zeros. For 
example (James et al., 2000), consider the following two pairs of 1024 bit fingerprints: A  and
B  have 412 bits set, of which 402 axe common; C  and D  have 5 bits set, none of which are in
common. The distance (2.3) between the first pair is the same as th a t between the second pair, 
10/1024 =  0.0098, yet the first pair are quite similar and the second pair axe not. The distance 
defined by (2.3) is only a relative similarity measure.
An intuitively more reasonable similarity measure is the Tanimoto (or Jacquard) coefficient, 
which is given by:
m # ( ^  AND B )Tammoto(A, B ) =  ----- -----——--------- — . (2.4)
v ' # ( A )  +  # ( £ ) - # ( A  AND B ) y }
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T hat is, the number of set bits in common divided by the to tal number of set bits (James et al., 
2000). In the example above, the Tanimoto similarity of A  and B  is 402/412 =  0.976, and the 
Tanimoto similarity of C  and D  is 0. The Tanimoto measure is very popular in drug design, for 
similarity-based prediction (Brown and M artin, 1997) and clustering (Butina, 1999).
2.3.3 Clustering
Clustering is the process of dividing a set of objects into subsets such th a t members of a subset 
are similar to each other and dissimilar to members of other subsets (Arabie et al., 1996). This 
requires a set of attributes to describe the objects, such th a t the objects can be thought of as 
points in some space, and a measure of similarity or distance in this space. The centroid of a 
cluster is defined to  be th a t point which has the highest average similarity, or lowest distance, to 
the cluster members. For example, when clustering in a Euclidean space the centroid is the mean 
of the cluster members.
Clustering is used for rational screening set design (Menard et al., 1998) and property prediction 
(Brown and M artin, 1997). The property prediction approach is similar to th a t used in similarity- 
based prediction (see Section 2.3.2 above). A test compound is clustered with compounds for 
which the property is known. The clustering is performed with respect to  descriptors th a t are 
known for all compounds, e.g. structural keys. The value of the property of the test compound 
is predicted to  be the mean value over other cluster members (Brown and M artin, 1997). The 
underlying assumption is th a t the similar property principle holds.
Clustering is used in rational screening set design in two ways. If no activity data  are available 
then clustering is used to select a representative subset of compounds for screening (McGregor and 
Pallai, 1997; Menard et al., 1998). The idea is th a t to maximize the number of hits (or, indeed, to 
obtain any hits a t all) on an assay for a target with unknown structure the compound space should 
be sampled diversely. The advantages and disadvantages of this approach axe discussed in Valler 
and Green (2000). If activity data  are available for a  target then clustering can be used to  predict 
activity in a manner analogous to the prediction of properties. A set of unscreened compounds is 
clustered w ith a  set of screened compounds. Those compounds th a t are clustered with compounds 
previously found to be active axe then considered for screening. The clustering should hopefully 
separate the actives from the inactives and cluster the actives together (Brown and M artin, 1996). 
A drawback to this approach is th a t there is little chance of breaking out and finding something 
novel — a New Chemical Entity — th a t is patentable.
One of the most popular clustering methods in drug discovery is due to  Jarvis and Patrick 
(1973). A similarity, or distance, measure is specified. Two parameters, j  and k, control the 
clustering. The j  nearest neighbours of each compound are calculated. Two compounds are then 
clustered together if (and only if) they are in each others j  nearest neighbour list and have k of 
those nearest neighbours in common. Brown and M artin (1996, 1997) show th a t this technique 
performs poorly in comparison to  others, including an agglomerative method (Ward, 1963) and a 
divisive method (Guenoche et al., 1991), in both predicting properties and screening set selection. 
Jarvis-Patrick clustering is very sensitive to the values of j  and k  (Menard et al., 1998) and 
tends to produce a few large clusters and many singletons. Singletons are undesirable since they 
are apparently not representative of anything else. Subsequent developments have been made in 
attem pts to  remedy the problems of Jarvis-Patrick clustering (Menard et al., 1998; Butina, 1999). 
Jarvis-Patrick clustering continues to be popular, despite its deficiencies, as it is very fast.
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2.3.4 D ecision Trees
Decision tree learning, also known as recursive partitioning, can provide an informative model, 
through which predictive rules are induced to  solve classification problems (Breiman et al., 1984). 
The method uses a process called recursive partitioning. In their simplest form, e.g. C4.5 (Quinlan,
1992), each attribu te of the data  is examined in turn  and ranked according to its ability to  parti­
tion the remaining data. The data  are propagated along the branches of the tree until sufficient 
attributes have been chosen to correctly classify them. The trained classifier has a tree-like struc­
ture. Each ‘leaf’ of the tree represents a subset of the data  th a t lies wholly in one class. Decision 
trees have a tendency to  overfit the training data. In the presence of noise, the tree can be pruned 
to  allow for misclassifications in the training data. Pruning is a heuristic process, usually requiring 
the use of a hold-out validation set to determine the optimal tree structure (Breiman et al., 1984). 
There may exist several tree structures capable of achieving a given training accuracy. Decision 
tree learning algorithms are biased to select the simplest of these trees. Decision trees can also 
be constructed where the branching criteria are allowed to  be linear or non-linear combinations of 
attributes, instead of just splitting on a single attribute. These methods, e.g. OC1 (Murthy et al., 
1994), axe more powerful but require extensive model selection. These methods produce shorter 
trees, with more complex branching rules.
Decision trees, and other algorithms th a t compute rule sets, are popular with medicinal chemists 
owing to their interpretability (Hann and Green, 1999). This interpretability can be enhanced by 
a careful choice of features. It is possible to generate decision trees and rule sets from the solu­
tions provided by more powerful techniques such as neural networks and support vector machines 
(Fellenz, 2001).
2.3.5 N eural Networks
Neural networks are a biologically inspired form of distributed computation (Bishop, 1995; Ripley, 
1996; Hertz et al., 1991). In a neural network, there are a large number of interconnected nodes 
th a t perform summation and thresholding, in loose analogy with the neurons of the brain. Feed­
forward neural networks can be used to  leaxn a real-valued or a discrete-valued decision rule. Neural 
networks do not explicitly model the underlying distribution but in certain cases the outputs can 
be treated in a rigorous probabilistic manner (Bishop, 1995).
Neural networks have been successfully applied in many settings, including speech recognition 
(Lang et al., 1990), handw ritten digit recognition (LeCun et al., 1989) and driving a car (Pomerleau,
1993). Nevertheless, they suffer from many problems and are not well controlled learning machines 
(Vapnik, 1998). Neural networks have been proposed as a useful tool for many areas of drug 
design (Schneider, 2000), and have exhibited good performance in optimizing chemical libraries 
(Sadowski, 2000) and SAR analysis (Kovesdi et al., 1999). However, in many cases the reasoning 
behind choosing a  particular architecture or training algorithm is unclear, and model selection 
and training times are rarely reported. This is not too im portant in small-scale drug design 
problems, but will become increasingly significant w ith the growth of pharmaceutical data  sets. 
Below I describe the perceptron and some extensions, the multi-layer perceptron and the radial 
basis function network.
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2.3.5.1 Multi-Layer Perceptrons
The perceptron (Rosenblatt, 1958) is an information processing unit of the form:
where sgn(z) =  +1 if z  >  0 and sgn(z) =  — 1 if z <  01. The output of a perceptron at node j ,  f j , 
is the weighted sum of its inputs, Xi, thresholded at Oj. Such a perceptron is able to  represent all 
decision hyperplanes over the space of its inputs x  € X .  In order to learn more complex decision 
functions the inputs Xi are fed into a number of perceptrons nodes, each with its own set of weights 
and threshold. The outputs of these nodes are then input into another layer of nodes and so on, 
until the output of the final layer of nodes is the output of the network. Such a network is termed 
a multi layer perceptron (MLP) and the layers of nodes whose input and output are seen only by 
other nodes are termed hidden. An MLP with enough hidden layers and nodes can approximate 
any decision function to  an arbitrary degree of accuracy (Bishop, 1995), but this result is not much 
use in practice as it does not specify the architecture of the network or the values of the weights 
and thresholds.
Normally the architecture of an MLP is specified in advance and the weights and biases are 
estimated by supervised learning. In order to propagate errors through the network the sgn function 
in (2.5) is replaced by a differentiable sigmoid transfer function such as tanh. See Hertz et al. (1991); 
Bishop (1995) for a discussion of supervised training algorithms for MLPs.
MLPs suffer from many problems and are not well controlled learning machines (Vapnik, 1998). 
Training can take many iterations to  converge and the speed is dependent on a number of param ­
eters which specify the learning rate, a momentum term  and stopping criterion. Also, MLPs are 
prone to over-fitting without some sort of capacity control (see Chapter 1, Section 1.3). Capacity 
control methods for NNs suffer from requiring a number of param eters to be set th a t affect the ra te  
of convergence and the quality of the solution. Model combination (Drucker et al., 1993; Breiman,
1994) and Bayesian methods (Neal, 1996) can partially overcome these deficiencies, but require 
many models to be trained and are hence computationally expensive. Even so, as noted a t the 
beginning of this subsection, neural networks have shown good performance in practice.
2.3.5.2 Radial Basis Function Networks
A Gaussian radial basis function classifier is of the form:
/ (x )  =  sgn ^  Wi exp . (2-6)
where 6, <r* are constants. T hat is, a new point x  is compared to a collection of prototypes 
Ci,i =  1 , . . .  ,m , the similarity measures, in this case Gaussian, are weighted and summed. If 
this quantity is not less than  —b then x  is assigned to class ‘true’, otherwise to class ‘false’. Such 
a weighted sum of Gaussian bumps can approximate any decision boundary arbitrarily well, given 
enough basis centres c* and appropriate values for the weights tu* and the bias b. Given a collection 
of centres the weights and bias can be computed by gradient descent as for an MLP (Bishop, 1995). 
The RBF centres c* and widths cr* are usually chosen in advance. Typically this is done by A;-means 
clustering. Training an RBF network is a two-stage process, in contrast to  training an MLP, for
1The case z  =  0 cam be assigned arbitrarily as ±1, randomly, or left as ‘don’t know’.
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which all weights are optimised simultaneously. The quality of an RBF solution thus depends on 
the quality of the clustering, which depends on the clustering algorithm and the choice of k.
2.4 Pharm aceutical D ata Analysis
In this section, I describe the application of some of the techniques outlined above on two problems 
characteristic of those found in drug development. The first problem consists of predicting the 
inhibition of dihydrofolate reductase by pyrimidines (this was the only publicly available QSAR 
data  set a t the time of study). Four algorithms were used to  learn neural networks of differing 
architectures and functionality. These are compared to  a decision tree. The neural networks 
required extensive model tuning and training times in comparison to  the decision tree, but, in 
general, gave better performance. The second problem is to rank compounds in order such th a t 
the compounds screened first are more likely to be active. If such a ranking were available then 
fewer compounds would need to be screened to obtain a given number of hits. Alternatively, if 
there are resource limitations, screening the n  compounds th a t are most likely to  be hits will give an 
enhancement over selecting compounds randomly. This problem can be treated as a classification 
problem or as a regression problem. These two approaches are evaluated using both standard 
statistical techniques and neural networks.
2.4.1 Pred icting th e Inhibition o f D ihydrofolate R eductase
The d ata  used in this experiment were obtained from the UCI D ata Repository (Blake and Merz,
1998) and are described in King et al. (1992). The problem is to  predict the inhibition of dihy­
drofolate reductase by pyrimidines. The biological activity is measured as log(l/A r*), where K i is 
the equilibrium constant for the association of the drug to dihydrofolate reductase. Such QSAR 
problems are generally formulated as regression problems, i.e. learn the conditional density of the 
target, y , given some predictive attributes, x. In this case the target is log(l/K i)  and the attributes 
are as follows. Each drug has three positions of possible substitution. For each substitution po­
sition there are nine descriptors: polarity, size, flexibility, hydrogen-bond donor, hydrogen-bond 
acceptor, 7r donor, 7r acceptor, polarizability and cr effect. Each of the twenty-four non-hydrogen 
substituents in the compound set was given an integer value for each of these properties (see King 
et al. (1992) for details); lack of a substitution is indicated by nine —Is. This gives twenty-seven 
integer attribu tes for each drug. This approach is adapted to avoid solving a regression problem 
by recasting it as one suitable for classification or inductive logic programming (ILP), as described 
in King et al. (1992). Here we focus on the classification problem.
The task is to  learn the relationship great(dn , dm) which states th a t drug dn has a  higher activity 
than  drug dm .2 Each instance consists of two drugs, giving fifty-four attributes in total, and a 
label ‘tru e ’ or ‘false’, indicating the value of the relationship great(). There are 55 compounds 
in the d a ta  set. In order to obtain a good estim ate of the performance of the algorithms, the 
data  were partitioned into a five-fold cross-validation series as follows. The 55 compounds were 
randomly partitioned into 5 sets of 11 compounds. Each fold consisted of a training set A  of 44 
compounds and a test set B  of 11 compounds. The classification training d ata  were constructed 
by labelling each pair (n ,m ) € A  x  A  according to  the true value of great(dn,d m). This gives 
44 x 43 =  1892 examples of great(). In practice, however, the training sets were slightly smaller 
since g reat() is not defined when the two drugs have the same activity. The classification test data
2The natural transitivity of the relationship great() is not exploited when learning nor when making the predic­
tions.
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were constructed by forming all pairs (n, m) € (A  x B )  U (B  x A) U (B  x B ) (i.e. all comparisions 
not in the classification training set) which gives slightly less than 44x11  +  1 1 x 4 4 + 1 1 x 1 0 =  1078 
examples of g reat().
Owing to the above construction each instance in the classification data  was followed by its 
inverse, for example if the first instance represents great(c^, d i) =  true then the second instance 
represents great(d i, c^) =  false. This produced a symmetric two-class classification problem where 
the classes were equal in size and had equal misclassification costs.
Each of the training sets was then used to train  an algorithm to produce a classification rule. 
This classification rule was then used to  make predictions on the test set. There axe two types 
of test comparison: between a test compound and a compound in the training set, and between 
two test compounds. There are 550 comparisons of the latter type. For each pair (n ,m ), the 
former type occurs twice during the five-fold cross-validation: once when n € A  and m  6 B , and 
once when m G A  and n  € B . There are 4840 such test comparisons. Thus there axe 5390 test 
compaxisons in total. The future probability of mislabelling a pair may depend on whether or 
not one of the pair was in the training set. If we intend to use the rule to  rank a laxge number 
of new compounds, then there will be many compaxisons between new compounds. If we intend 
to incorporate only a  few compounds into the ranking learned for the training compounds, then 
most comparisons will be with only one or two training compounds. In the results presented here, 
I assume the two misclassification rates are equal. A further point is th a t the test compaxisons 
axe not independent within each fold or across folds. Mislabelling (n ,m i)  is not independent of 
mislabelling (71, 7712). Nor is mislabelling (n ,m ) when n  € A  and m  G B  independent of the 
converse. One approach would be to  estimate all of the probabilities involved. However, with only 
55 compounds, this is infeasible. The approach taken here is to assume th a t mislabelling (n, m i) 
is independent of mislabelling (n, m 2) and the mislabelling (n, m) is the same whether or not n  or 
m  is in the training set. I also assume that mislabelling (m, n) is equivalent to mislabelling (n, m). 
The cross-validated error rate, £, is thus reported as the proportion of the 5390 test pairs which 
are mislabelled and the standard error is calculated as y /e ( l  — e)/1485, where 1485 is the number 
of essentially distinct compaxisons under these assumptions.
Finally, note th a t in learning the relationship great() the compounds could be ranked in terms 
of their activity w ithout going to  the effort of predicting th a t activity. This is in contrast to the 
more general and harder problem of learning a set of rules or a regression equation to predict the 
real-valued activity.3
2 .4 .1 .1  A lg o rith m s
Full details of the implementation and the various param eter settings are given in Burbidge et al. 
(2000). All of the algorithms were implemented in the data  mining package C le m e n t i n e  5.1 
(SPSS, 1999). Below I summarize the salient details.
The C5.0 algorithm of Quinlan’s was used to  learn a ruleset to classify the data. This algorithm 
is a modification of the well-known C4.5 algorithm (Quinlan, 1992). This algorithm required no 
model selection (which is to say, after a bit of experimentation it appeared th a t the defaults were 
optimal).
Four neural networks were also trained, as described below.
M L P  A two-layer sigmoid network was trained with the number of nodes in the hidden layer 
varied from 2 to 54, in steps of 2. A validation set of size 20% was held out from the training
3The regression approach has recently been shown by others to be successful. This work has not yet been 
published.
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Algorithm Error s.e. T im e/s
MLP 0.1381 0.0090 857
‘Dynamic’ 0.1488 0.0092 613
‘P rune’ 0.1620 0.0096 692
C5.0 0.1870 0.0101 4
RBF 0.2272 0.0109 199
Table 2.3: Predicting the inhibition of dihydrofolate reductase: Estim ated generalization errors 
and training times averaged over the five cross-validation folds. The manually tuned MLP has the 
best performance, but the longest training times. The RBF performed badly. (Reproduced from 
Burbidge et al. (2000).)
Algorithm Tim e/s
MLP 20715
RBF 11719
‘Prune’ 13338
‘Dynamic’ 4748
Table 2.4: Predicting the inhibition of dihydrofolate reductase: Model selection time for the neural 
networks. No model selection was performed for C5.0. The manually tuned neural network required 
the most com putation time, and this led to the best performance (see Table 2.3). (Reproduced 
from Burbidge et al. (2000).)
d ata  to  estim ate the optimal number of hidden nodes (viz. 20).
D y n a m ic  Starting from a minimal network, nodes were dynamically added during training. A 
validation set of size 20% was used to estim ate the optimal architecture.
P ru n e  S tarting a from a large network, nodes were selectively pruned if they did not appear 
to  contribute significantly to the performance of the network (again, on a validation set). 
This m ethod includes the possibility of removing input nodes, i.e. it can perform feature 
selection. However, the set of features removed varied over folds, suggesting that this method 
is unstable.
R B F  k  -means clustering was used to select the RBF centres and widths. An RBF network was 
then trained to classify the data. The number of clusters (i.e. hidden nodes) was varied 
in steps of 2 from 2 to  54. The optimal number of clusters (viz. 14) was chosen as th a t 
minimizing the error ra te  on a hold-out validation set.
Note th a t for the neural networks, once the optimal architecture had been estimated, the networks 
were retrained using all of the available training data.
2 .4 .1 .2  R e s u lts  a n d  D iscu ssio n  (Q S A R )
The estim ated generalization errors and training times reported by Burbidge et al. (2000), averaged 
over the five cross-validation folds, are reproduced in Table 2.3. Also shown are the standard errors; 
in the following, the one-tailed t-test a t 95% confidence is used. If speed were the key issue then 
the C5.0 decision tree would be the preferable algorithm. However, this had significantly worse 
generalization accuracy than  the manually tuned (MLP) and ‘Dynamic’ sigmoid neural networks. 
The RBF network was significantly worse than  the other algorithms on these data, which may be 
due to  the quality of the clustering. The MLP was significantly better than the other algorithms, 
except for ‘Dynamic’.
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Four different neural network architectures were used on these data, all of them requiring 
heuristic methods for model selection which are computationally intensive. The total times for 
model selection and validation are shown in Table 2.4. Note th a t once a neural network architecture 
has been selected on the basis of the hold-out set it was then retrained using all of the training 
data. Again, if speed were the most im portant issue then C5.0 would be chosen as model selection 
provided no increase in accuracy in this case. This not a general rule, however, as decision trees 
usually require extensive model selection to  avoid overfitting (Breiman et al., 1984). I will return 
to this problem later in Chapter 3 (Section 3.3.1), where the SVM is used to  classify these data.
2.4.2 A nalysis o f H TS D ata
The screening of large numbers of compounds produces a large amount of data. Typically, there 
may be thousands to  tens of thousands of compounds for which activity d ata  are generated. In 
competitive binding assays, results are usually given as a percentage of the relative inhibition of the 
tool ligand. In HTS the compounds are present in minute quantities which can lead to processing 
problems (e.g. liquid handling) and results can be variable. Higher throughput of screens leads 
to a  reduction in the precision of this activity measurement. The measured inhibition is usually 
thresholded at some pre-specified value in order to label the compounds as a hit or miss. Many of 
the ‘h its’ from HTS tu rn  out to be inactive. If the threshold were increased then there would be 
fewer of these false positives, but there would be an increased risk of missing potential opportunities. 
The threshold is thus a pragmatic one.
The standard QSAR approach is to learn a regression function and hence these techniques 
are not immediately applicable to  analysis of higher throughput data. The problem lies not with 
the concept of QSAR itself, but w ith the statistical techniques used in the analysis. A further 
complication with these data  is the significant error rate. Compounds th a t are predicted active by 
an HTS screen may tu rn  out to be inactive upon further testing (false positives), more worryingly, 
HTS may miss active compounds (false negatives). There have been some attem pts to  characterize 
the reliability of HTS (Zhang et al., 1999, 2000). Traditional QSAR techniques are very sensitive 
to outliers and errors and this consideration must be taken into account when constructing a 
predictive tool based on these data  (Labute, 1999).
Note th a t the QSAR techniques of linear and neural net regression are not usually used in the 
analysis of HTS data in the way presented below. They were included in the following analysis to 
serve as a  benchmark for the techniques introduced and developed in the thesis.
2.4.2.1 M easuring Performance
Below, the classification and regression approaches to  analysing HTS d ata  axe considered. In order 
to compare the two approaches, and to provide a more useful measure of performance with respect 
to the compound selection process, the following performance measure due to  Gillet et al. (1998) 
is used. The A50 is defined to be the number of compounds th a t must be tested to find half 
of the active molecules. Gillet et al. (1998) define the global enhancement (GE ) as the ratio of 
the A50 expected for random selection (which would be half of the compound set) to the actual 
A50. This is a more practical measure of performance than reporting error rates or risk for eithe? 
classification or regression. It also provides a meaningful comparison between the classification and 
regression approaches. To calculate an A50 requires a ranking of compounds according to activity 
(cf. Section 2.4.1) — compounds can then be screened in order of predicted activity. The regressioi 
approach provides this ranking immediately. The classification approach provides a labelling witl
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Assay No. Compounds 7r+i
a l 8835 0.0862
a2 3533 0.0436
a3 2151 0.0604
a5 8733 0.0641
a6 3875 0.0456
a7 7990 0.0354
a8 7467 0.0371
Table 2.5: HTS Statistics. The number of compounds screened on each assay (for which features 
were available) is shown with the hit ra te 71+j (the proportion of positive examples in the training 
sample) for each assay.
a confidence value that can be used to rank the compounds. Clementine’s logistic regression 
provides a class probability and the neural network classifiers provide a confidence measure in 
their predictions.
2.4.2.2 R esults and Discussion (HTS)
The data  used for this analysis were generated by high-throughput, competitive binding assays. 
The targets were all G-protein coupled receptors (Howard et al., 2001), which form the largest and 
most diverse group of transmembrane proteins involved in signal transduction. T hat is, they are 
all proteins th a t span cell membranes in humans and are involved in the transport (transduction) 
of various chemicals into and out the cell. The screening is performed robotically by pipetting the 
receptor into a well with a  tool ligand, which binds to  the receptor (i.e. it behaves agonistically). 
The compound under test is then introduced and the reduction in specific binding (i.e. inhibition) 
of the agonist is determined. For example, the tool ligand may be radio-labelled, in which case the 
amount of free radioligand corresponds to the level of inhibition.
Activity d a ta  for seven HTS assays for a to ta l of around 9000 compounds were available. Not 
all compounds have been screened in all assays. The number of compounds screened, for which 
features were available, in each of the assays is given in Table 2.5, together with the hit ra te  for 
each assay. The hit ra te is the proportion of compounds having activity greater than  a threshold 
set by the screening group. The data  sets are all unbalanced, w ith the ratio of inactives to  actives 
varying from 11:1 to  27:1. Hence, predicting all compounds to  be inactive achieves between 91% 
and 96% accuracy rate. Classification accuracy is not a useful measure of performance. The global 
enhancement GE defined above (Section 2.4.2.1) is more suitable.
For the purpose of obtaining unbiased estimates of the true performance, the data  sets axe 
partitioned into training and test sets, in the ratio  3:1. The training set is further partitioned 1:1 
to provide a validation set during model building.
There were three feature sets, labelled fsOl, fs02, and fs03, provided by SmithKline Beecham 
(now GlaxoSmithKline). The first feature set, fsOl, consisted of a 55 variable vector representing 
variable-length molecular structure information th a t had been tranformed to a fixed length using 
M. Waegner’s autocorrelation methods. The second feature set, fs02, consisted of one attribute, 
CLOGP (Leo and Weininger, 2000). The third feature set, fs03, consisted of 12 attributes computed 
from partial atomic charge information for a single three-dimensional conformation of the molecule. 
These were the polar moments of inertia scaled by the number of atoms, the ratio of molecular 
volume to  the molecule’s bounding box, and the dipole components projected onto the principal 
axes.
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The goal of the analysis is to  rank unscreened compounds in order of activity. The compounds 
can be then screened in order. The GE measures the increase in hits detected over random 
selection of compounds for screening. This can be treated either as a regression problem or as a 
classification problem. The regression framework is the most natural since the activities are real- 
valued. However, owing to the uncertainty in the measurements when screening large numbers of 
compounds the problem is usually converted to one of classification by thresholding the activity 
at some level specified by the screening group.
Four algorithms, implemented in C le m e n t i n e  6.0 (Clementine 6.0, 2001), were used to  rank 
the compounds in order of activity. The algorithms were as follows.
L in e a r  R e g re ss io n  This learns a linear relationship between the features and the activity, under 
the assumption th a t the noise in the activity measurement is independent normal (Smith 
and Draper, 1998). Regression models are fast to train  and well understood.
L o g is tic  R e g re ss io n  This learns a relationship between the input fields and the probability of 
being active (Ripley, 1996). This can be used to rank compounds according to the probability 
th a t they are hits, w ithout actually estimating the real-valued activity.
N e u ra l  N e tw o rk  R e g re ss io n  (NNR) This learns a non-linear equation in the features th a t pre­
dicts the activity (Bishop, 1995). Dynamic neural networks were used, i.e. the architecture 
is optimized automatically by using 20% of the training d a ta  for validation.
N e u ra l  N e tw o rk  C lass ifica tio n  (NNC) This learns a non-linear discriminant to  identify active 
compounds (Bishop, 1995). The distance from a data  point to  the separating surface is 
used to  give a measure of the confidence in a prediction. This can then be used to rank the 
compounds in order of predicted activity. Dynamic neural networks, optimized automatically 
as above, were used.
C l e m e n t i n e  defaults were used for linear regression and logistic regression. The dynamic neural 
networks were stopped when there had been no change in predicted performance for 200 cycles 
through the training data.
The global enhancement over random screening of the four techniques is shown in Tables 2.6- 
2.8. The linear techniques outperformed the neural networks in 20 out of the 21 tasks. Logistic 
regression was better than  linear regression on five out of seven of the tasks using feature set fsOl 
(Table 2.6), and on four out of seven using fs03 (Table 2.8). On feature set fs02 (Table 2.7) the 
performance of the two linear techniques is equal except for assay a6 (and for assay a2, just), 
where logistic regression wins. The best GE achieved for each assay is shown in Table 2.9, with 
the corresponding feature set and algorithm. Logistic regression wins five out of seven times (but 
is tied on a8). Feature set fsOl wins four out seven times. The neural networks do badly on these 
data, which implies th a t more sophisticated model selection is required when using these more 
flexible techniques.
Note th a t the standard QSAR approach of linear regression would not normally be used for 
these data. The purpose of the above analysis is to  provide a reference benchmark against which 
to compare other algorithms.
2.5 Summary
The work presented in this chapter concerns the application of supervised learning techniques to 
facilitate the early stages of the drug discovery process.
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Assay Linear Logistic NNR NNC
a l 1.18 1.51 1.14 1.12
a2 1.87 2.48 0.93 1.19
a3 2.35 1.92 1.20 0.81
a5 1.79 2.17 1.01 0.96
a6 3.00 5.21 0.81 1.39
a7 2.15 1.72 0.79 1.02
a8 2.82 4.15 1.00 1.22
Table 2.6: HTS Results: fsOl. The highest global enhancement for each assay is emphasized. 
Logistic regression wins five out seven times. Across these assays, the neural networks are not 
better than  random selection on average and never win in comparison to the linear techniques.
Assay Linear Logistic NNR NNC
a l 1.27 1.27 0.86 0.98
a2 2.56 2.57 0.93 0.91
a3 3.27 3 .27 1.54 1.54
a5 1.37 1.37 0.97 0.97
a6 0.84 1.28 1.22 1.27
a7 1.08 1.08 1.18 1.18
a8 4.54 4 .54 0.93 0.96
Table 2.7: HTS Results: fs02. The highest global enhancement for each assay is emphasized. 
The linear techniques win six times out of seven. For the linear techniques, classification and 
regression have approximately equal performance. This also holds to  a slightly lesser extent for the 
neural networks. Across these assays, the neural networks are not better than random selection 
on average.
Assay Linear Logistic NNR NNC
a l 1.09 1.26 1.25 0.92
a2 2.09 2.07 0.92 0.92
a3 4.37 3.49 0.81 0.62
a5 1.22 1.35 0.99 0.97
a6 1.76 2.93 1.05 1.16
a7 1.64 1.66 1.36 0.90
a8 4.32 3.65 4.04 0.77
Table 2.8: HTS Results: fs03. The highest global enhancement for each assay is emphasized. 
Logistic regression wins four out of seven times. Across these assays, the neural networks are not 
better than  random selection on average and again never win.
Assay GE Algorithm Features
a l 1.51 Logistic fsOl
a2 2.57 Logistic fs02
a3 4.37 Linear fs03
a5 2.17 Logistic fsOl
a6 5.21 Logistic fsOl
a7 2.15 Linear fsOl
a8 4.54 Log./Lin. fs02
Table 2.9: HTS Results: Summary. The highest global enhancement (GE)  for each assay is shown 
with the corresponding algorithm and feature set. The linear techniques win on all of the assays. 
Logistic regression wins four out of seven times and is tied on a8.
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• The biological activity of a compound is related to its physicochemical properties and struc­
tural features.
•  Advances in robotics allow mass screening of compounds against targets. Idealized, the early 
stages in the drug discovery process today are as follows.
1. A target is identified.
2. Library design methods are used to select compounds (i) for synthesis from virtual 
libraries, (ii) from in-house collections, (iii) from external suppliers.
3. Tens of thousands of compounds are screened against the target at a single concentra­
tion.
4. ‘H its’ from prim ary screens are identified and screened over a range of concentrations 
to  determine an 7(750, a measure of binding affinity.
5. Low throughput assays are used to  determine the functional activity of the confirmed 
hits. Progressible hits, i.e. those representative of a compound series with acceptable 
activity (i.e. binding affinity and functional activity) are identified and screened for 
ADME and toxicity properties.
6. Non-toxic, novel, progressible hits with good ADME properties become leads, i.e. they 
have sufficient potential to  progress to a full drug development program.
There are too many drug-like compounds to synthesize and screen them all, even with projected 
advances in robotics and miniturization. D ata analysis can be used to select compounds for 
screening, and to characterize compounds and targets. The aim of the experiments reported in 
this thesis is to  predict biological activity from screening data. This could improve efficiency in 
the early stages of drug discovery.
The contributions to supervised learning presented in this thesis have been motivated by the 
problems encountered when analysing the data  generated during the early stages of drug discovery. 
The key points of the data  analysis presented in this chapter are as follows.
•  QSAR analysis attem pts to model biological activity as a function of physicochemical de­
scriptors for a  small group of related compounds.
• HTS d ata  have characteristics th a t prevent the use of standard QSAR techniques.
• An evaluation of linear and non-linear predictive techniques on high-throughput screening 
data  established the following.
— Standard statistical techniques outperformed autom ated neural networks on these data. 
However, these traditional QSAR techniques are still considered inadequate. This sug­
gests th a t more sophisticated model selection is required for the neural networks.
— Logistic regression slightly outperformed linear regression, i.e. it was easier to rank the 
compounds in terms of activity than to predict activity.
— There appeared to be no relationship between the hit ra te  of an assay and the perfor­
mance of the predictive techniques.
— The enhancement over random selection varied from 1.5 to 5.2. This can be compared to 
results of (Gillet et al., 1998) where an enhancement of 3.1 was achieved for a  comparable 
data  set (although the target was ‘drug-likeness’ and not any specific activity).
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•  Some standard intelligent d ata  analysis techniques were evaluated on a small QSAR problem 
that had been recast as a ranking problem. The following conclusions were drawn.
— The C5.0 decision tree was fast to train  but gave poor performance.
— Radial basis function networks had surprisingly poor predictive performance.
— Manually tuned sigmoid neural networks outperformed the other techniques, including 
autom ated neural networks, but required an extensive model building phase.
The analysis of data  generated during the early stages of drug discovery poses many chal­
lenges. On one problem, non-linear machine learning techniques performed well, but required a 
lot of human intervention. On another, more difficult, problem, standard linear techniques per­
formed better than the more powerful techniques. Better learning machines are desired in the 
pharmaceutical industry for both  of these, and other, problems.
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Chapter 3
Support Vector Classification
Neural networks are the second best way o f doing ju s t about any­
thing.
John D enker, N eural N etworks for Computing
The support vector machine (SVM) was introduced by Vapnik and co-workers (Vapnik, 1995; 
Cortes and Vapnik, 1995) initially as a learning algorithm for binary classification by hyperplanes 
in the input space. The motivation behind the SVM is th a t of structural risk minimization based 
on statistical learning theory (Vapnik, 1998). This provides a principled way to quantify and 
minimize the expected risk of using a classifier on unseen data. For linearly separable classes, the 
basic idea of the SVM is to maximize the distance between the decision hyperplane and the nearest 
data  points, this distance is term ed the margin. Intuitively, if the hyperplane is constructed to  be 
in the middle of the separating band then the SVM is likely to perform well. Statistical learning 
theory quantifies this concept of the margin. Restricting the space of hypotheses to those which 
separate the data  with a large margin reduces the size of the hypothesis space and hence prevents 
over-fitting of the available data. This basic idea has been extended to allow for training errors in 
classification.
The solution to the SVM is found by solving a convex quadratic program (QP) which has 
a global optimum. The learning param eters of the QP solver affect only the time and space 
complexity and have almost no effect on the quality of the SVM solution. This leaves very few 
free param eters. These can be optimized by applying the risk bounds of statistical learning theory 
without the need to  reserve a portion of the data  for model validation.
The SVM has been generalized to allow non-linear decision surfaces by learning an hyperplane 
in some feature space th a t is the image of a non-linear mapping of the input space (Aizerman 
et al., 1964). This is achieved by constructing a kernel function th a t acts as the interface between 
the data  and the learning algorithm. The SVM has been shown to be competitive with existing 
algorithms on a range of classification tasks including handw ritten character and digit recognition 
(Cortes and Vapnik, 1995), text categorization (Joachims, 1998) and gene classification (Brown 
et al., 2000).
In the remainder of this chapter, I describe the support vector machine for classification, its 
implementation and some estimates of its performance (Section 3.1). In Section 3.2, I describe 
the receiver operating characteristic curve and relative advantage as measures of performance. In 
Section 3 .3 ,1 present some results for support vector classification of pharmaceutical data. Finally, 
in Section 3.4, I summarize the salient points and conclusions of the chapter.
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3.1 The Support Vector Machine
In this section, I describe the problem of binary classification by hyperplanes and define the opti­
mal separating hyperplane, which is the SVM solution (Section 3.1.1). I then briefly outline the 
formulation of the SVM as a quadratic program (Section 3.1.2) and discuss some implementation 
issues (Section 3.1.3). More details can be found in the tutorials by Burges (1998) and Osuna et al. 
(1997b) and in the book by Cristianini and Shawe-Taylor (2000) (see also Burbidge and Buxton 
(2001)). In Section 3.1.4, I briefly outline the extension to the case of unequal misclassification 
costs which are frequently encountered in real life classification problems such those occurring in 
chemoinformatics. In Section 3 .1 .5 ,1 describe some estimates of the expected generalization error 
of an SVM, together with a brief analysis of their behaviour on real-world data  sets.
3.1.1 Binary Classification
Consider learning a binary decision function on the basis of a set, S , of training d a ta  drawn 
independently and identically distributed (i.i.d.) from some unknown distribution p(x, y),
S  = { (x i ,y i) , . . . ,  (xi,yi)}, Xi € 9£d, y* G { -1 ,+ 1 } . (3.1)
One common approach (Rosenblatt, 1958) is to search for a pair (w, b) such th a t the decision 
function is given by:
/ (x )  =  sgn((w, x) -I- b). (3 .2 )
The weight vector w  determines the orientation of the decision hyperplane and the operating point 
b determines its distance from the origin. The pair (w, b) should be chosen so as to minimize the 
expected risk. Minimizing the risk on the training set is termed empirical risk minimization (ERM). 
This does not necessarily minimize expected risk. By the law of large numbers the empirical risk 
of a function converges to its expected risk. T hat is,
Re mp ( f )  —► R ( f )  as Z —► oo. (3.3)
This does not imply th a t for the function f l minimizing the empirical risk and the function / opt 
minimizing R  the following holds:
i w / ' )  -> * ( / opt). R ( f )  - >  R ( r 1)- (3.4)
T hat is, there is no guarantee th a t the empirical risk of the ERM solution converges to  the true 
risk of the optimal solution, or th a t the true risk of the ERM solution converges to the true risk 
of the optimal solution (Vapnik, 1998). If the conditions (3.4) do hold then the ERM principle is 
said to be consistent. For consistency of the ERM principle it is necessary to  limit the number of 
decision functions th a t can be implemented by the learning machine.
The following example, due to  Scholkopf et al. (1999a), illustrates why this restriction is neces­
sary. Consider a learning machine th a t can implement all functions from 9£d to {—1,+1}. Given 
a training set (3.1) and test set,
{ x i , . . . , x 7}, x j  G 9?d, (3.5)
such that:
{x1 , . . . , x z } n { x i , . . . , x r} =  0, (3.6)
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for any function f  there exists a function /*  such that:
/* (x i) =  /(x i)V i, (3.7)
/*(x?) ±  /(x j)V j. (3.8)
T hat is, based on the training set there is no way to distinguish the two functions. On the test set 
they make opposite predictions. This is an extreme example of the phenomenon of overfitting. T hat 
is, the decision hyperplane is faithful to the training d a ta  to the extent of capturing idiosyncracies 
caused by noisy or irrelevant measurements. Such a decision hyperplane will not lead to  good 
predictions on unseen data  with differing idiosyncracies.
Vapnik-Chervonenkis (VC) theory (Vapnik and Chervonenkis, 1974) provides ways to measure
the size of the hypothesis space. A separating hyperplane w ith respect to  the set S  (3.1) is a pair
(w, b) such th a t (V i)(yj/(xi) >  0), i.e. all of the training points are correctly classified. The margin 
of an hyperplane is the distance from the hyperplane to  the nearest training point. A necessary and 
sufficient condition for consistency of ERM is th a t the classification margin is large with respect 
to the scale of the data. The optimal separating hyperplane is th a t separating hyperplane such 
th a t the distance from {x| (w, x) +  b =  0} to the nearest training point is maximal (Vapnik and 
Lerner, 1963). To eliminate the scaling freedom in the definition of the hyperplane the following 
definition is made (Vapnik, 1998). An hyperplane is said to be in canonical form with respect to 
the training data  (3.1) if minx .€^d | (w,Xj) +  6| =  1. For canonical hyperplanes the margin is:
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w  / w w (3.9)
By maximizing the margin it is possible to ensure th a t the difference between the empirical risk 
and the true risk is not large, and tends to zero as I —> oo. Thus it is possible to learn hyperplanes 
in very high dimensional spaces without overfitting the training data.
3.1.2 M argin M axim ization as a Quadratic Program
The SVM learns an hyperplane in the feature space 7i defined by the mapping:
X - + H ,  
x  —>• V>(x )-
The mapping ip need not be explicitly constructed as it only occurs in the training algorithm and 
decision function in terms of its inner product, which is defined by the kernel function:
K ( x , z )  =  ('tp{x),ip(z))n . (3.10)
Any continuous symmetric kernel of a positive definite integral operator on L 2(X),  where X  is some 
compact space, corresponds to  an inner product in some feature space (Mercer, 1909). It is usual 
to specify the kernel function as opposed to the mapping as the kernel function can be constructed 
based on domain knowledge (Zien et al., 2000). Alternatively one can generate a known classifier 
structure such as a Gaussian RBF network or two-layer perceptron (Osuna et al., 1997b). Two
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commonly used kernels are the linear kernel,
d
K {x ,  z) =  <x,z) =  ^  Xpzp, (3.11)
p= 1
and the Gaussian kernel,
K {x ,  z) =  exp . (3.12)
The linear kernel (3.11) learns an hyperplane in the input space. The Gaussian kernel (3.12) learns 
an hyperplane in a countably infinite dimensional space. As will be seen below, this corresponds to 
the decision function (2.6) used above in Chapter 2 (Section 2.3.5.2), i.e. th a t of an RBF network.
As described in Chapter 1 (Section 1.3) and Section 3.1.1 above, if the hypothesis class is very 
large then there is the danger of overfitting. The SVM m ethod avoids overfitting by maximizing 
the margin between the two classes of the training data. This is equivalent to minimizing the norm 
of the weight vector, ||w ||2 =  (w, w) by (3.9). This is achieved by solving the quadratic program 
(QP):
Minimize 4>(w, b) =  | | |w | |2, (3.13)
w,6
subject to  y*((w, V’fci)) +  b) > 1, i =  1 , . . . ,  I. (3-14)
The constraints (3.14) enforce separability of the training data. To allow for training errors a
vector of slack variables £ =  (£ i , . . . , £/)r  is introduced, which yields the following QP (Burges, 
1998):
Minimize * ( w ,0  =  | | |w | |2 +  C £ ' =1 (3.15)
w,6,£
subject to  yi({w, VKxO) +  6) >  1 — £», £* >  0, i =  1 , . . . ,  /, (3.16)
where C  is a regularization param eter th a t must be specified beforehand. The slack variables £*
measure the violation of the separability constraints (3.14) and k  defines the norm on such errors. 
If k  =  0 then solving the quadratic program amounts to minimizing the number of errors while 
maximizing the margin. This is an NP-complete problem (Vapnik, 1998). The lowest value of k 
for which the QP (3.15) is tractable is k  =  1. Although the case k =  2 is also tractable it is likely 
to be more sensitive to outliers (Huber, 1981). An experimental comparison (Mangasarian and 
Musicant, 2000) shows there to be little difference in practice. In the following the value A: =  1 is 
used. The QP (3.15) is termed the soft margin formulation of the SVM, since margin violations 
are allowed.
The QP (3.15) is said to the in the primal form. It is normally formulated in the Wolfe dual 
(Cristianini and Shawe-Taylor, 2000). This allows computation in the feature space H  to performed 
using only inner products K ( x ,  z) =  (^(x ), 'ip(z))n . The solution to the QP (3.15) is found by 
maximizing
i 1 i i  1 1
W (a)  =  E a ‘ - 2 l|w||2 =  2 > ~ 2 ^ X  &i otj yi Uj Ar(x*, Xj), (3.17)
i=l i=l i=l j =1
subject to
i
^  yiOi =  0, C > a i > 0 ,  i = 1 , . . . ,  I. (3.18)
i=l
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The coefficients a* axe the Lagrange multipliers associated with the constraints (3.16). At the 
maximum dW /da. =  0 so th a t the weight vector is given by:
i
w  =
i= l
where a* =  ( a f , . . .  , a ’l ) T is the maximizer of (3.17). The operating point b* is given by (Burges 
and Crisp, 2000):
b* = max \ max ( - 1  -  (w,V>(x*))w), max (1 -  (w ,ip(xi))n ) I . (3.20)
l.oti^O y»=+l,ai=0 J
This yields the decision function:
/ (x )  =  sg n ((w ,ip(x))n  + b*) =  sgn ^ ^ a - t / iA :(x,xi) +  6* j  . (3.21)
Note th a t a t the maximum of (3.17) many of the Lagrange multipliers a* may be zero. Thus 
the decision function (3.21) will be an expansion on a subset of the data. These points axe known 
as support vectors. A solution th a t is an expansion on a small subset of the data  is desirable since 
it aids model interpretation — the support vectors are in some sense the most informative patterns 
in the d a ta  set — and reduces evaluation time. The support vectors form a compression scheme 
for the data  set (Littlestone and Waxmuth, 1986) and so minimizing the number of support vectors 
should lead to better generalization (see Section 3.1.5.2 below).
It is possible th a t enforcing a low training error, by setting C  high in (3.15), will lead to a 
poorer generalization accuracy. Maximizing the margin w.r.t. all training points can lead to  a 
small maxgin. If some points are allowed to be margin errors, th a t is lie within the margin band 
(£i >  0), then a larger margin can be achieved w.r.t. the other training points. Conversely, if C  
is too small then little emphasis is placed on minimizing the training error and an oversmoothed 
hypothesis will be returned. Hence it is possible to underfit the training data  by setting C  to be 
too small, or overfit by fitting C  too high. This is illustrated in Figure 3.1 for the Diabetes dataset 
(see Section 3.1.5.3 below for details). The solution tends to be fairly insensitive to the constant 
C  for Gaussian kernels. It is much more sensitive to the width param eter a. The sensitivity of the 
SVM to a  is investigated below in Section 3.1.5.3.
The kernel actually plays two roles. Firstly, it allows com putation to be carried out in the high­
dimensional feature space. Secondly, it acts as a regulaxizer, the type of regularization depending 
on the kernel (Mangasarian, 2000; Williamson et al., 1999). For a more detailed discussion on the 
nature of the regularization performed by SVMs see Smola et al. (1998) and Evgeniou (2000).
3.1.3 Im plem entation
Once a solution has been obtained, it may be desired to retrain  with additional data, or to retrain 
with some d ata  removed (e.g. incorrect examples). In a cross-validation exercise, many of the 
training points remain the same from one optimization to the next. In these cases, it is desirable 
to s ta rt retraining from the previous solution a*. For example, in the case of a leave-one-out 
procedure, if example (x*, yi) is left out then the initial vector of Lagrange multipliers is taken to 
be (qJ, . . . ,  a*+1, . . . , ajT). W hen maximizing the Wolfe dual (3.17) it is necessaxy to  enforce
the constraint £)i= i PiOti =  0. Thus this initial vector suggested will not be feasible. If the primal
(3.19)
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Figure 3.1: Regularization: Diabetes. The test error (solid line) has a minimum at around C  =  1. 
The proportion of training examples that become support vectors (dotted line) decreases as C  
increases. When C  is too small the SVM underfits the training data, when C  is too large then 
the SVM overfits the training data. The SVM was trained with a Gaussian kernel K (x , z) =  
exp(—||x — z\\2/d). Results are averaged over ten partitions of the data into training and test sets 
of equal sizes.
formulation (3.15) with k = 1 is modified to:
Minimize $ (w ,6 ,f)  =* | | |w | |2 +  \b 2 +  C]C!=i (3.22)
w,6,£
subject to y i«w , V»(xi))w +  b) > 1 -  &, & > 0, i = 1, . . .  ,1, (3.23)
then this constraint need not be enforced. An initial vector such as ( a j , . . . ,  a»_i,  . . . ,  cq*)
would then be feasible. Additionally, this QP is more easily implementable. In this case the 
operating point is given by:
i
b' = J 2 v i a i-(3-24)
1= 1
Solving the QP (3.22) is equivalent to learning an hyperplane in the space generated by the mapping 
V>(x) =  (^>(x),l) (Cristianini and Shawe-Taylor, 2000). This is analogous to having an input 
unit in a neural network that has a fixed input of 1 and a weight of itfo =  b (Bishop, 1995). 
Theoretically, the performance of the classifier given by (3.22) is slightly worse than that given 
by (3.15) (Cristianini and Shawe-Taylor, 2000). In practice the performance of the two learning 
machines is the same (Hsu and Lin, 2002).
Standard QP packages are not well suited to the QP arising in the SVM formulation (Friefi 
et al., 1998). The QP associated with the SVM has I Lagrange multipliers and the number of inner 
products, K (x i ,x j ) ,  is I x  I. The QP (3.22) is usually solved in its dual formulation (3.17) by a 
decomposition routine (Osuna et al., 1997a; Joachims, 1999a; Hsu and Lin, 2002). A subset of the 
data of size q is chosen at each iteration. This subset is termed the working set. The Lagrange 
multipliers for this subset are then optimized whilst keeping the remainder of them fixed. This
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procedure is repeated until convergence. The advantages of this method are th a t the memory 
constraints are reduced — by caching kernel calculations K ( x i , X j )  during training as opposed 
to evaluating the entire m atrix beforehand — and training time is reduced. A further advantage, 
exploited in Chapter 4 and Joachims (1999a), is that, at each iteration, heuristics can be applied to 
accelerate training, tune the model parameters, such as C  and <7 , or reduce the model complexity.
An hyperplane (w, b) is an optimally separating hyperplane, if and only if the corresponding 
a  and £ values are a global optimum to the QP (3.22). This is the case if and only if the Karush 
Kuhn-Tucker (KKT) criteria are met (Vapnik, 1998). The K K T conditions for the QP (3.22) are 
equivalent to (Hsu and Lin, 2002):
- e  <  ((Q +  yyT )ot)i -  1 <  £, if 0 <  Qj <  C,
((Q +  yyT)a)i -  1 >  - e ,  if ati =  0, (3.25)
{(Q + yyT)a)i  -  1 <  C, if cx.i = C,
where Qij = aiajK (x.i,'x .j), y  = (y i , - - - ,y i )T and a  = (ct*,. . .  ,a / ) r . Theoretically the KKT 
conditions require t  =  0, in practice a looser stopping criterion of e =  0.001 is used (Joachims, 
1999a; Hsu and Lin, 2002). The solutions obtained by enforcing a stricter stopping criterion are 
rarely different from those obtained with e =  0.001.
Unless stated otherwise, the SVM implementation used in this work uses the working set
selection strategy of Hsu and Lin (2002), implemented in M atlab 6.0 (M atlab 6.0, 2001). The
working set size is set at q =  10. The subproblem optimization on the working sets is performed 
using the method of Hildreth (1957). The termination precision of the subproblem optimization is 
machine accuracy (10-16) and the precison of the term ination criteria (3.25) is e =  0.001.
3.1.4 Variable M isclassification Costs
In the optimization problem (3.22) all of the errors £* have equal weight C  in the minimand. That 
is, the cost A (+ l, —1) of mislabelling a negative example as a  positive one is the same as the cost 
A(—1, +1) of mislabelling a positive example as negative. W hen there are unequal misclassification 
costs it is necessary to  place different weights on the errors. I t may also be known th a t the 
proportion of positives in the training sample is different to  the proportion 7r+i of unseen 
examples th a t we wish to classify. This may be the case in drug discovery. For example, a set of
compounds may have been chosen for screening since they were expected to show some activity,
whereas the proportion of actives in general is low. Conversely, a set of compounds whose activity 
it is desired to  predict may be have been chosen on the basis of compounds already screened, and 
are likely to exhibit higher activity. In either case it is necessary to  reweight the errors in the 
optimization.
Lin et al. (2000) show th a t the term  C Y a =i f* (3-22) should be split into C + 5Zi|yi=+i £i +  
C~ Yli\yi= -i The regularization constants C + and C~ are then given by:
C + = A(—1, + l)7i+17r_iC, (3.26)
C~ = A (+ l, —IJttIjTT+i C, (3.27)
where 7r^x axe the proportions of positive and negative examples in the training sample and n±i 
are the ‘tru e’ proportions (or the proportions for the set of examples on which we wish to  make 
predictions)1. It is still only necessaxy to specify one regularization param eter C, which controls
1 Which could be estimated from previous experience.
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the overall amount of regularization.
3.1.5 Bounds on the E xpected  Error
The SVM maximizes the margin w.r.t. those points with & =  0 whilst minimizing 1 Margin 
maximization is an example of capacity control, th a t is, restricting the ‘size’ of the hypothesis space. 
The ‘size’ of an hypothesis space can be quantified by its Vapnik-Chervonenkis (VC) dimension. 
A set of points { x i , . . .  ,x*} is said to  be shattered by the set of hypotheses T  if for any labelling 
{j/i, ,  2/1} G {—1, -|-1}Z there exists a function /  G T  such th a t f ( x i ) = yi, i =  1 , . . . , / .  For 
example, hyperplanes / (x )  =  sgn((w, x) +  b) in can shatter any set of d +  1 points, in general 
position. The VC dimension, h , of a set of hypotheses T  is defined to be the size of the largest 
set of points th a t can be shattered by the set T .  There is no set of d -f 2 points in 9^ th a t can 
be shattered by hyperplanes. Hence, the VC dimension of hyperplanes in 5Rd is d +  1. This is also 
the number of free parameters of an hyperplane. This relationship between VC dimension and the 
number of parameters does not generally hold for more complicated classifiers. VC theory provides 
bounds on the expected generalization error of a classifier.
An alternative estimate of the expected generalization error of a classifier is the leave-one-out 
error. The leave-one-out (LOO) error of a classifier is calculated by training on I — 1 points and 
predicting the label of the remaining point. This is repeated for all I points and the errors averaged. 
The expected leave-one-out error is an almost unbiased estimate of the expected generalization error 
(Vapnik, 1998). The leave-one-out error is computationally expensive to compute. For support 
vector machines, the leave-one-out error can be upper bounded by analysing the geometry of the 
support vectors (Chapelle et al., 2002).
These bounds on the generalization error and LOO error avoid the need to reserve a portion 
of the d a ta  as a validation set for model selection, or to use computationally expensive cross- 
validation.
3.1.5.1 Bounds from VC-Theory
If the training data  (3.1) are linearly separable in the feature space 7i then the following bound 
on the expected generalization error e holds (Vapnik, 1998; Shawe-Taylor et al., 1996):
* <  O ( ^ )  . (3.28)
where R  is the radius of the smallest ball in feature space containing the training data, I is the 
number of training examples and 7  is the margin. The quantity R 2/ 7 2 is an estimate of the 
VC-dimension of the set of hyperplanes separating the data  with margin 7 .
The radius R  can be found by solving a quadratic programme of size I (Burges, 1998). This 
additional computational time can be avoided in certain cases. W hen using a  linear kernel, the 
training examples can be normalized to have length 1. For high dimensional data, e.g. in document 
classification (Joachims, 2000), this reduction in dimensionality does not affect the performance. 
W hen using a radial basis function kernel, the input data  are mapped to the surface of the unit 
sphere in feature space, since (0(x), <£(x))w =  exp(—||x — x ||/2 tr2) =  1. Hence, one can take 
R  =  1 as an upper bound on the radius of the smallest enclosing sphere. If cr is large then 
the d a ta  tend to be mapped to a very flat ellipsoid in feature space (Scholkopf et al., 1999b), the 
approximation R  =  1 then leads to a loose bound. To obtain a better estimate of the generalization 
error the data  can be rescaled in feature space (Chapelle and Vapnik, 2000) using the method
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of kernel principal components analysis (Scholkopf et al., 1997a), although this requires further 
com putational expense.
For the case where the errors £ are penalized linearly, i.e. k — 1 in (3.22), this bound is only 
applicable when the data are separable. For all of the data  sets used in this thesis, enforcing 
separability leads to a poorer solution than  does allowing errors (£ >  1) or margin errors (f >  0). 
Hence, this bound was not used in the work presented in this thesis. For the case where the 
errors are penalized quadratically (k =  2) this bound can be used for separable and non-separable 
problems, and has been shown to be predictive on a number of data sets (Duan et al., 2001; 
Chapelle et al., 2002).
3.1.5.2 Bounds on the Leave-One-Out Error
An alternative estimate of the expected error is the leave-one-out error. The leave-one-out (LOO) 
error of a classifier with respect to  a training set S  (3.1) is:
1 1 . ^
y £ ( x i , y i , . . . , x z,y/) =  -  ^  <S(/s\*(x*), Vi), (3.29)
1 = 1
where f s \ i  is the classifier trained on the set S  w ith the example (x», y*) removed, and 5 is the Kro- 
necker delta. The leave-one-out error is an almost unbiased estim ate of the expected generalization 
error (Vapnik, 1998), th a t is,
E (e /_1) =  i .E ( £ ( x i ,y i , . . . , x f,yi)), (3.30)
where s i_1 is the generalization error of a classifier trained on / — 1 examples and the expectations 
are taken over random choice of sample. The leave-one-out error is expensive to compute. For an 
SVM it is possible to obtain an upper bound on this quantity. Since, on removing a non-support 
vector from the training set, the solution computed does not change, the non-support vectors will 
not be misclassified in the leave-one-out procedure. Hence (Vapnik, 1995),
£ ( x i , y i , . . . , x t ,yz) <  N Sv,  (3.31)
where N s v  is the number of support vectors. Tighter bounds can be achieved by analysing the 
geometry of the support vectors (Chapelle et al., 2002). Vapnik and Chapelle (2000) provide a 
quantity based on the concept of the span of a support vector. Under the assumption that the 
set of support vectors remains unchanged during the leave-one-out procedure this gives the exact 
number of errors made during the leave-one-out procedure. This assumption is not likely to  be true 
in practice, but empirical evidence (Chapelle et al., 2002; Chapelle and Vapnik, 2000) suggests that 
this bound is predictive and tight. The authors suggest using the VC bound (3.28) in practice, 
however, as calculation of the span bound requires approximately as much computational time 
as training the SVM. During param eter selection typically many models are built and need to 
be rapidly evaluated. The VC bound is only valid for separable data  if the errors are linearly 
penalized (A: =  1 in (3.22)). The VC bound (3.28) can be used for non-separable data  if k = 2. 
This formulation is not used here.
A computationally efficient estim ate of the leave-one-out error, related to  the span bound, is 
given by the following.
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D efin ition  3.1 The a£ estim ator of generalization error is given by:
=  | # { i  = P ^ R 2 + ( i >  1}. (3-32)
where #  denotes cardinality, p =  2 and R 2 is an upper bound on maXi(K(xi ,Xi )) ,  i.e. the radius
of a sphere centred on the origin in feature space containing all of the training examples.
The a£ estim ator is an upper bound on the leave-one-out error.
Theorem 3.1 (Joachims, 2000) Provided (3 a i)(a i ^  C ), the leave-one-out error of an SV M  
on a training set S  is bounded as:
y £ (x i ,s / i , . . . ,X i ,y i)  < £ a €. (3.33)
If (3a*) (a* ^  C) then the solution is said to  be stable. There is no guarantee th a t this is the case, 
although it is usually true in practice (Burges, 1998). If R  is taken to  be 1, as in the special cases 
mentioned above (Section 3.1.5.1) then £la  ^ can be computed a t little extra cost from the SVM 
solution.
When there are unequal misclassification costs, the leave-one-out estim ator of risk is defined 
analogously to (3.29) as:
y £ A (x i,y i,- - - ,X |,y i)  =  (3.34)
1 1
j Y L x(fs\i(xi)>yi) =
1 = 1
n  £  A ( + l , - l ) F P s \ i +  5 3  \ ( - l , + l ) F N S\i  1 , 
i:y»=+l 1 J
where A is the loss function and F P s\i  and FN $\i are the number of negative and positive points, 
respectively, misclassified by the classifier trained on the set S \ i .  It follows from the theorem of 
Lunts and Brailovskiy (1967) th a t the leave-one-out estim ator of risk (3.35) is an almost unbiased 
estimator of the true risk.
Definition 3.2 The a£ estimator o f risk is given by:
: Vi = +!> Pa iR2 + & >  1}A(-1, +1) (3.35)
+  j- j# { i : yi =  —1, poiiR2 +  f* >  1}A(+1, —1),
where R 2 is an upper bound on maxj(.fiT(xi,Xi)), and p = 2, as before, and P  (resp. N )  is the
number o f positive (resp. negative) training examples.
A corollary of Theorem 3.1 is the following.
Corollary 3.2 Provided (3a*)(a* ^  C), the leave-one-out estimator o f risk of an SV M  on a 
training set S  is bounded as:
y £ A( x i ,y i , . . . ,x / ,y j )  <  e*a f . (3.36)
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This formulation will be useful for model order selection when there are unequal misclassification 
costs, which is often the case in pharmaceutical data analysis.
(Note th a t the proof given in Joachims (2000) is for the case where the QP is formulated as 
(3.15). Since the formulation (3.22) is equivalent to adding a constant to the kernel function and 
not enforcing the constraint a Ty  =  0  the proof follows as before.)
3.1.5.3 Empirical Comparison
The results presented above (Section 3.1.5.2) axe theoretical in nature. They provide estimates 
of the expected leave-one-out error or risk, but the following practical questions arise: Do the 
param eters minimizing the a£ estim ator provide minimal test error? How close to the test error 
axe the estimates? These questions are answered empirically for the problem of choosing the width 
param eter a  of a Gaussian kernel (3.12) for three data  sets. The d a ta  sets are as follows.
Cancer This data  set was obtained from the University of Wisconsin Hospitals, Madison from 
Dr. William H. Wolberg (Mangasarian and Wolberg, 1990; Bennett and Mangasarian, 1992). 
There are 699 examples of tum our cells, characterized by nine physiological measurements. 
One of the features has 16 missing values, these are replaced by the feature mean. The task 
is to  distinguish benign tum our cells (y =  —1) from malignant tum our cells (y =  +1). The 
proportion of malignant tum our cells is 71+! =  0.345.
D iabetes This data  set is from the National Institute of Diabetes and Digestive Kidney Diseases 
(Smith et al., 1998). There axe 768 examples of female Pim a Indians, chaxacterized by eight 
physiological descriptors. The task is to  predict presence (y =  +1) or absence (y =  —1) of 
diabetes. The proportion of the sample with diabetes is =  0.349.
H T S  This d ata  set consists of 489 compounds from the high throughput screening assay a3 (see 
Section 2.4.2). There axe 13 descriptors (feature set fs03). The task is to  predict whether 
a  compound is active (y =  +1) or inactive (y =  —1). The proportion of actives on this 
subsample is 7T+! =  0.056. This is much more unbalanced than  the other two data  sets.
The first two data  sets are available from the UCI Machine Learning Repository (Blake and Merz, 
1998). The third is proprietary to  GlaxoSmithKline. The attributes of all of the data  sets axe 
scaled to lie in the range [—1 , + 1]. This has proven in my experience to  result in faster convergence 
of the QP and is common in the SVM literature. It can be considered to  be a 1-norm version of 
standardizing the empirical distribution to have mean zero and standaxd deviation one.
Each data  set is randomly partitioned into training and test sets of equal size. An SVM was 
trained with C  =  1 and Gaussian kernel K (x , z) =  exp(—||x — z ||2/ 2 cr2) with cr e  {0 .1 , 0 .2 , . . . ,  1.0, 
1 .2 ,. ..  ,3.6}. The a£ estim ator (3.32) was calculated with R  =  1. The error on the test set was 
evaluated and the procedure was repeated for ten random partitions of the data  into training and 
test sets and the results averaged. The estimates and test errors axe plotted in Figures 3.2-3.4. 
The minimizer, <x, of the error estim ate has performance close to the minimal on the Cancer and 
Diabetes data. The error estimate is qualitatively different from the test error for the HTS data 
set. This set has a low proportion of positives and the low error estiam ate occurs when the SVM 
predicts all compounds to be inactive. This is obviously not desirable in practice as it simply tells 
the chemist not to bother screening anything.
As all three of these data  sets have more positive examples than  negative examples an alternative 
measure of performance is to assign a higher cost to misclassification of positive examples. If the
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Figure 3.2: Error Bound Comparison: Cancer, C  =  1. The minimizer, a, of the a f  estimate (dotted 
line) underestimates the minimizer, a*, of the test error (solid line). The test error obtained, e(d), 
is close to the optimal, e((T*).
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Figure 3.3: Error Bound Comparison: Diabetes, < 7 = 1 .  The test error (solid line) attains a 
minimum at around a  =  1.5 and increases slightly afterwards. The minimizer of the a£  estimate 
(dotted line) underestimates the minimizer of the test error.
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Figure 3.4: Error Bound Comparison: HTS, C = 1. The test error (solid line) is more-or-less 
constant over the range of a  tried. The a£ estimate (dotted line) increases with a. The behaviour 
of the a£  estimate is qualitatively different from that of the test error on these data.
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Figure 3.5: Risk Bound Comparison: Cancer, C  =  1. The minimizer of the a£ estimate (dotted 
line) is close to the minimizer of the test risk (solid line). The relative advantage (dash-dotted 
line) varies inversely with the test risk.
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misclassification costs are reweighted according to the class distributions then the cost of a false 
negative is A(—1, +1) =  1/tt+ i and the cost of a false positive is A (+l, —1) =  l / 7r_i.
The risk functional for classification is:
w ,6)) =  A ( + l , - l ) 7r_1P r{ / ( x ;w ,6) = + l |y  = - 1 ) }  (3.37)
+  A ( - l ,+ l ) 7r+ iP r { / ( x ;w ,6) =  - l \ y  =  +1)},
where 7nt is the prior probability of class k € {—1, +1} and A (I, k) is the loss incurred for making 
prediction I when the true class is k. If we set A(=pl, ±1) =  1 /tt± i then this becomes:
# ( /( • ;  w >h)) =  P r{ /(x ; w, b) =  + l \y  =  - 1 )} +  P r{ /(x ; w, b) =  - 1 |  y = +1)}. (3.38)
In practice, the training set proportions ir£ axe used instead. Minimizing this risk functional is 
equivalent to  minimizing:
FP F N
N  +  P  ’
instead of:
FP + F N  
N  + P  ’
where FP  (resp. FN)  is the number of false positives (resp. negatives) and P  (resp. N )  is the 
number of positives (resp. negatives) in the training set. The two approaches are equivalent for 
balanced data.
The estimate of expected risk was calculated by (3.35). The range of cr used above was 
in a neighborhood of the optimal value. To obtain a broader picture of the performance and the 
risk estimate, log(cr) was varied in {—2, —1.5 ,.. .,2} . The estimates and test risk are plotted in 
Figures 3.5-3.7. (The performance and estimates for cr = 0.001 were identical to those for a  =  0.01 
for all data  sets.) Also plotted is the relative advantage. We will return to  relative advantage as a 
performance measure later in Section 3.2.2.
For the first two data sets (Figures 3.5 and 3.6) the estim ate is similar to  the test risk. For 
the HTS data  the estimate is not predictive since it is much tighter when the risk is close to 1 than 
a t other values. This corresponds to predicting all negatives as positive, which is not desirable.
In summary, for Gaussian kernels the a£ estimate is a tight upper bound on the test error, 
and can be generalized to estimate test risk. The minimizer, a, of the estimate is close to the 
minimizer of the risk. Furthermore, the risk obtained by using a value of a th a t minimizes the 
estim ate is close to the risk of using the optimal value. There are two disadvantages in using the 
a£ estimate. Firstly, it is not valid when the solution is unstable, i.e. when all of the Lagrange 
multipliers a* are bounded at C. Anecdotal evidence suggests th a t this does not happen very often 
and th a t unstable solutions are rarely optimal. Secondly, the estim ator is not a reliable predictor 
near regions in param eter space where the SVM is predicting y  = — 1 (or y = 1) for all x. This 
is more likely to be the case when the proportion of positives or negatives (resp.) is low. On the 
HTS data, the propotion of positives is low and the estim ator performs poorly. These solutions 
can be discarded as the SVM will also predict yi = 1 for all x* in the training set.
Duan et al. (2001) show th a t the best estim ator of test error for an SVM is given by five­
fold cross-validation. However, this is a computationally intensive technique. They compared 
several easily computable estimators of a Gaussian SVM’s performance. They showed th a t the 
a£  estimate and generalized approximate cross-validation (GACV) (Wahba et al., 2000) perform 
well. However, GACV tends to be biased towards small a  and small C. The other measures
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Figure 3.6: Risk Bound Comparison: Diabetes, C = 1. The minimizer of the estimate (dotted 
line) is the minimizer of the test risk (solid line). The solution is unstable for log(<r) >  0.5 so the 
error estimate does not hold. The relative advantage (dash-dotted line) varies inversely with the 
test risk.
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Figure 3.7: Risk Bound Comparison: HTS, C = 1. The estimate (dotted line) is tighter when 
the risk (solid line) is 1. This corresponds to predicting all positives or all negatives. The a£ 
estimate is qualitatively the same for the other values, although overall it is not predictive since it 
is too loose. The relative advantage (dash-dotted line) varies inversely with the test risk.
69
evaluated were the radius margin bound (see Section 3.1.5.1), an approximation to the span bound 
of Chapelle et al. (2 0 0 2 ), and a VC bound of Vapnik (1998). All of these performed poorly, yielding 
bounds qualitatively different to the error and not predictive of the optimal parameters.
3.2 Performance M easures
Before considering the application of SVMs to pharmaceutical data  analysis, I describe some per­
formance measures. The first is the ROC curve, it is more informative than reporting a single 
number such as error rate or risk. The second is relative advantage, which is related to the global 
enhancement described in Section 2.4.2.1 .
3.2.1 R eceiver O perating Characteristic Curves
W hen classifying unseen data  two types of mistake are possible: misclassifying a positive example 
(y =  +1) as negative (y =  — 1 ) and misclassifying a negative example as positive. The first type 
of error is called a false negative (FN)  and the second a false positive (FP).  We can write:
total positives(P) =  true positives( TP)  +  false negatives (FN),  
to tal negatives(TV) =  true negatives(TW) +  false positives (FP).
Thus, the performance of the classifier can be summed up by two ratios: the true positive rate, or 
hit rate, T P / P  and the false positive rate, or false alarm rate, F P / N .  Under fixed misclassification 
costs X(l, k), l ,k  G {—1, +1} with no rewards, X(l, I) = 0, the aim is to minimize the expected risk,
W (* ; w, 6)) =  A ( + l , - l ) 7r_ iP r{ /(x ;w ,6) = + l |y  = - 1 ) }  (3.39)
+  A(—1, + l ) 7r+ iP r{ /(x ; w, b) = - l | y  =  +1)},
where 7Tfc is the prior probability of class k,  i.e. the class population proportion. Note that:
FP (  TP  \
A (+ 1 ,-1 ) tt_ i—  +  A (-1 ,+ 1 )tt+i 1 ^ 1 -— J  -► /? ( / ( . ;W ,6))
as Z —> oo. In practice, the true positive and false positive rates and the risk are evaluated on some
set of data  held out from the training set, known as a test set.
It is now easy to see how a classifier giving high accuracy (say, on the test set) can fail to be
of any use. In the drug discovery domain we wish to identify active compounds. In a given set 
of compounds the proportion of actives may be 5%. In this case a classifier could happily predict 
th a t all compounds are inactive and achieve 5% error. T hat this high level of accuracy is totally 
useless is apparent from the TP  rate of 0 (the FP  rate will be 0 also). A classifer with a TP  rate 
of 0.8 and an FP  ra te of 0.2 will have a higher error of 20% but will correctly identify 4% of the 
compounds as active. From (3.39) the error is the risk under equal misclassification costs. In order 
to  obtain a useful classifier the misclassification costs must taken into account. When classifying 
compounds as active or inactive, the cost of a false positive is the cost of subsequently screening 
th a t compound in vitro (or in vivo). The cost of a missed positive is very difficult to quantify, but 
will vary over different assays, a t different stages of the process and according to the opinions of 
different chemists.
In many domains the misclassification costs are not known a priori, or may be variable. In this
case it is desirable to have a classifier th a t performs well over a range of costs. If the cost of a
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Figure 3.8: ROC curves: Cancer. The ROC curve is generated by varying the decision threshold b  
for an SVM (C  =  1). Neither the RBF kernel (dashed line) nor the linear kernel (dotted line) has 
an ROC entirely containing the other. Both are much better than random (solid line). Note that 
only a small portion of the ROC curves are shown, as beyond a false positive rate of 0.06 both 
classifiers have a true positive rate of 1.
false alarm A(+l, —1) is increased then a lower false positive rate is desired. If the cost of a missed 
positive A(—1,4-1) is increased then a higher true positive rate is desired. The true positive rate 
and false positive rate of an SVM, or of any classifier of the form (3.2) or (3.21)) can be varied for 
a given w by varying the parameter 6, known as the operating point. As b —» — oo both rates —► 0, 
whilst as b —* oo both rates —> 1. This produces a receiver operating characteristic (ROC) curve 
that gives a picture of the performance of the classifier over a range of costs. The area under the 
ROC curve (AURO C) is a measure of the performance. It is equal to the Wilcoxon statistic, a 
distribution independent measure of classifier performance (Hanley and McNeil, 1982). A random 
classifier will have AUROC = 0.5 and a classifier that has perfect performance over all costs will 
have AUROC  =  1. (If a classifier is worse than random, i.e. AUROC < 0.5, then reverse its 
outputs to obtain AUROC > 0.5.) An example ROC curve is shown in Figure 3.8.
Note that for an SVM there is no guarantee that the operating point given by (3.20) or (3.24) 
is Bayes optimal, i.e. minimizes the true risk (Platt, 2000). Thus it may be advantageous to plot 
an ROC curve even if the misclassification costs are fixed, in order to optimize the operating point. 
The Bayes optimal risk, for a given w, is obtained by setting the operating point to be such that 
the slope of the ROC curve is A (+l, —1)/A(—1,4-1).
Friedman (1997) decomposes expected classification error rate into ‘boundary-bias’ and ‘vari­
ance’ and shows that intuition derived from the bias-variance trade-off in function estimation does 
not carry over to classification. He suggests, and supports with empirical evidence, that optimizing 
the operating point can reduce error rate (or risk) for biased learning algorithms such as /c-nearest 
neighbour (Mitchell, 1997) and naive Bayes (Duda and Hart, 1973), and aggregated methods such 
as bagging (Breiman, 1994). For unequal class priors the correction to the operating point is 
achieved by reweighting the examples according to the priors. This is equivalent to specifying the 
cost function of Section 3.1.5.3 above. Even when the priors are equal, the operating point can be 
optimized. Feng (2001) shows that the operating point of the standard SVM is suboptimal when 
the classes are asymmetric.
The ROC curve of a classifier allows us to calculate the empirical risk for any specification 
of costs. It allows the user to set the optimal operating point for a range of criteria including 
Neyman-Pearson, minimum recall, workforce utilization, etc. (Provost and Fawcett, 2000). It is
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thus a more useful indicator of performance than simply reporting error rates, or true and false 
positive rates, a t a given operating point.
An alternative, bu t equivalent, summary of the performance is to consider the trade-off between 
precision and recall. Precision is the probability th a t a  compound classified as positive truly is 
positive and recall is the probability th a t a positive example is correctly classified as such. These 
quantities are estimated as:
TP
precision =  Pr{?/ =  + l |/ ( x ;  w, b) =  +1} =  T p  + p p > (3-40)
TP
recall =  P r{ /(x ; w ,6) =  + l |y  =  +1} =  — . (3.41)
The precision-recall break-even point is defined to be th a t value for which the recall and precision 
axe equal, i.e. for which the number of false positives equals the number of false negatives. This is 
a commonly used measure of performance in text classification (Joachims, 1998) where documents 
may belong to  more than one category. These measures axe also useful in dxug design since a 
compound may be active against no targets, one target, or many targets.
3.2.2 R elative Advantage
In Chapter 2 (Section 2.4.2.1) above, the global enhancement was introduced as a useful measure 
of performance when analysing screening data. This measure was derived from the A50 and thus a 
ranking of compounds in order of activity is required to calculate it. A related measure is outlined 
below, which does not require such a ranking.
Define the AQ  of a predictive technique to be the number of compounds it is necessary to screen 
to  find Q% of the actives. Recall the definitions of Section 3.2.1. For a classifier, the percentage
of actives found is Q = T P / P  x 100. The number th a t must be screened to  find these actives is
the number predicted positive, viz.:
A Q = T P  + FP.  (3.42)
For a random  selection:
A Q = ™ ( P  + N) .  (3.43)
The global enhancement with respect to A Q is defined as the ratio of these quantities,
GE  =  +  =  * = * ! “  (3.44)
P / { P  + N )  7T+1 V '
This is equivalent to  the definition of relative advantage (R A ) proposed in Muggleton et al. (2000). 
The authors state th a t this measure of performance is useful when the number of positives is 
small, and when there is no guarantee th a t the all of the positives can be identified. This is 
generally the case when analysing HTS data. The relative advantage is related to the precision 
by (3.44), when the precision =  1, R A  is maximized and equals 1 /tt+ i. R A  is not a paxticulaxly
meaningful measure of performance unless TP  0. Dividing the precision by the proportion of
active compounds allows a  comparison across screens.
It is not possible to maximize relative advantage by minimizing a risk functional of the form (3.39). 
For a given assay, 7r+i is fixed, so maximizing relative advantage is equivalent to maximizing the 
precision, i.e. minimizing:
TP + FP FP
  -----= --------h i .  (3.45)
TP TP  v '
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Multiply the RHS of (3.45) by the constant P /N  and use the binomial expansion to obtain
argmax(JM ) =  argmin +  O  ( ( ) ) ) , (3.46)
where A =  F P / N  is the (unknown) false positive ratio. Setting A =  1 assumes T N  = 0 and so 
errs in favour of minimizing the error rate on the positives (active compounds). This leads to the 
risk functional already encountered in Sections 3.1.5.3 and 3.3.2. Recall from Figures 3.5-3.7 that 
minimizing this risk functional corresponds empirically to  maximizing relative advantage.
3.3 Applications
The support vector machine has shown good performance on many classification problems including 
handwritten digit recognition (Cortes and Vapnik, 1995), document classification (Joachims, 1998) 
and face detection (Osuna et al., 1997b). In Section 3 .3 .1 ,1 present results on the ordinal regression 
problem of Section 2.4.1. This work has appeared in Burbidge et al. (2000, 2001a). In Section 3.3.2, 
I present results on a problem of predicting the activity of competitive antagonists. In Section 3.3.3, 
I return to the problem of ranking compounds for high-throughput screening.
3.3.1 Predicting th e Inhibition o f D ihydrofolate R eductase
Recall the problem of predicting the reduction of dihydrofolate reductase from Section 2.4.1. It 
was shown th a t a multilayer perceptron achieved a cross-validated error of 0.1381% (s.e.: 0.0090), 
outperforming a radial basis function network and a decision tree. This improvement in accuracy 
was at the expense of longer training time. The neural network minimizing expected generaliza­
tion error was found by time-consuming manual tuning. This model tuning required an order of 
magnitude more computational time than  the training itself. The neural network algorithms in 
Clementine th a t attem pt to learn the network structure from the data  required correspondingly 
less computational time, a t the expense of performance.
As described in Burbidge et al. (2001a), an SVM was used to  classify these data. The SVMs used 
in th a t experiment were trained using the SVM h9ht package described in Joachims (1999a), on a 
SunOS Ultra-2 with 2 processors. Thus, a strict time comparision was not possible as Clementine 
was run on an NT workstation. Recently SVM h9ht has been ported to NT, the results reported 
below are for the same platform as th a t on which Clementine was run.
The kernel function used was a Gaussian RBF,
AT(x, z) =  exp )  ’ (3-47)
which projects the data  into a countably infinite dimensional feature space. The data  axe separable 
in this space for a suitable value of a, but, to avoid overfitting, the soft margin formulation of the 
SVM is used. This leaves two free parameters to  be specified, a  and C. These were selected by 
training an SVM for various values of these parameters, and selecting th a t pair which minimized 
the estim ator (3.33). The values tried were cr G {ctq, 2ao, 3<ro} and C G {Co, 10Co, lOOCo}, 
where <xo is given by a heuristic of Jaakkola et al. (1999) (see also Chapter 4, Section 4.2); and, 
Co =  R ~ 2 where R  is the radius of the smallest ball in feature space containing all of the data, 
as suggested by Cristianini and Shawe-Taylor (2000). Note th a t model selection is much easier for 
an SVM than for neural network algorithms. There are no learning rates or decay terms, and the
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free param eters can be set w ithout use of a hold-out validation set.
The cross-validated error of the SVM was 0.1269% (s.e.: 0.0086), which is lower, but not 
significantly so (again, using the t-test a t 95% confidence), than the manually tuned and ‘dynamic’ 
neural networks. It is significantly lower than  the other algorithms tested. The main advantage 
of the SVM in this case is th a t much less human effort was required during model selection. The 
compuational time was also significantly reduced. The mean training time was 29s, which is an 
order of magnitude less than for the manually tuned neural network. The to tal model selection 
time for the SVM was 596s, compared to 5000-20000s for the various neural networks. Note also, 
th a t the model selection time for the SVM includes the training time, as the model selection is 
performed using all of the available training data. The decision tree was quickest to train, but gave 
poorer generalization accuracy.
It is interesting to note th a t an SVM with a Gaussian RBF kernel performed well, yet C l e m e n ­
t i n e ’s RBF network performed worst of all of the algorithms tested, even though the number of 
RBF centres was varied from 2 up to the number of support vectors in the SVM solution (about 
200). This suggests either th a t the fc-means clustering method of C l e m e n t in e  is not as good at 
locating centres as the SVM, or th a t a Gaussian RBF is not a good choice for these data. It has 
been suggested th a t perhaps the d ata  are poorly distributed and hence a  large number of RBF 
centres are required2. An RBF network with a large number of centres is likely to  overfit (Bishop,
1995), whereas an SVM, even with many centres (i.e. support vectors) avoids overfitting by means 
of margin maximization. A comparison of RBF networks and SVMs is provided by Scholkopf et al. 
(1997b). In th a t study the improved performance of the SVM appeared to  be due to the location 
of the RBF centres. It is not possible to specify the location the RBF centres in C l e m e n t in e , s o  
this was not investigated. It remains an avenue for further research.
3.3.2 Predicting A ctiv ity  o f C om petitive A ntagonists
The data  analysed in this section were provided by GlaxoSmithKline. The compound set is com­
posed of various groups. Each group is fairly homogeneous, as it is composed of congeners of 
compounds th a t were confirmed active at the early screening stage. There are also likely to be 
present other compounds, or compound groups, th a t were added later after a chemist had analysed 
the screening results, or incorporated domain knowledge. Some of the compounds are so similar 
th a t they are indistinguishable on the basis of physicochemical properties. For example, chiral 
pairs have slightly differing structures but the same molecular weight, number of hydrogen bond 
donors, etc. When activity is thresholded this may lead to inconsistent data. T hat is, a point in 
d ata  space is labelled both +1 and —1. This is not a problem for the SVM, as one compound will 
be treated  as an error and the other classified correctly. It does however, preclude separation of 
the data, necessitating the need for the soft margin formulation. (See Chapter 5, Section 5.1.1, for 
a discussion of this aspect of the data.)
Competitive antagonists are described in Section 3.3.2.1 , together with details of the screening. 
The results of SVM classification of these data  are presented and discussed in Section 3.3.2.2 
together w ith some approaches th a t a ttem pt to improve the accuracy of the classifier.
3.3.2.1 C om petitive Antagonists
An agonist is a signalling molecule which binds to a receptor inducing a conformational change 
which produces a response. An antagonist is a drug which attenuates the effect of an agonist.
2Tom Khabaza, personal communication.
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Assay Assay
1 0.28 7 0.49
2 0.38 8 0.56
3 0.70 9 0.52
4 0.38 10 0.35
5 0.56 11 0.42
6 0.58
Table 3.1: Competitive Antagonists: Proportion of active compounds (positives) in each of the 
training sets. Since these compounds are further downstream in the drug discovery process than 
those screened in HTS there is a higher proportion of actives to inactives, between 2:5 and 7:3.
Antagonists may be competitive, non-competitive or uncompetitive. A competitive antagonist 
binds to  a region of the receptor which overlaps the region bound by an agonist. The agonist and 
antagonist compete for the same binding site and cannot simultaneously occupy the receptor. The 
potency of a competitive antagonist is quantified by the equilibrium dissociation constant, K b , 
as determined in a functional assay. This is the concentration of antagonist which would occupy 
50% of the receptors at equilibrium. This may be determined by Schild analysis (Arunlakshana 
and Schild, 1959) — a concentration-response curve is plotted for the agonist, in the presence of 
varying quantities of the antagonist. Theoretically, this value should be the same as the K i  value 
determined in a radioligand competition binding assay. In  this assay the agonist is radio-labelled 
and is screened a t only one concentration, usually below its equilibrium dissociation constant for 
the receptor, K d • The specific level of binding of the agonist is then determined in the presence 
of a range of concentrations of a competing non-radioactive ligand (the antagonist). The data  for 
each competing ligand are usually fitted to  an hyperbolic equation from which the IC50 can be 
determined. The IC50 is the concentration of antagonist required to reduce the specific binding 
of the radioligand by 50%. This is then converted to a K i  value by the Cheng-PrusofF equation 
(Cheng and Prusoff, 1973),
IC50
i _l M  ’ (3.48)
1 +  Kd
where [L ] is the concentration of free radioligand used and K d  is its equilibrium dissociation 
constant for the receptor. Whereas the IC50 value for a compound may vary between experiments 
the K i  is an absolute value. Typically, the negative logarithm of this quantity, p K i , is reported 
as the measure of activity against the receptor. Since a ligand is screened over a limited range of 
concentrations it may not be possible to specify an exact p K i , instead it may be reported as less 
than or greater than those limits implied by the concentration range.
The 1415 compounds analysed in this report were screened against 11 targets (receptors), of 
various classes, in competitive binding assays and the corresponding pK i values calculated. The 
proportion of active compounds in each of the training sets, 71+!, is shown in Table 3.1.
The problem is to predict the pK i values based on some set of descriptors. For the purposes of 
classification, a compound is treated as active if its pK i is greater than  6 . The feature set included 
six descriptors considered biologically relevant by GlaxoSmithKline (though not previously used 
to predict pK j values), and eight one-dimensional descriptors such as molecular weight, CLOGP 
(Leo and Weininger, 2000), number of hydrogen bond donors and acceptors, etc. The attributes 
were all scaled to  lie in the range [—1 , + 1].
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pK j C * Error AUROC RA
Train s.e Test s.e. t P
1 1 0.16 0 .0 2 0 .2 2 0 .0 1 2 .6 6 0 .0 0 0.77 2.77
2 10 0 .1 0 0 .0 2 0.27 0 .0 1 8.28 0 .0 0 0.76 1.65
3 1 0.14 0 .0 2 0.26 0 .0 1 5.40 0 .0 0 0.72 1.05
4 1 0.13 0 .0 2 0.25 0 .0 1 5.53 0 .0 0 0.78 1.82
5 10 0.14 0 .0 2 0.33 0 .0 1 8.32 0 .0 0 0.72 1.29
6 1 0.17 0 .0 2 0.37 0 .0 2 8.26 0 .0 0 0 .6 8 1 .1 2
7 10 0.04 0 .0 1 0.32 0 .0 1 15.89 0 .0 0 0.73 1.36
8 10 0 .0 2 0 .0 1 0.27 0 .0 1 16.04 0 .0 0 0.78 1.37
9 1 0.14 0 .0 2 0.31 0 .0 1 7.49 0 .0 0 0.74 1.38
10 10 0.04 0 .0 1 0.23 0 .0 1 11.55 0 .0 0 0.80 1 .8 6
11 1 0 .1 1 0 .0 2 0.24 0 .0 1 6.29 0 .0 0 0.82 1.83
Table 3.2: Competitive Antagonists. Error rate for SVM, with a Gaussian kernel. The test error is 
much higher than  the training error, i.e. the SVM is overfitting the data  (t and p  values are shown 
for the null hypothesis th a t the SVM is not overfitting). The last two columns show the area under 
the ROC curve (A U RO C ) and the relative advantage (R A ). C* is th a t value minimizing the 
estimator.
3.3.2.2 R esults and Discussion (SVC pKi)
To evaluate the performance of the various classification algorithms the data  were partitioned 
randomly into training and test sets of sizes 395 and 1020 respectively (this choice will be explained 
in Chapter 5, Section 5.1.1, below). For each of the 11 screens, an SVM was trained using the 
physicochemical descriptors. A Gaussian RBF kernel AT(x,z) =  exp(—||x — z ||2 / 2 <x2) was used. 
The RBF width a  was set using the heuristic of Jaakkola et al. (1999) as in Section 3.3.1. The 
param eter C  was varied in {1 ,10} and chosen as th a t which minimized the a£  estimator (3.32). (In 
the case of a tie, the classifier with the lower number of SVs was chosen, as motivated by (3.31).) 
The generalization error was estimated as the misclassification rate on the test set.
The error rates and their standard errrors on the training and test sets are shown in Table 3.2, 
together with the area under the ROC curve {AUROC)  on the test data  (see Section 3.2.1). 
The ROC curve is generated by varying the operating point b in the SVM solution, / (x ;  w, b) =  
sgn((w, ip{x.))n  +  b). For seven of the data  sets the optimum value of C  from {1,10} was 1, in 
three cases it was 10. The difference in test error between C  =  1 and C  — 10 was not significant 
for any one d ata  set. The value of C  minimizing the estim ator was the minimizer of test error 
for C  £ {1,10} in eight cases. (Under the null hypothesis th a t the a f  chooses randomly, this 
has probability 0 .1 1 .) Thus, even though the classifiers obtained by setting C  =  1 or C  =  10 
were similar, the a£  estim ator still tended to choose the slightly better one. It is evident from 
Table 3.2 th a t the SVM is overfitting the training data. The error rates are significantly lower on 
the training set than on the test set, particularly for C  = 10. This is probably because a is too 
small, see Chapter 5.
For comparison, a C5.0 decision tree, implemented in C l e m e n t in e  6.0 (Clementine 6.0, 2001) 
was trained on the same data. The error rates and their standard errors on the test set are shown in 
Table 3.3. The performance of C5.0 is comparable to that of the SVM. The SVM has a significantly 
lower test error (£-test at 95%) on three of the eleven assays. I t may be possible to determine if 
the SVM is performing better than C5.0 on the other assays by using the McNemar test (Ripley,
1996) or by averaging over repeated partitions of the data into training and test sets. However, 
the error rates are so large th a t the difference is of no practical importance.
A dynamic neural network (see Section 2.4.1.1) was also trained on these data. The dynamic
76
pK i
Test
C5.0 
s.e. t P Test
Dynamic 
s.e. t V
1 0 .2 2 0 .0 1 0 .0 0 0.50 0.36 0 .0 2 7.05 0 .0 0
2 0.29 0 .0 1 1 .0 1 0.16 0.45 0 .0 2 8.62 0 .0 0
3 0.30 0 .0 1 2 .0 1 0 .0 2 0.31 0 .0 1 2.51 0 .0 1
4 0.23 0 .0 1 -1.06 0.15 0.36 0 .0 2 5.43 0 .0 0
5 0.37 0 .0 2 1.90 0.03 0.43 0 .0 2 4.68 0 .0 0
6 0.38 0 .0 2 0.47 0.32 0.43 0 .0 2 2.77 0 .0 0
7 0.33 0 .0 1 0.48 0.31 0.37 0 .0 2 2.38 0 .0 1
8 0.32 0 .0 1 2.48 0 .0 1 0.33 0 .0 1 2.96 0 .0 0
9 0.32 0 .0 1 0.49 0.31 0.41 0 .0 2 4.73 0 .0 0
10 0.25 0 .0 1 1.06 0.15 0.30 0 .0 1 3.59 0 .0 0
11 0.25 0 .0 1 0.53 0.30 0.28 0 .0 1 2.06 0 .0 2
Table 3.3: Competitive Antagonists. Test error rates for C5.0 and a dynamic neural network. The 
performance of C5.0 is comparable to th a t of the Gaussian SVM. The dynamic neural network 
performs badly, t and p  values are shown for the one-tailed test th a t C5.0 or Dynamic has the 
same performance as the SVM.
neural network is implemented in C l e m e n t in e  6.0, 20% of the training data  are held out as a 
validation set to automatically optimize the network architecture. The error rates on the test set 
are also shown in Table 3.3. The error rates of the dynamic neural network are significantly higher 
than the SVM on all assays and significantly higher than those of C5.0 on eight assays.
On these data, using a Gaussian SVM does not lead to  better predictive accuracy than the 
decision tree. This could be because the Gaussian RBF kernel is not a  good choice for these data, 
or has not been correctly tuned. If the width param eter a  is set too small then many of the training 
data become SVs and the decision surface thus overfits the training data. As <j  —» 0 the kernel 
becomes the Dirac delta function, i.e. the SVM is behaving as a memory machine. If a  is large 
then the decision surafce is too smooth and many SVs are again needed to capture the variation 
in the training data. As a  —> oo all of the training data are projected to the same point in feature 
space (since all of the inner products —» 1 ).
The number of training points th a t become SVs on each of these d ata  sets is shown in Table 3.4. 
Also shown is the number of iterations for each run. The training requires more iterations a t the 
higher value of C  since the seaxch space for the optimization is laxger (0 < a* <  C). This also 
leads to  a larger function space, containing more flexible basis functions, hence fewer SVs axe 
needed. The proportion of training points th a t become SVs is large (55%-85%). This is a further 
confirmation th a t the SVM is overfitting the training data.
There axe a number of ways to attem pt to increase the accuracy of a classifier, and to reduce 
the model complexity. The problem of tuning a Gaussian RBF kernel is postponed to Chapter 4 
(Section 4.2). An alternative is to  use domain knowledge to  construct alternative representations 
of the objects of interest (in this case chemical compounds). This and other approaches axe 
investigated further in Chapter 5 (Section 5.3.3).
3.3.3 A nalysis o f  H TS D ata
In this section, I return to the high throughput screening d a ta  of Section 2.4.2. The standaxd 
SVM is used to classify each of the twenty-one data  sets (corresponding to the seven assays and 
three feature sets). The attributes were scaled to lie in the range [—1,+1]. In these experiments 
the software package LOOMS (Lee and Lin, 2000) is used. This learns an SVM classifier with a
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p K j C =  1 C  = 10
Wjter N sv Niter N sv
1 832 269 4169 238
2 1029 312 4976 264
3 1655 310 2757 282
4 1 0 1 1 304 2833 273
5 936 337 3011 298
6 1537 324 2795 306
7 892 329 5256 298
8 1343 318 4307 265
9 1443 329 2473 297
10 1153 260 4150 218
11 1496 277 2495 244
Table 3.4: Competitive Antagonists. Number of iterations (N neT) and number of SVs (N sv) for 
the standard  SVM. Training requires more iterations for C  =  10 since the search space for the 
Lagrange multipliers is larger (0 <  a* <  C). Fewer SVs are needed to  construct the decision 
surface at C  =  10 as the function class is larger.
Gaussian kernel. The model param eters C  and a  are chosen to  minimize the leave-one-out error by 
performing an extensive search over hypothesis space. While such a search will introduce bias into 
the performance estimates (Ng, 1997) we would still expect LOOMS to  have good performance. 
A disadvantage is th a t it is not possible to  specify misclassification costs in LOOMS. Owing to 
the low proportion of positives, the SVM thus classifies all of the compounds as inactive. This 
is useless in practice. However, there are good reasons for expecting the unthresholded output of 
the SVM to be monotonic in the posterior probabitity of a compound being active (P latt, 2000). 
Thus, it is still possible to rank the compounds for screening set selection. Even so, the standard 
SVM fails to  improve on the classical techniques of linear and logistic regression, despite the search 
over param eter space. Although much slower, the M atlab implementation (Section 3.1.3) allows 
one to  adjust the misclassification costs. This compensates for the low hit ra te and improves 
performance.
3 .3 .3 .1  R a n k in g  C o m p o u n d s
Recall the performance measure of Chapter 2 (Section 2.4.2.1). A prediction method is used to 
rank the compounds for in vitro screening. The A50 was defined to  be the number of compounds 
th a t it would be necessary to  screen in order to find half of the active compounds. The global 
enhancement ( GE) was defined to be the ratio of the A50 for random selection to the actual A50. 
To calculate an A50 it is necessary to rank the compounds according to  predicted activity. For 
classification, a conditional probability p(x) =  Pr{y =  + l |x }  or confidence measure is required 
to rank the compounds. An alternative method of ranking the compounds is to  use classification 
to perform ordinal regression, as was done for the pyrimidine data  (Chapter 2, Section 2.4.1). 
However, this leads to  a classification data  set of size 2 1(1 — 1), i.e. all comparisons and their 
inverses, which is impractical if I is large, as it is for HTS data.
The support vector machine solution,
/ (x )  =  sgn((w, V»(x))w +  b), (3.49)
cannot be used immediately to  rank the compounds. Although (3.49) is an estim ator of sgn(p(x) — 
1 / 2 ), it is not the case th a t (w, -0(x) ) w + 6  is an estimator of p(x) (Lin et al., 2000). It is possible to
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fsOl
SVM
fs0 2 fs03 fsOl
Logistic
fs02 fs03
a l 1 .0 2 0.83 1.24 1.51 1.27 1.26
a2 2.05 2.57 2.70 2.48 2.57 2.07
a3 1 .1 0 0.62 2 .2 0 1.92 3.27 3.49
a5 1.91 1.35 0.95 2.17 1.37 1.35
a6 18.80 1.28 1.91 5.21 1.28 2.93
a7 1 .1 1 0.94 1 .1 1 1.72 1.08 1 .6 6
a8 2.83 4.54 2.51 4.15 4 .54 3.65
Table 3.5: HTS Results: LOOMS. The global enhancement (GE) over random screening is shown 
for the LOOMS software (left). This performs autom ated model order selection for an SVM with 
Gaussian kernel. The best performance (emphasized) is the same as the best classical technique 
(logistic regression, right) on one assay, poorer on four assays and better on two. The range of 
GE is surprisingly large. Although assay a6  with feature set fsOl was easiest for the classical 
techniques, the GE for the SVM is over three times higher.
obtain an estim ator of p (x ) by training a kernel classifier to  minimize a regularized log-likelihood 
score (P latt, 2000). However, this will produce a non-sparse representation of the decision function. 
P la tt (2000) suggests fitting a sigmoid to  (w, /ip(x))n  after training the SVM. This requires some 
kind of validation to  avoid over-fitting the sigmoid to the training data, and is computationally 
intensive. A recently suggested technique (Zhu and Hastie, 2002) is to minimize the regularized 
log-likelihood on only a subset of the training data. This aims to  estimate p(x) directly, whilst 
maintaining the sparsity of the SVM solution. A greedy forwards search strategy is required to 
determine a good subset of the data.
As we require only a  ranking of the compounds, it is not necessary to estimate p(x) explicitly. 
There is a strong reason for assuming th a t the unthresholded output of the SVM (w, ip(x))n  is 
monotonic in p(x) (P latt, 2000). Hence we may use the unthresholded output of the SVM to rank 
the compounds. This approach is taken here.
3.3.3.2 R esults and Discussion (SVC HTS)
The global enhancement (GE) of LOOMS over random screening is shown in Table 3.5. The overall 
performance of LOOMS is worse than  th a t of the best classical technique, viz. logistic regression. 
On feature set fsOl logistic regression wins six out of seven times. On feature set fs02 logistic 
regression wins four out seven times, and ties with LOOMS on three. On fs03 logistic regression 
wins on six out of seven assays. If we assume th a t the best feature set could be chosen for each 
assay then logistic regression would win on four assays and LOOMS would win on two assays. 
The poor performance of LOOMS suggests th a t it is im portant to  allow for the fact that the data 
sets are unbalanced. LOOMS performs model selection by minimizing the leave-one-out error rate. 
This will be minimized when predicting most or all of the compounds to  be inactive. If the lowest 
error rate is achieved by predicting all examples to  be in one class, then the lowest LOO error rate 
will be given by the smoothest solution. In 14 out of 21  cases, the param eters minimizing the LOO 
error ra te were C — 1, the smallest considered, and a  =  44, the largest considered. The decision 
surface is highly oversmoothed and underfits the training data. In such a situation, the assumption 
that the distance of a compound in feature space to the separating hyperplane is proportional to 
the probability th a t the compound is active is unlikely to hold.
In an attem pt to improve the global enhancement, an SVM was trained with the loss func­
tion (3.38). This was shown empirically, in Section 3.1.5.3, to be inversely related to the relative
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C  =  1 C =  1 0 0 0
fsOl fs02 fs03 fsOl fs0 2 fs03
a l 1.14 1.27 1.40 1 .1 0 1.17 1.36
a2 1.80 2.56 2.36 2.59 1.25 2.74
a3 4.80 3.27 3.88 1 .8 6 3.27 1.76
a5 1 .2 0 1.37 1.24 2.25 1.37 1.30
a6 1.76 1.28 1.75 9.12 1.05 5.30
a7 1.52 1.08 1.54 2 . 0 0 0.85 1.55
a8 2.18 4.53 3.90 3.57 0.94 3.96
Table 3.6: HTS Results. The global enhancement (GE) over random screening is shown for the 
SVM when trained with unequal misclassification costs. The best performance (emphasized) is 
better than  LOOMS on five assays, and poorer on two assays.
advantage (RA). The R A  of a classifier is equivalent to the GE of a ranking (Section 3.2.2). These 
experiments were implemented in M atlab. Owing to computational time only two values of C  
and one value of a  were tried. As LOOMS did not provide any guidance as to a good choice of 
these, the following were used (Hsu and Lin, 2002). The SVM was trained with C  € {1,1000} and 
K (x .,z)  =  e x p —(||x  — z ||2/d ). When C  =  1000 the SVM was term inated after 10000 iterations 
owing to excessive training time. The global enhancements are reported in Table 3.6.
This led to much denser models and non-zero true positive rates, which implies th a t the decision 
surface actually passes through the data (as opposed to  the data  being entirely on one side of it). 
Overall there was an improvement in performance. The SVM with unequal costs had a  higher GE 
than LOOMS on five assays and lower GE on two. It had a higher GE than  logistic regression on 
six assays and lower on one. This analysis assumes th a t the optimal feature set could be chosen 
for each algorithm, and the better value of C  for the SVM with unequal costs could be chosen.
The risk on the test set was very close to  the risk on the training set for all assays and feature 
sets. This implies th a t the SVM is not overfitting the data. It seems unlikely th a t the solutions 
could be improved by much. It may be possible to increase the GE by adjusting the loss functional, 
or by examining the ROC curve.
These d a ta  are not investigated further in this thesis. The results of this and the previous 
chapter are reconsidered in Chapter 6  with some suggestions for further work.
3.4 Summary
The SVM is an established learning machine for classification th a t has been shown to have state-of- 
the-art performance on a wide range of applications. The advantages of the SVM are often cited as 
good predictive performance, sparsity of the solution, and few free parameters. These advantages 
are not always obtained when the SVM is applied to classification problems from drug discovery.
The key points and contributions of this chapter are as follows.
•  The few free param eters of an SVM can be set by minimizing an error or risk estimate.
— The width, a , of a Gaussian kernel can be set by minimizing Joachim’s estim ator ela 
This is computationally efficient and provides an estim ate of cr giving performance close 
to  optimal.
— A minor disadvantage is that it does not hold for unstable solutions. These are easily 
identified and, in the author’s experience, are rarely optimal.
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— ela£ can also be used to estimate risk when the misclassification costs are unequal. 
Solutions which predict all examples to  be in one class should be discarded, as ela  ^ is 
much tighter for these solutions, and is hence misleading.
— The £la£ estimator performed poorly for model order selection on the HTS data. This 
was probably because the data  set has few postives.
•  Care should be paid to performance analysis when the class priors are unequal. The mis­
classification rate may not be a useful indication of performance. The area under the ROC 
curve {AUROC) and relative advantage (RA) are more suitable measures of performance 
when learning decision rules for drug discovery.
— Reweighting the misclassification costs according to  the class priors can provide more 
meaningful solutions.
— Minimizing this risk empirically maximizes the relative advantage, this quantity is anal­
ogous to the global enhancement.
•  On a  small-scale QSAR problem the SVM achieved a lower error rate than  autom ated neural 
networks and a C5.0 decision tree.
— An SVM achieved better performance (but not significantly so) than  a manually tuned 
neural network.
— The SVM was much faster to train  than the neural networks, although it was slower 
than  a decision tree.
— In addition to requiring less time for model selection, tuning the SVM required much 
less human effort.
•  In Chapter 2 it was shown th a t an RBF network did badly on these data, yet the SVM with 
equivalent kernel performed well. A sigmoid neural network performed well. These contrasts 
suggest the following as further work.
— Train an RBF network with centres a t the support vectors selected by the SVM. An 
improved RBF performance would suggest th a t the autom ated selection of centres per­
formed by the SVM led to the improved performance.
— Train an SVM with a kernel to  mimic a sigmoid neural network with one hidden layer. 
An improved performance would suggest th a t a sigmoid is better able to describe the 
data  than an RBF.
•  In predicting the activity (pKi) of competitive antagonists the SVM did not generally out­
perform a simple, quick to train  decision tree, but it did outperform an automatically tuned 
neural network. The aim of the present work is to investigate the SVM for pharmaceutical 
data  analysis. W hilst C5.0 may seem a better avenue of investigation based soley on this 
analysis, past experience of chemoinformaticians has shown th a t decision trees are not good 
enough. The vanilla SVM has not significantly outperformed C5.0. In the remainder of the 
thesis, I present attem pts to improve the SVM.
— Across the 11 assays ela^ tended to select that C  minimizing test error, although the 
differences between C = 1 and C = 10 were not large.
81
— The SVM overfitted the training data, this may have been due to a poor choice of the 
param eter a  in the kernel. The problem of autom atically tuning a  is considered in the 
next chapter.
— The solutions had many support vectors. One of the advantages of the SVM was lost. 
The problem of reducing the number of SVs is considered in the next chapter.
— Predictive performance will be poor when the descriptors used do not encode sufficient 
information to  accurately separate active from inactive compounds, contain noise, axe 
irrelevant, or are redundant. In Chapter 5 alternative feature sets are used to learn a 
classifier for these data.
•  A state-of-the-art autom ated SVM with Gaussian kernel was slightly worse than the best 
linear technique (logistic regression) over a range of HTS classification problems.
— The software package LOOMS performs a search over model space, and chooses that 
model minimizing the LOO error. However, it has equal misclassification costs and thus 
predicts all compounds to be negative (since this gives the lowest error).
— This deficiency can be partly overcome by treating the unthresholded output of the 
SVM as being monotone in the probability of a compound being a hit.
— The GE of LOOMS was in general worse than th a t of logistic regression.
— The poor performance is unlikely to be due to inadequate param eter selection, since 
LOOMS performs an extensive search.
— Training an SVM to minimize a loss function related to R A  led to  higher GE in general 
than obtained by LOOMS or logistic regression.
— W ith this loss functional, the solutions had many support vectors. Again, the advantage 
of sparsity was lost.
— The SVM was not overfitting the data. The solutions probably cannot be improved by 
much.
• These d a ta  are not investigated further. Some possibilities for future work are as follows.
— The performance attained seems near optimal for a Gaussian kernel. Future work could 
investigate use of alternative kernels for classifying these data.
— To improve G E , R A, or whatever performance measure is of interest, the loss functional 
could be adjusted. Use could also be made of the ROC curve. (Note th a t GE is 
independent of the operating point, but R A  is not.)
— Logistic regression performed well. Incorporating the flavour of the SVM would suggest 
regularized kernel logistic regression.
The SVM has been introduced and its advantages and disadvantages discussed and demon­
strated on public domain and drug discovery d ata  sets. In the next chapter, heuristics are intro­
duced to  overcome some of the disadvantages. In Chapter 5, these are applied to the analysis of 
the pKi data sets.
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Chapter 4
H euristics for SVC
h e u r is tic  . . .  Computing proceeding to a solution by trial and 
error
T h e  C o n c is e  O x f o r d
In the previous chapter, the SVM for classification was introduced. Its advantages and disadvan­
tages were discussed and dem onstrated on some public domain and drug discovery data sets. The 
disadvantages highlighted in the analysis of the GlaxoSmithKline d ata  motivated the development 
of the heuristics presented in this chapter. In Section 4.1, a new stopping criterion for the SVM 
is introduced. This allows early termination of the SVM w ithout loss in predictive performance. 
This stopping criterion is also useful when using the other heuristics, since the modified SVM is 
no longer guaranteed to converge to a global (or even local) optimum. In Section 4.2, the LAIKA 
heuristic for tuning the width of a Gaussian kernel is introduced and developed. In Section 4.3, 
the STAR heuristic for reducing the number of support vectors is described. The results and 
conclusions are summarized in Section 4.4.
4.1 Stopping Criteria
1 In many practical data-mining situations it is not necessarily desired to obtain a global maximum, 
assuming one exists. Many existing applications of machine learning to data-mining have many 
local optima, e.g. neural networks (Hertz et al., 1991) and decision trees (Breiman et al., 1984). 
The SVM, in contrast, is the solution to a convex quadratic program and as such has a global 
optimum.
Work on reducing the run-time complexity of support vector classification has thus far concen­
tra ted  on decomposing the quadratic program (Joachims, 1999a; P la tt, 1999; Hsu and Lin, 2002) 
or developing on-line perceptron like algorithms (Freund and Schapire, 1999; Friefi et al., 1998; 
Gentile, 2001; Li and Long, 2001). The stopping criteria of these algorithms are defined in terms 
of the optimization problem. From a data-mining point of view this may not be necessary. For 
example, during exploratory d ata  analysis the data  miner usually desires to  obtain approximate 
solutions for a variety of algorithms before deciding which is most suited to the task in hand. For 
this purpose one can specify various stopping criteria. In designing an SVM toolkit therefore one 
should include stopping criteria based on training time, number of cycles through the data  set (for 
online algorithms), and expected generalization error.
1This work has recently been accepted for publication (Burbidge, 2002b).
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In the following section, a heuristic stopping criterion for support vector classification is pre­
sented. In Section 4.1.2, the performance of the SVM with this stopping heuristic is compared to 
the performance of the classifier obtained by training until a global optimum is found. Stopping the 
SVM early can lead to a substantial reduction in training time, w ith little or no loss in accuracy. 
This is especially the case when the regularization constant C  is high.
4.1.1 Persistence
The expected generalization error is of particular relevance to  support vector classification of 
complex d ata  sets. For example, for the Diabetes data set analysed in Chapter 3 (Section 3.1.5.3) 
convergence to the global optimum of the QP can be very slow for certain kernels and param eter 
settings. The same phenomenon is observed on many d a ta  sets provided by GlaxoSmithKline. 
However, on all of these data  sets solutions sub-optimal in term s of the QP perform as well as 
the global optimum in term s of classification risk. This may be related to observations about the 
hypothesis space made by Herbrich et al. (2002) namely th a t there are a large number of hypotheses 
that have the same performance characteristics. These sub-optimal solutions to the QP can often 
be found in considerably less training time than the global optimum of the QP.
In order to assess the quality of a solution, optimal or otherwise, use can be made of error 
bounds or estimators. The estimator (Joachims, 2000, see also Chapter 3, Section 3.1.5.2) can 
be evaluated at little cost during training. This quantity is an estim ator of the expected leave- 
one-out (LOO) error over the data  set, which is an almost unbiased estim ator of the expected 
generalization error. However, this estimator is only valid a t the global optimum. Theoretically, 
this is when e =  0 in (3.25). In practice, the SVM is only trained to e =  0.001. Lee and Lin 
(2000) have shown, on a number of publicly available data  sets, th a t the LOO error rate of an 
SVM trained to  a precision of e =  0.1 is qualitatively the same as th a t of an SVM trained to  a 
greater precision. This result has also been confirmed on the competitive antagonist data  analysed 
in Chapter 3 (Section 3.3.2) and Chapter 5 (Section 5.3.3) . 2 This empirical evidence suggests th a t 
the a£  estim ator may be used heuristically during training to  a give a rough measure of the relative 
change in estimated risk.
Thus one can specify a value for ‘persistence’ and term inate the algorithm when this number of 
iterations (or cycles through the data  set for online algorithms) have been performed with little or 
no change in the value of the a£ estimator. Such criteria are often used for termination of neural 
network training, e.g. as in Clementine (SPSS, 1999). The advantage of using such a criterion for 
an SVM however is th a t little computation is required to evaluate it. When using such a stopping 
criterion for a neural network a subset of the training data, known as a hold-out or validation set, 
must be witheld from training. The neural network is evaluated on this set to provide an estimate 
of the true error. This method has two disadvantages: not all of the available data are used 
for training, and evaluating the learned decision function on the hold-out set introduces further 
computation. Both of these disadvantages axe avoided with an SVM since the estim ator is 
calculated a t little cost from the a  and f  values, a hold-out set not being required.
The behaviour of the a£  estim ator and of the test error of an SVM during training is illustrated 
in Figure 4.1 for the Diabetes data  set (see Chapter 3, Section 3.1.5.3 above) and the following 
data set.
Io n o sp h e re  This data  set was created by Vince Sigillito a t Johns Hopkins University, Maryland 
(Sigillito et al., 1989). There are 350 examples of radar returns, characterized by 34 attributes.
2 Steven Barrett, GlaxoSmithKline, personal communication.
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Figure 4.1: HERMES. An SVM with Gaussian kernel was trained on 50% of the data, with 
C = 1000. The a£ estimator (dotted line) is qualitatively the same as the test error (solid line) 
during the later stages of training. The behaviour of the a£ estimator can thus be used to define a 
heuristic stopping criterion. Note that the test error attains its minimum after only a few iterations. 
Moreover, the test error is rather poor, both for the Diabetes data  (left) and the Ionosphere data 
(right), thus stopping early is advisable when searching for a good value of C  or a.
The problem is to discriminate between ‘good’ radar returns (y = +1) from the ionosphere 
and ‘bad’ radar returns (y = —1). The proportion of good returns is 7T+J =  0.64.
A Gaussian kernel was used with cr = y/d/2 , where d is the number of input attributes, and 
C = 1000. The data were split into training and test sets of equal sizes. The figure illustrates 
that the test error reaches its minimum many iterations before the termination criteria for the 
QP are satisfied. The a£  estimator also levels off when the minimum of the test error is attained, 
suggesting that, at least under these conditions, the above heuristic is a useful stopping criterion. 
It should be noted that, unlike a neural network trained with an iterative gradient-based method 
— where stopped minimization can prevent overfitting (McLoone and Irwin, 2001) — the SVM 
does not begin to overfit the training data with increased training.
A further point is that the test error on both data sets is rather high, which implies that the 
choice of C  and a may be poor. It is desirable to stop training early during parameter selection 
to avoid wasting effort on such, possibly poor, parameter settings. In the following, this heuristic 
will be termed HERMES (Heuristic Error Rate Method for Early Stopping).
4.1.2 Results and Discussion (HERM ES)
The data sets used in the evaluation of HERMES were the Diabetes data (see Chapter 3, Sec­
tion 3.1.5.3) and the following.
H e a rt This data set was created by Robert Detrano at the V.A. Medical Center, Cleveland. (The 
version used here is that used in Statlog (Michie et al., 1994)). There are 270 examples of 
patients characterized by 13 physiological attributes. The task is to discriminate between 
absence (y = —1 ) and presence (y =  +1) of heart disease. The proportion of patients with 
heart disease is 71+j =  0.44.
A d u lt This data set was created by Ron Kohavi and Barry Becker at Silicon Graphics (Kohavi,
1996). The two data  sets used here, A dultl (1605 examples) and Adult4 (4781 examples), 
are the versions used by P la tt (1999). The data are census data. The problem is to predict 
whether or not a person earns more than S50K per year (y = + 1), based on 14 attributes, such
85
c 1 5 10 1 0 0 0
Australian 0.1449 0.1377 0.1420 0.1783
Diabetes 0.2250 0.2250 0.2289 0.2724
Heart 0.1741 0 .2 0 0 0 0 .2 0 0 0 0.2407
Adult 1 0.1700 0.1694 0.1675 0.2131
Adult4 0.1626 0.1634 0.1651 0.2249
Table 4.1: HERMES. 10 fold CV error rates. The SVM was trained with a Gaussian kernel, with 
cr =  y /d /2 , and persistence of 100. Individually, the results are not significantly different, at 95%, 
from the standard SVM.
C 1 5 10 1 0 0 0
Australian 0.1464 0.1377 0.1435 0.1783
Diabetes 0.2307 0.2281 0.2307 0.2568
Heart 0.1778 0.1926 0 .2 0 0 0 0.2482
Adult 1 0.1682 0.1701 0.1738 0.2118
Adult4 0.1625 0.1671 0.1728 0.2248
Table 4.2: BSVM. 10 fold CV error rates (Hsu and Lin, 2002). The SVM was trained with a 
Gaussian kernel, with a  =  y/d /2 . Individually, the results are not significantly different, at 95%, 
from using HERMES.
as m arital status, occupation, etc. There axe eight categorical variables and six continuous 
variables. The continuous variables have been discretized into quintiles. This results in 123 
binary variables in total. The proportion of persons earning over $50K per year is 7T+! =  0.25.
A u s tra lia n  This data  set consists of 690 examples of credit card applications, described by 14 
attributes (Quinlan, 1987). The problem is to predict whether an application is approved (y =  
+1) or declined (y =  —1). Missing values have been replaced by the mean (for continuous 
attributes) or the mode (for nominal attributes). Nominal attributes are coded as integers. 
The proportion of applications th a t were approved is 71+j =  0.68.
All of the attributes were scaled to lie in the range [—1 , + 1]. The SVM was trained with a Gaussian 
kernel K {x , z ) =  exp(—||x —z||/d ), where d is the dimensionality of the data. The SVM was trained 
for C  G {1,5,10,1000}. The persistence was set a t 100, i.e. the SVM was halted if there had been 
no change in for 1 0 0  iterations .3
The results for the standard SVM are those reported by Hsu and Lin (2002) for their software 
BSVM. The M atlab implementation used for HERMES uses the same QP formulation and the 
same chunking strategy as BSVM (and the same parameters). There are minor differences in the 
number of iterations of the M atlab implementation and BSVM since the M atlab implementation 
solves the subproblem to machine precision using the Hildreth and D ’Espo algorithm, whereas 
BSVM uses TRON (Lin and More, 1999). The M atlab implementation requires about 10% fewer 
iterations on the Heart and Adult data  sets. (In terms of absolute runtim e BSVM is much quicker 
since it is implemented in C. Hence, the number of iterations is recorded here for purposes of 
comparison.)
The 10 fold cross-validated error rates of the SVM with HERMES are shown in Table 4.1. These 
are almost identical to those obtained by training the SVM to a global optimum, see Table 4.2. 
The only notable differences are for Adult4, with C  =  10, where early stopping did slightly better 
(p  =  0.08), and Diabetes, with C =  1000, where BSVM did slightly better (p  =  0.16).
3 Recall that ela  ^ is a discrete variable.
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HERMES BSVM
D ata I Nsv verr N ite r Nsv N e rr N ite r
Australian 690 245 98 205 245 98 2 0 0
Diabetes 768 447 168 132 447 168 131
Heart 270 130 36 47 130 36 53
Adult 1 1605 695 243 261 691 228 293
Adult4 4781 1877 716 765 1888 700 841
Table 4.3: HERMES. C  =  1. Since the number of iterations required is fairly small when C  is 
small, the SVM converged before the HERMES criterion was satisfied. The minor differences in 
the results are due to the differing implementations of the QP solver.
HERMES BSVM
D ata I Nsv N e rr N i te r Nsv N e rr N ite r
Australian 690 242 28 4304 2 2 2 28 12609
Diabetes 768 403 127 4939 377 128 21908
Heart 270 10 2 0 706 101 0 1230
Adult 1 1605 690 16 3177 649 14 9098
Adult4 4781 1987 11 0 27731 1811 97 85103
Table 4.4: HERMES. C  =  1 0 0 0 . The SVM was halted by the HERMES criterion on all five data 
sets. The reduction in the number of iterations (Viter) required varies from 43%-77%. The price 
paid is a slight increase in the number of support vectors (N sv)  and the number of training errors 
(Verr).
The number of iterations required by the SVM w ith and w ithout early stopping are shown 
in Table 4.3 and Table 4.4 for C  =  1,1000 respectively. Also shown are the number of support 
vectors and the number of training errors. For the smaller value of C  the SVM converged before the 
HERMES criterion was satisfied. For the larger value of C  the SVM term inated on the HERMES 
criterion on all five data  sets. The reduction in the number of iterations varied from 43%-77%, 
although up to  10% of this is due to the different QP solvers used. The price paid is a slight increase 
in the number of support vectors (1%-10%) and in the number of training errors (0%-14%). These 
increases are related since training errors become SVs. These could be removed heuristically by 
the R aR method of Burbidge et al. (2001b) or by STAR (see Section 4.3, below).
Training past a certain point, then, does not improve the generalization accuracy of the SVM, 
but it can slightly reduce the number of support vectors and the number of training errors. The 
stopping criterion HERMES can substantially reduce the training time of an SVM, without a 
reduction in generalization accuracy. The most significant increase (p  =  0.16) in generalization 
error when stopping early was on the Diabetes data, with C  =  1000. This also corresponded to the 
greatest reduction in the number of iterations. This suggests that, as with all heuristics, one should 
take caxe to  validate the solution obtained. Finally, note th a t BSVM was specifically developed 
for the case where C  is high and was shown to require substantially fewer iterations a t C = 1000 
than the then state of the art SVM**sW (Hsu and Lin, 2002; Joachims, 1999a).
4.2 Autom ated M odel Order Selection
The simplest kernel for data  in a Euclidean space is the linear kernel V (x , z) =  x Tz, which uses 
the scalar product between examples as the similarity measure. O ther popular kernel functions are 
designed to  mimic well-known classifier systems, such as the polynomial kernel K (x, z) =  (xTz + l ) d 
and the Gaussian radial basis function kernel (RBF) K (x ,  z) =  exp(—||x — z ||2/2cr2). When using
87
a Gaussian RBF kernel the scale param eter a must be specified in advance. This parameter can be 
thought of as the width of the RBF. It controls the trade-off between faithfulness to the training 
d a ta  and smoothness of the decision surface in the input space. W hen a  is too small the SVM 
overfits the training data, essentially every training point becomes an RBF centre (support vector). 
If a  is too large then the SVM underfits the training data, as it is not able to  adequately capture 
the inherent complexity of the data  generating process. The quality of the solution depends on 
the choice of a  (see Figures 3.2-3.7).
One basic approach is to train  the SVM for a range of values of a  and use that value which 
minimizes some estimate of the generalization error (e.g. those given in Chapter 3, Sections 3.1.5.1 
and 3.1.5.2). This approach is prohibitive in terms of training time, which for an SVM has been 
found empirically to scale quadratically in the sample size (P latt, 1999; Joachims, 1999a).
In Section 4.2.1, below I describe some incremental approaches to  automatically tuning kernel 
parameters. These approaches train  the SVM for a range of parameters and choose th a t param eter 
minimizing an error bound. In the subsequent sections, I present and refine a heuristic for updating 
the width param eter a  during optimization. This heuristic is evaluated on a number of publicly 
available d ata  sets and compared to  the underlying (fixed) heuristic on which it is based.
4.2.1 Increm ental Tuning
Consider the case of a Gaussian kernel with one free param eter a. The most basic approach to 
model order selection is to train  an SVM for a range of values of a  and choose th a t value minimizing 
some estim ate of the generalization error. The generalization error, e , of an hyperplane classifier 
with margin 7  can be upper bounded as follows (Vapnik, 1995):
(41)
where R  is the radius of the smallest ball containing the training set and I is the number of training 
points. The radius R  is approximable by 1 for a Gaussian kernel (see Chapter 3, Section 3.1.5.1). 
Cristianini et al. (1998) show that this bound is smooth in cr. They suggest the following procedure 
for Gaussian kernels.
1 . Initialize cr to a very small value.
2 . Maximize the margin.
•  Compute the error bound.
•  Increase the kernel param eter cr«— cr +  5a.
3. Stop when a predetermined value of cr is reached, else repeat 2 .
The motivation here is th a t for small cr convergence is rapid, and few iterations will be required to 
bring the solution back to the maximal margin solution after each update. This approach, when 
implemented with the kernel-adatron algorithm (Friefi et al., 1998), provides a reasonable value of 
a  for good generalization. The experiments reported used hard margin SVMs, for which there is 
no regularization param eter C.
W hen there is more than one param eter to choose for the SVM the above approach becomes 
computationally infeasible. For example, Lee and Lin (2000) consider 14 values of a  and 11 values 
of C  for soft margin SVMs with Gaussian kernels. This leads to  154 param eter sets. To evaluate 
the performance of the SVM on all 154 param eter sets in a reasonable amount of time the authors
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use some numerical tricks to calculate efficiently the actual leave-one-out error rate. Further, in 
calculating the error rate the stopping precision used in (3.25) is e =  0.1, instead of the more 
precise and more standard e =  0.001. This relaxed criterion allows an approximate solution and 
error ra te  to  be calculated more rapidly and provides close to optimal param eter selection over the 
ranges tested.
A more principled approach to param eter selection is provided by Chapelle et al. (2002). If 
the errors & in (3.15) are quadratically penalized, corresponding to k = 2, then the regularization 
param eter C  can be treated as a kernel param eter. The kernel m atrix in the Wolfe dual is modified 
according to  ^ (x ^ x * )  «— K (x i,X i)  + l / C  and the constraint C > cti >  0 in (3.18) becomes a* >  0. 
W ithin this framework it is possible to calculate the differential of an error bound with respect to 
the kernel param eters. Chapelle et al. (2 0 0 2 ) calculate the derivative of the VC bound (4.1) and 
of the span bound. The span bound (Chapelle and Vapnik, 2000) is a tight upper bound on the 
leave-one-out error rate, but is not continuous in the kernel parameters. In order to overcome this 
a regularized version is used. This introduces a further parameter.
S tarting from small values of C  and a  for a Gaussian kernel the SVM is trained and the gradient 
of the bound calculated. A step is taken in param eter space in the direction of maximum decrease 
in the error bound and the SVM is retrained. They compared this approach to  estimating error 
rate by five-fold cross-validation for 10 values each of C  and cr, as described in Ratsch et al. (2001). 
The main advantage of the gradient descent approach is th a t the number of SVMs trained is much 
less than the 500 required by the cross-validation approach. In practice, Chapelle and Vapnik 
(2 0 0 0 ) recommend performing the gradient descent with respect to the VC bound (4.1) as this is 
easier to  calculate than the span bound and has fewer local minima. Note th a t the VC bound (4.1) 
can only be used for non-separable data  when the errors are penalized quadratically.
4.2.2 H euristic Approaches
The above approaches to adaptive tuning of SVMs suffer from two disadvantages. Firstly, they all 
require sequential retraining of the SVM for a range of values of cr. The solution to each successive 
quadratic program should be close to  the previous one since the margin depends smoothly on 
a  (Cristianini et al., 1998). This results in an approximate doubling of the training time for 
the method of Cristianini et al. (1998). Chapelle and Vapnik (2000) also report an approximate 
doubling of training time. Secondly, the gradient descent algorithms have an additional layer of 
machinery. This introduces extra parameters regarding the training rate and extra computation 
in calculating the gradients.
One aspect common to all of the above techniques is th a t a  is tuned according to  predicted 
error. An alternative approach is to tune a  to be on the scale of the margin of separation, i.e. 
to let the d a ta  dictate directly the value of cr. An RBF network is usually trained by first using 
some clustering technique to  choose the RBF centres c* and widths cr* and then performing a 
classification (or regression) step in the feature space implicitly defined by the RBFs (Bishop, 
1995; Ripley, 1996). Bishop (1995) suggests setting all cr* equal to some multiple of the average 
separation of the centres. To allow for different widths in different areas of space, the widths may 
be set to  be the average distance from each basis function to  its fc-nearest neighbours, for some 
small value k. Jaakkola et al. (1999) suggest a similar heuristic for the RBF kernel of an SVM,
o'j d h  =  m ed ian ! min ||x *  — Xj| |2 ) ,  (4.2)
V lw=+i )
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T hat is, a  is set to be the median separation of each example to  its nearest neighbour in the other 
class. The positive and negative examples are not transposable in this definition. If the classes 
are highly imbalanced, e.g. 7r+i <  0 .0 1 , then the median should be taken with respect to the 
under-represented class. The difference is negligible for the d ata  sets considered here.
Since the SVM solution depends only on the support vectors, which axe the RBF centres, it 
seems desirable to apply this heuristic to the support vectors only. The simplest way to do this 
would be to  train  the SVM, calculate a  from the set of support vectors obtained, and retrain with 
the updated cr. This process could be repeated until the solution appeared to  stabilize (although 
there is no guarantee that this would happen). This simple procedure involves retraining the SVM 
for a range of values of cr and is hence undesirable. In the following sections, I describe and analyse 
some online approximations to  this process.
4.2.3 A pproxim ating th e Support V ector Set
Since we wish to  apply the above heuristic only to the basis function centres (support vectors) an 
approximation to the set of support vectors is required. LAIKA (locally adaptive4 iterative kernel 
approximation) updates a  during training based on some estim ate of the final support vector set. 
Initially, the width is set to be <t j d h - After every ha iterations of the decompostion algorithm cr is 
updated according to:
a  =  median ^min llx i ~  x j l |2^  > (4-3)
where A  and B  are as described below.
Version 1.0 of LAIKA (Burbidge, 2002a) updates a  on the current SV set, th a t is a t the £th 
iteration (where t is some multiple of ha),
A (t) = {xi|c*j(£) >  0 & yi =  - 1 } ,
B (t) = {xi|a*(£) >  0 & yi =  1} ,
where a*(£) is the Lagrange multiplier of x* at the £th iteration. Initially, the sets A  and B  will 
provide very poor approximations to the sets of SVs. Nearer convergence, the approximations will 
improve.
Burbidge (2002a) demonstrated th a t this algorithm converged to a value of cr close to  that 
predicted by a line search to minimize the estimator, for the Cancer, Heart and Ionosphere 
data sets. On the Diabetes d ata  set, the 10 fold CV error of LAIKA was significantly worse than 
that obtained by the line search. It was postulated th a t this may be due to the high number of 
training errors and support vectors. The main advantage of using LAIKA instead of a line search 
was th a t the training time was reduced by a factor of four to 2 0 0  for the various data sets.
This algorithm was also implemented on the pharmaceutical classification problem of Sec­
tion 3.3.2 and was shown to suffer from some disadvantages. The results are discussed more fully 
in Chapter 5 (Section 5.2.2). The data  sets consisted of overlapping classes, with the SVM error 
rate being around 25%. This led to  dense solutions with the m ajority of the training data  becoming
support vectors. T hat is, the median separation of SVs was approximately the same as for the
entire data  set. The adaptive tuning had little effect. Also, the 25% of the training data  that 
become errors are also SVs — thus, errors contribute to  the adaptive tuning, which is intuitively 
unsound.
4Note that adaptive is used here in the standard English sense, not in the statistical sense meaning convergence 
to the optimal value.
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Version ha =  2 0 40 60 80 1 0 0
1 .0 0.0360 0.0360 0.0383 0.0394 0.0377
1 .1 0.0323 0.0323 0.0323 0.0323 0.0326
1 .2 0.0329 0.0331 0.0331 0.0334 0.0329
Table 4.5: LAIKA Version 1: Cancer, £7 =  1. The test error is almost constant for different values 
of the update frequency ha. Versions 1.1 and 1.2 slightly outperform version 1.0. The errors are 
lower than for C  =  10.
Version
o<MII8 40 60 80 1 0 0
1 .0 0.0526 0.0531 0.0531 0.0526 0.0531
1.1 0.0469 0.0471 0.0471 0.0474 0.0477
1 .2 0.0460 0.0469 0.0469 0.0463 0.0463
Table 4.6: LAIKA Version 1: Cancer, C  =  10. The test error is almost constant for different values 
of the update frequency ha. Versions 1.1 and 1.2 slightly outperform version 1.0. The errors are 
higher than  for C  =  1.
Version 1.1 of LAIKA attem pts to  address these problems by using
A (t)  =  { x i |a i(t) > 0  k  £ < 1  & y i = - 1 } ,
B ( t ) =  {xj|a!i(i) > 0 & f < l & y j  =  l} ,
th a t is, letting cr depend only on the current set of correctly classified SVs. This should overcome 
some of the disadvantages of version 1.0. Also, since fewer points are being used in the calculation, 
it is quicker to evaluate. An extension of this is version 1 .2  for which
A (t) =  {x i|a i(t) > 0 & £  =  0 & y i  =  -1 }  ,
B ( t ) =  {xi|c*i(t) > 0 & £  =  0 & y i  =  l} ,
th a t is, a  depends only on support vectors that lie on the edge of the margin band (i.e. are not 
margin errors). For separable data, these constitute all of the SVs, whereas for non-separable data 
these axe termed free SVs.
Since the objective is to automatically tune one of the few free param eters of the SVM the 
question arises as to whether this has been achieved. The above heuristics update a  according 
to (4.3) every ha iterations. This appears to have removed the param eter a  a t the expense of 
introducing a new param eter ha• The param eter ha is not strictly required, as the most obvious 
thing to do is to  update on every iteration. After each update it is required to  recalculate the 
cached values of the gradient and the Hessian for the quadratic program. To speed up training 
time it is advisable to update a  only periodically.
The above three versions of LAIKA were used to classify the Cancer d ata  set (see Section 3.1.5.3). 
The update frequency ha was varied in {20,40,60,80,100}, for C7 6  {1,10}. The algorithm was 
trained on 50% of the d ata  and evaluated on the remaining 50%, all results axe averaged over ten 
such runs. Since the algorithm is not guaranteed to converge, the maximum number of subproblem 
iterations was set at 10000. The test errors axe shown in Table 4.5 for C  =  1 and Table 4.6 for 
C  =  10. For this data  set the update frequency has almost no effect on the test error, for either 
value of C. This data set is not particularly challenging in my experience — there is a large region 
in param eter space th a t gives the same error rate.
A more challenging data  set is Diabetes (see Section 3.1.5.3). The optimal region in parameter
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Version ha =  20 40 60 80 100
1.1 0.2516 0.2520 0.2513 0.2516 0.2516
1.2 0.2402 0.2422 0.2406 0.2406 0.2399
Table 4.7: LAIKA Version 1: Diabetes, C  =  1. The test error is almost constant for different 
values of the update frequency ha. Versions 1.2 slightly outperforms version 1.1. The errors are 
lower than  for C  =  10.
Version ha =  20 40 60 80 100
1.1 0.2832 0.2832 0.2835 0.2832 0.2832
1.2 0.2721 0.2728 0.2725 0.2721 0.2721
Table 4.8: LAIKA Version 1: Diabetes, C  =  10. The test error is almost constant for different 
values of the update frequency ha . Versions 1.2 slightly outperforms version 1.1. The errors are 
higher than  for C = 1.
space is smaller, see Lee and Lin (2000) for visualizations of the error surface for this and other 
publicly available data  sets. The test errors are shown in Table 4.7 for C  =  1 and Table 4.8 
for C  =  10. Owing to excessive training time and poor performance, version 1.0 was not fully 
evaluated on this data  set. Again, the update frequency has almost no effect on the error rate. 
Version 1 .2  slightly outperforms version 1 .1 .
In  Section 3.1.5.3, an SVM was trained on both of these data  sets (with C  =  1) for a range of 
values of the width param eter cr. The error ra te achieved by LAIKA in one run is the minimal 
error ra te achievable on these data, under these conditions.
4.2.4 Reducing Training Tim e
The objective of this approach has been to adaptively tune the SVM without increasing training 
time. In an attem pt to  reduce training time the heuristics were adapted. Instead, of updating cr 
according to the present set of (correct, free) support vectors, a  is updated only on those points 
th a t have been (correct, free) support vectors for the last ha iterations. Analogously to  shrinking 
(Joachims, 1999a) and STAR (Burbidge et al., 2001b), these points are more likely to be (correct, 
free) support vectors in the final solution. Updating only on these points requires less computation, 
and should avoid unnecessary deviations during learning caused by adapting cr to  points which will 
not appear in the final solution. The corresponding heuristics are term ed versions 2.0, 2.1, and 2.2. 
For these three versions the update frequency had almost no effect on the error rates, which were 
the same as versions 1.0, 1.1 and 1 .2 , respectively, on the Cancer data. On the Diabetes data the 
error rates for versions 2.1 and 2.2 were the same as those for versions 1.1 and 1.2 respectively. In 
general, the test accuracy only depended upon the type of support vector used in the calculation 
of cr and not upon the update frequency. Updating on free SVs gave the best results, followed by 
updating on correct SVs and updating on all SVs.
Since the update ra te  ha does not affect the error ra te  it may be possible to select it such 
th a t the training time is lowest. The effect of ha on training time is shown in Figure 4.2 for the 
Cancer data  set and Figure 4.3 for the Diabetes data. Figures are only shown for C  =  1 as this 
was optimal for both data  sets. The graphs for C  =  10 are similar, w ith training times being of 
the same order.
These figures show th a t a high value of ha leads to shorter training times. This is to be expected 
since there are fewer updates and hence less computation. Increasing ha further may lead to  shorter 
training times but ultimately the behaviour of LAIKA will be lost. Over all of the experiments
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Figure 4.2: LAIKA: Cancer C  =  1. Training time decreases as ha increases, since fewer updates are 
being made. Versions 2.1 (crossed, dashed line) and 2.2 (crossed, dotted line) are fastest. Versions 
1.1 (circled, dashed line and 1.2 (circled, dotted line) approach the fastest as ha increases. Version 
2 .0  (crossed, solid line) is slowest.
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Figure 4.3: LAIKA: Diabetes C = 1. Training time decreases as ha increases, since fewer updates 
are being made. Versions 1.1 (circled, dashed line) and 2 .1  (crossed, dashed line) are fastest. 
Versions 1.2 (circled, dotted line), 2.0 (crossed, solid line) and 2.2 (crossed, dotted line) approach 
the fastest as ha increases.
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Figure 4.4: HERMES and LAIKA. As in Figure 4.1, the estimator (dotted line) is qualitatively 
the same as the test error (solid line) during training. Note that the test error is much lower on 
Diabetes when using LAIKA than using the original value (cf. Figure 4.1).
version 2.1 tended to be fastest. Version 2.2 tended to give the lowest error rates but sometimes 
failed to converge within 10000 iterations. Version 2.2 is actually the quickest for those cases where 
it does converge. If an alternative stopping criterion were available (other than optimality of the 
QP), then version 2.2 would be the favoured heuristic. Such a criterion was proposed in Section 4.1. 
A further motivation for preferring version 2.2 is that it usually gives the sparsest solution (i.e. 
the one with the fewest support vectors), and always gives a solution sparser than that of version 
2.1. This seems to confirm the motivation behind LAIKA. The RBF centres should ideally be free 
support vectors, since these are less likely to be noisy points, and the RBF width should be on the 
scale of their separation, such that fewer SVs are needed to construct the boundary.
4.2.5 Stopping Criterion
It is proposed to use version 2.2 of LAIKA to automatically tune the parameter a during training. 
However, as noted in the previous section, this heuristic is not guaranteed to converge and an 
alternative stopping criterion is required. Such a heuristic criterion was presented in Section 4.1.1 
above. One should be wary of combining heuristics however.
The behaviour of the a£ estimator and the test error of an SVM during training with LAIKA is 
illustrated in Figure 4.4 for the Diabetes and Ionosphere data sets (see Chapter 3, Section 3.1.5.3 
and Section 4.1.1, above, respectively, for details). The update frequency was set at ha = 20. 
Again, C  =  1000 and the data were split into training and test sets of equal sizes. The same 
conclusions can be drawn as before, suggesting that HERMES and LAIKA are compatible.
4.2.6 R esults and Discussion (LAIKA)
The chief objective of the above work has been to develop a heuristic for obtaining a Gaussian 
SVM solution without prespecifying the width parameter a. The development of the heuristics 
was motivated by the observations of Burbidge (2002a) regarding the heuristic of Jaakkola et al. 
(1999) and LAIKA version 1.0. On complex or noisy data sets, where ~  2 (% of the training data 
become training errors, these heuristics underestimate a. Given this motivation, it is appropriate 
to evaluate the performance of the refined heuristic on such data sets. The data sets: Diabetes, 
Heart, Adult 1, Adult4 and Australian are used here. These vary in the number of examples and
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c 1 5 10
Australian 0.1449 0.1580 0.1551
Diabetes 0 .2474 0.2592 0.2803
Heart 0 .1889 0.2037 0.1926
Adult 1 0.1712 0.1775 0.1837
Adult4 0.1649 0.1766 0.1866
Table 4.9: SVM. 10 fold CV error rates. The SVM was trained with a Gaussian kernel, with width 
(Tjdh- T hat minimum error over the three values of C  is emphasized.
C 1 5 10
Australian 0.1449 0.1478 0.1420
Diabetes 0.2276 0.2526 0.2513
Heart 0.1926 0.1889 0.1815
Adult 1 0.1681 0.1662 0.1725
Adult4 0.1703 0.1707 0.1887
Table 4.10: LAIKA. 10 fold CV error rates. The SVM was trained with a Gaussian kernel, with 
the width param eter updated by LAIKA version 2 .2 . T hat minimum error over the three values 
of C  is emphasized.
dimensions, and in the types of the attributes and preprocessing, but all typically have 15%-25% 
training errors after SVM classification.
For the SVM, cr was set using the original heuristic <t j d h  (4.2). This value was also used as the 
initial value (<ro) for LAIKA. LAIKA version 2.2 is used here, as this was the preferred version. 
The update period was ha =  100 iterations. HERMES is used as the stopping criterion with a 
persistence of 1 0 0 .
The 10 fold cross-validated (CV) error rates of the SVM axe shown in Table 4.9. The error 
rates for LAIKA are shown in Table 4.10. The error rate of LAIKA is lower than th a t of the SVM 
except on Heart with C  =  1 and Adult4 with C  =  1 , 1 0 . None of the individual differences are 
significant. The p-values for the two-tailed t-test of the null hypothesis th a t LAIKA and the SVM 
have the same error ra te  over the five data  sets are 0.1292, 0.0540, and 0.0234 for C  =  1,5,10, 
respectively.
If ela£ had been used to select the optimal value of C  E {1,5,10} then LAIKA would have won 
three times and the standard SVM once (with one draw). This is because ela  ^ selected the optimal 
value of C  on only two data  sets when using LAIKA. For the standard SVM, elaie selected the 
optimal value of C  on all five data  sets. One should be wary of combining too many heuristics.
The optimal value of C  for the SVM was 1 for all five data  sets. The performance deteriorated 
as C  was increased. For the higher values of C, LAIKA partially compensated for these poorer 
choices of C  (this is reflected in the p -values quoted above). The coefficient of variation of error 
with C  was on average about 30% less than  th a t of the SVM. Overall, any improvement in accuracy 
in using LAIKA over using the original heuristic is minor and not significant for any individual 
problem.
The training times of the SVM and the SVM with LAIKA are shown in Table 4.11 and Ta­
ble 4.12 respectively. Training with LAIKA took on average 35% longer than training the SVM. 
The training time of LAIKA varied haphazardly with the size of the data  set and the value of 
C. On average, the number of iterations of LAIKA was the same as for the SVM. The number 
of iterations was in general reduced for the larger data sets and larger values of C  and increased 
in the opposite scenario. In other words, when the SVM required few iterations, LAIKA required
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c 1 5 10
Australian 4 7 8
Diabetes 6 11 16
Heart 1 2 3
Adult 1 17 26 34
Adult4 134 226 360
Table 4.11: SVM. Training times (in minutes). The SVM was trained with a Gaussian kernel, with 
width <t j d h *
C 1 5 10
Australian 12 2 0 2 0
Diabetes 10 26 43
Heart 1 4 4
Adult 1 45 61 51
Adult4 501 694 842
Table 4.12: LAIKA. Training times (in minutes). The SVM was trained with a Gaussian kernel, 
with the width param eter updated by LAIKA version 2.2.
about 50% more iterations. W hen the SVM required many iterations, LAIKA required about 20% 
fewer iterations.
The training time of LAIKA could be reduced by implementing a more efficient update strategy. 
The strategy implemented here was simply to  clear the cached columns of the Hessian Q and 
recalculate from scratch as required. A better strategy would be to  update the cached calculations 
using a power transformation (Lee and Lin, 2000).
The motivation behind the development of LAIKA was th a t the heuristic value o jdh  underes­
tim ated the optimal value of cr when the classes were overlapping. It was suggested that this led 
to  a high number of support vectors and a poor generalization performance. The final value of cr 
obtained when using LAIKA was on average about 50% higher than c t jd h - It was lower in only 
one case, and unchanged in three cases. A search over both cr and C  using the software package 
LOOMS (Lee and Lin, 2000) did not lead to better performance than  LAIKA. The estimate of 
cr from LOOMS was highly variable. The estimate from LAIKA was more stable with respect to 
changes in the training data.
The percentage reductions in the number of SVs obtained when using LAIKA are shown in 
Table 4.13. On the Australian, Diabetes and Heart data  sets, there was, as expected, a reduction 
of up to 26% in the number of SVs. On the Adult data sets there were only negligible differences 
between LAIKA and the SVM. In general, the number of SVs was reduced in proportion to the 
increase in cr (Pearson’s p =  0.92).
In summary, the LAIKA heuristic estimated a  to be higher than th a t suggested by the original
C 1 5 10
Australian 26 22 17
Diabetes 15 18 13
Heart 0 17 14
Adult 1 1 0 -4
Adult4 2 3 0
Table 4.13: LAIKA. Percentage reduction in number of SVs.
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heuristic. This increase led to a more smoothed decision surface th a t correspondingly had a  simpler 
description in terms of the number of support vectors. This smoother decision surface had a slightly 
better generalization performance. The improvement was more marked when C  was high, i.e. when 
there was less explicit regularization. It is debatable whether these improvements justify the longer 
training times, although these could be reduced by use of more efficient algorithmics.
4.3 Inducing Sparsity
W hen learning complex decision functions, and in noisy domains, the number of support vectors 
can be very high. Osuna et al. (1997a) give an example of a data  set with 110000 points that 
generates 100000 support vectors. This leads to a complex model th a t is difficult to interpret and 
can be “abysmally slow in test phase” (Burges, 1998). As for other classification algorithms, when 
the d ata  are non-separable the SVM solution is a trade-off between smoothness of the decision 
function and training error. The resultant set of SVs contains all training errors, and these data 
points make the largest contribution to the decision function. This counterintuitive result is an 
indirect result of the way th a t the optimization problem, (3.15) or (3.22), is specified. Heuristics 
for constructing a decision function to which the training errors contribute less can be incorporated 
into the SVM to provide a sparser solution with little or no loss in generalization performance.
In Section 4 .3 .1 ,1 describe a heuristic for data  cleaning introduced by Burbidge et al. (2001b). 
In Section 4 .3 .2 ,1 describe the data  sets used and the experimental set-up, followed by performance 
results and a discussion.
4.3.1 D ata  Cleaning
In the support vector machine solution all training points x* with a* >  0 appear in the solution. 
This includes bounded support vectors, for which a ,  =  C, 0 <  & <  1, which lie within the margin 
band (also term ed margin errors), and training errors, for which a* =  C, & >  1 . Intuitively, it is 
not desirable for training errors to  appear in the solution, especially not with maximal weight.
Training errors appear in the expansion (3.21) since a* =  C  for points x* that are misclassified. 
Intuitively, we would prefer a decision function th a t did not depend on noisy training examples. 
Also, if the data  are noisy, or the classes overlap, the SVM solution will have many SVs. This 
removes one of the oft-cited advantages of SVMs — sparsity of the model. A sparse model is 
preferable for two reasons: it is easier to interpret and quicker to evaluate.
A simple method of excluding noisy points from the decision function is to run a standard SVM 
on the training data, to  obtain an intitial solution. Training errors are identified as noisy points 
and removed. The algorithm is subsequently retrained on the reduced data. This m ethod was 
called RaR (Remove and Re-train) in Burbidge et al. (2001b). On the data  sets analysed, RaR 
provided a sparser model than  the SVM with no significant drop in test accuracy. However, the 
total training time was around 50% more than the standard SVM.
In analogy with LAIKA (see Section 4.2), an online heuristic to approximate this is as follows. 
If a point is consecutively misclassified for a set number, he, of subproblem iterations, then it is 
likely to be a  training error a t the global optimum. Such points are removed during training. This 
algorithm was called STAR (Sparsity Through Autom ated Rejection). Burbidge et al. (2001b) 
showed th a t STAR was quicker to train  than the SVM. The update frequency he controlled the 
trade-off between quality and sparsity.
In order to effectively remove an example from the training set the gradient of the Hessian
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c 1 5 10 1 0 0 0
australian 0.1493 0.1478 0.1478 0.1565
diabetes 0.2250 0.2329 0.2368 0.2526
heart 0.1741 0.1852 0.1815 0.2037
adult 1 0.1788 0.1869 0.1850 0.2288
adult4 0.1674 0.1444 0 .1527 0.2238
P 0.1403 0 .0 0 0 2 0 .0 0 1 2 0.0114
Table 4.14: STAR. 10 fold CV error rates. The SVM was trained with a Gaussian kernel, with 
a  =  y jd/2, and he = 100. Error rates significantly different, a t 95%, from the standard SVM are 
emphasized (cf. Table 4.1). The last row shows the p -values for the two-tailed t-test of the null 
hypothesis th a t STAR and the SVM have the same error ra te  over the five data sets.
w.r.t. th a t example is set to  be —oo (Lee and Lin, 2 0 0 0 ). This is an efficient way to ensure th a t 
this example is never selected by the working set selection routine of Hsu and Lin (2002). This also 
ensures th a t the term ination criteria are trivially satisfied w .r.t. such points. Thus no reordering 
of the data  or of the cached computations is required.
In the following section, I compare STAR with the standard  SVM on five real-world data  sets5.
4.3.2 R esults and D iscussion (STAR)
The d a ta  sets used in this comparison are the Australian, Diabetes, Heart and Adult data  sets 
described previously.
The range of each d a ta  set a ttribute is scaled to  [—1,+1]. Gaussian kernels, K (x ,z )  =  
exp(—||x  — z ||2 /d ), are used. A point was removed if it had been misclassified for the last he =  100 
iterations.
The generalization error ra te  was estimated by ten-fold cross-validation. The 10CV error rates 
are shown in Table 4.14. These can be compared with the results of the standard SVM, as reported 
by Hsu and Lin (2002), and reproduced in Table 4.1. The standard SVM has a lower CV error in 
half of the 20 experiments. However, if £la  ^ were used to  select the optimal value of C  for STAR6, 
then the standard SVM wins on all five data sets7 (although the difference is only significant, at 
95%, for Diabetes). This again highlights the danger of combining heuristics. If the optimal value 
of C  could somehow be selected, then STAR would win on three of the five data sets (the only 
significant difference, a t 95%, being on Adult4).
The performance of STAR relative to the SVM does not seem to be related to the size or 
dimensionality of the data  sets. W ithout further experiments, it is not possible to  say a priori 
whether or not STAR would lead to a deterioration or improvement in generalization accuracy 
over the standard SVM.
The number of support vectors (N sv)  and the number of iterations (N\tei) are shown in Ta­
ble 4.15. These can be compared with the results of the standard SVM, as reported by Hsu and 
Lin (2002), and reproduced in Table 4.3. STAR never increased the number of support vectors. 
When there were few iterations STAR had no effect. In these cases the update time he could be 
decreased. The reduction in N sv  varied between 9% and 84%
5The performance of STAR is better than the results of Burbidge et al. (2001b), since in that work there were 
some minor bugs in the calculation of the fi and in the updating of the cache when examples were removed. The 
effect of these was that the optimization algorithm terminated by circling before the global optimum was attained.
6 In the calculation of removed points are assumed to be LOO errors.
7If we assume that ela  ^ always picks the optimal C for the SVM, which is reasonable given the published results 
and our experience.
98
C =  1 C =  1 0 0 0
D ata I N sv -Viter N sv Niter
australian 690 192 2 0 2 150 13259
diabetes 768 447 132 1 1 0 19116
heart 270 130 47 101 1484
adult 1 1605 192 1005 593 16787
adult4 4781 287 1777 1546 1 0 0 0 0 0 °
“Terminated Early.
Table 4.15: STAR. The number of SVs (Nsv) in the solutions when using STAR is never more 
than  th a t of using the standard SVM and was up to 84% lower. The number of iterations (N\teT) 
was in general increased.
The number of iterations required was in general increased. This increase was roughly in 
proportion with the reduction in the number of support vectors.
Overall, the generalization accuracy of STAR was the same as th a t of the standard SVM. 
However, £lag should be used with caution for selecting the optimal value of C. STAR reduced the 
number of support vectors by up to 84%, which would save considerable time during classification 
phase. This required an increase in training time roughly in proportion with the reduction in 
the number of SVs, up to twice as long as the standard SVM. Thus when classification time is 
more im portant than  training time, STAR offers computational advantages with little or no loss 
in performance.
4.4 Summary
The SVM is a powerful and increasingly popular machine for classifying data. It has been argued 
th a t there is room for improvement. Training can be halted before the global optimum of the QP is 
attained, w ith little change in the resultant hypothesis. The width param eter of a Gaussian kernel 
can be automatically tuned to improve performance and avoid model order selection. Training 
errors can be removed during training to  simplify the solution, with little change in performance.
The main aspects of these three heuristics, the contributions presented in this chapter, and 
some suggestions for future work are summarized below.
H E R M E S  is a stopping criterion for the SVM based on an approximate estimate of the gen­
eralization performance. It is designed to  reduce training time without deteriorating per­
formance. Early stopping to obtain a rough idea of the SVM’s performance may be useful 
during param eter selection and exploratory data  analysis.
•  Terminating training with HERMES can lead to a considerable reduction in training 
time.
• The accuracy of the solution was almost the same as that given by the global optimum 
of the QP.
•  The number of training errors, and hence SVs, was increased.
•  HERMES can be used to halt the SVM when other heuristics are used which are not 
guaranteed to converge.
• There is a slight risk th a t the SVM will term inate very early, which could result in a 
poor solution.
99
Some possibilities for further work include the following.
•  To avoid very early stopping, only check the HERMES criterion once the KKT condi­
tions have been met to  a certain precision, say e =  1 .
•  Instead of insisting that £la  ^ remain constant, allow some finite tolerance.
•  Investigate the relationship between the number of examples, the dimensionality, the 
noise level, the working set size and the value of persistence. Ideally a default value 
would be supplied by some rule-of-thumb.
•  It has been argued above that early stopping is useful during exploratory d ata  analysis. 
To verify this claim or otherwise it would necessary to  compare param eter selection with 
and without HERMES. In particular Lee and Lin (2000) dem onstrate th a t solutions with 
e =  0.1 in the KKT conditions are good enough for param eter selection on many public 
domain d ata  sets.
L A IK A  is a  heuristic to adjust the width a  of a Gaussian kernel during training. The width is 
adjusted to be on the scale of separation of the support vectors, in analogy with heuristics 
for Gaussian RBF networks. It is designed to avoid the need for model order selection and 
to  improve accuracy over using a fixed heuristic value of a.
•  Adjusting a  to  be data-dependent led to an increase in its value over the initial estimate, 
as expected.
•  This resulted in solutions with fewer SVs, and thus shorter classification time.
•  LAIKA is not guaranteed to converge. HERMES can be used as the stopping criterion.
•  The accuracy of the SVM was not significantly improved by LAIKA. Adjusting a  com­
pensated for a  poor choice of C.
•  ela£ was not reliable for selecting C , but note th a t it does not hold for such solutions.
•  Any gains in accuracy and spaxsity may not be worth the increase in training time.
•  The estimates a  from LAIKA were much more stable over different data  samples than 
those of LOOMS.
•  The performance was barely affected by the update period ha (provided ha N[tei). 
Some possibilities for further work include the following.
•  In cases where ha > Niter, update a  after training and repeat training with ha *— ha/ 2, 
say.
•  Investigate the effect of ha on training time, with respect to the number of examples and 
dimensionality. As for the other heuristics, it would be desirable to  have a rule-of-thumb 
for this param eter.
•  A larger o  increases regularization, which implies th a t a higher C  is required than for 
the initial value a jdh- This suggests investigating the optimal C  value for the SVM 
with <tjdh and with LAIKA and whether or not this is quantifiable.
•  Similarly to  Chapelle et al. (2 0 0 2 ), a different ap could be introduced for each feature. 
Adaptive scaling of these could lead to improved performance and feature selection. 
(This has shown some promise on early trials, but a heuristic th a t accounts for interac­
tions between features is probably required.)
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• A similar heuristic could be developed for other kernels, for example the polynomial 
A (x , z) =  ( x ^ / a  +  r )d. (For a linear kernel, r  =  0, d = 1, this is equivalent to auto­
matically tuning C. On the pKi data  with MACCS keys, this usually led to improved 
performance and a sparser model. The results are not reported in this thesis.)
• The recalculation of the cache could be made more computationally efficient (Lee and 
Lin, 2000).
• As for the other heuristics, it may be preferable to only update <r when the SVM is near 
convergence, e.g. when the KK T conditions are satisfied to e =  1.
• In analogy with RBF networks, it is possible to  allow a different Oi for each SV. This 
should result in a sparser solution. The kernel function is then not guaranteed to be 
positive definite, other optimization techniques could be used (Mangasarian, 2000).
S T A R  is a heuristic to remove potential training errors during training. It is designed to result in 
a solution with the same predictive performance as the SVM with fewer SVs. Such a solution 
is quicker to  evaluate and may be easier to interpret.
•  The solutions provided by STAR had very similar accuracy to the SVM.
•  The number of SVs was reduced, considerably in some cases.
•  The number of iterations was increased.
• ela£ was not reliable for selecting C. Note th a t it is not valid for such solutions.
Some possibilities for further work include the following.
•  It would be interesting to  investigate whether or not the removed points axe training 
errors, or SVs, in the original SVM solution and whether or not they are misclassified 
by the STAR solution.
•  The optimal update period he is likely to  depend on the training set size and dimen­
sionality and the amount of noise. Removing points too soon may be over-zealous.
• When he > N^er, remove the training errors (cf. RaR, Burbidge et al., 2001) and retrain 
with he <r— he/ 2 , say.
• For larger d ata  sets, STAR may remove points too soon. As for the other heuristics, it 
may be preferable to  invoke STAR only once the K K T conditions have been satisfied to 
some loose precision.
•  The behaviour of STAR has only been investigated for the Gaussian kernel. Its effect 
on the SVM with other kernels is of interest. STAR is used with a linear kernel in 
Chapter 5.
•  Remove all margin errors (& >  0) as well as training errors (& >  1). This should further 
reduce the number of SVs. (Early trials have been inconclusive.)
•  The principle behind STAR could be applied to  other classification, or even regression, 
algorithms. T hat is, use a learning machine as a w rapper to  remove spurious examples 
from the training data  before training. A fast algorithm could be used as a filter for a 
more sophisticated, slower algorithm.
• Analysis of the proportion of removed examples, in comparison to  the proportion of SVs 
may suggest further avenues.
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•  Since ela  ^ is qualitatively the same as the test error before convergence, it could be used 
to remove likely leave-one-out errors during training.
All of the heuristics achieved their aims to  some extent. They should prove useful in the 
classification of drug discovery data. This is investigated for the pKi data  in the following chapter. 
The heuristics also have wider applicability to  the SVM and to other learning machines.
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Chapter 5
A pplication to p K \  D ata
I f  your experiment requires statistics you should have designed a 
better experiment.
E r n e s t  R u t h e r f o r d
In Chapter 3 (Section 3.3.2) the pKi data  were described. There were activity data  for 1415 
compounds (ligands) which had been screened against 11 targets (receptors) in competitive binding 
assays. The activities were reported as pKi values, which are directly comparable across different 
screens. The aim was to  learn a classification rule to discriminate between ‘active’ and ‘inactive’ 
compounds, where ‘active’ means having a pKi value greater than 6. This is a pragmatic threshold 
set by the screening group.
It was found that, on the basis of 14 physicochemical and one-dimensional structural properties, 
the standard SVM with a Gaussian kernel did not provide a significantly higher accuracy than a 
decision tree. In Section 5.1, two methods to  improve the SVM’s performance are considered. 
These are selecting the training data  by clustering in the space of fingerprints, and adjusting the 
misclassification costs according to the class priors.
It was suggested th a t the SVM was overfitting the training data. This is possibly because the 
width of the Gaussian kernel was underestimated. This was also suggested by the high number of 
support vectors. These observations, and similar observations from analysis of public domain data 
sets, motivated the development of the heuristics of the previous chapter. In Section 5.2, these 
heuristics are used in the analysis of the pKi data. Note th a t although the heuristics have already 
been presented in their ‘finished’ form, they were actually developed concurrently with the data 
analysis. Thus, the early versions of STAR and LAIKA were first applied to  the analysis of the pKi 
data. They were found wanting, and subsequently further developed on public domain data  sets 
as described in the previous chapter. These improved versions were then reapplied to  the analysis 
of the pKi data. This process will have introduced some bias into the analysis (‘data  snooping’). 
The earlier results are not reported as the experimental set-up varied considerably.
A further suggestion in Chapter 3 (Section 3.3.2.2) was to use an alternative representation of 
the compounds. Three alternative representations are used to  learn a classifier. In Section 5.3, the 
‘finished’ heuristics are also applied to  these classification problems. Although the compounds are 
the same as before, from a classification perspective the data  sets are very different. Thus there 
should be minimal ‘data  snooping’ bias in these later analyses.
In Section 5.4, the performance of the SVM and the heuristics for the various experimental set­
ups is summarized. These suggest further analysis and possible improvements to the heuristics.
103
5.1 Some D ata M ining Considerations
Before considering the application of the improved heuristics to the analysis of these data, it is 
useful to  consider some generic methods to improve the performance. In Section 5.1.1, the problem 
of selecting training d a ta  is considered. A clustering algorithm, popular in chemoinformatics, is 
applied to this problem. This also highlights some benefits of exploratory data  analysis. In 
Section 5.1.2, the problem of maximizing relative advantage (R A ) is considered. Minimizing a risk 
functional is chosen as a proxy to this. However, it is shown th a t minimizing expected error leads 
to  a higher RA, for these data. Which method should be used for selecting training data, and which 
risk functional should be used depend on the requirements of the analyst. Some pragmatic issues are 
discussed in these sections. In Section 5.1.3, the relationships between the performance measures 
and between the performance measures and their estimates are summarized. In Section 5.1.4, these 
considerations are summarized.
As in Chapter 3 (Section 3.3.2), the SVM was trained with a Gaussian kernel with width ajDH- 
For a fair comparison with the heuristics later in this chapter, the training was term inated by 
HERMES with a persistence of 1000. The SVM was trained for C  € {1,10}.
5.1.1 Training D ata  Selection
Obviously, increasing the amount of training data  will always improve the performance of a clas­
sifier (given th a t the i.i.d. assumption holds). Obtaining this d a ta  is expensive though as more 
compounds must be screened. More training data  also means longer training time, so smaller, 
more informative training sets are preferable. One possibility is to attem pt to  identify in advance 
which as yet unscreened compounds would be most informative as training data  were they to  be 
screened. Fung and M angasarian (1999) use fc-mediod clustering to  select a subset of the available 
(unlabelled) data  to  be labelled and used to  train  an SVM. This is analogous to  using clustering 
to  determine the centres of an RBF network (Bishop, 1995).
A similar approach is taken here, incorporating domain knowledge. The compounds were 
clustered using the clustering of Ward (1963) (see also, C hapter 2, Section 2.3.3) in the space of 
Daylight fingerprints (Chapter 2, Section 2.2.3). The Tanimoto measure was used as the measure 
of similarity. The clustering is controlled by a similarity threshold. At a threshold of 0.7 this 
led to 395 clusters1. The ‘centroid’ of each cluster is included in the training set. This is not a 
true centroid, since the Tanimoto measure does not define a metric space. Also, the bit string 
most Tanimoto-similar to the cluster members may not correspond to  an actual compound. T hat 
compound is chosen which is most similar to the other cluster members (McGregor and Pallai,
1997).
If the training data  are chosen thus, it is hoped th a t the resulting classifier will be sparser 
and more accurate, since the training data  should be more representative and more informative. 
Since there is only a finite amount of data, the SVM is trained on the centroids and tested on 
the remainder (the analogues). The training and test d ata  no longer satisfy the i.i.d. condition on 
which the SVM methodology and error bounds are based.
The clustering revealed an aspect of the data  th a t could have biased the results. There were 150 
compounds in the analogues set th a t were identical to  their respective cluster centroids with respect 
to the fourteen properties used. T hat is, although all the compounds were distinct physically, there 
were pairs of compounds indistinguishable on the basis of the features used. Visual inspection of 
the structures of some of these revealed that they were chiral pairs (enantiomers of each other).
1 Hence, this was chosen as the size of the random training set, for the purposes of comparison.
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T hat is, the only difference between such a pair was the orientation of the substructures on a 
particular carbon atom.
When training on the random  d ata  set, there are three possibilities for such a pair:
1. Both compounds are in the training set. If they have the same label (i.e. both active or both 
inactive) this amounts to  a duplication of th a t datum . If they are labelled differently, the 
training data  are inconsistent, hence there will necessarily be non-zero training error. Which 
enantiomer is mislabelled by the trained SVM will depend on the other training data.
2. Both compounds are in the test set. The above argument then applies to the test set, so 
there will be non-zero test error if the compounds are labelled differently.
3. One compound is in the training set and one is in the test set. If they are labelled the 
same, this should lead to  an increased probability of a correct prediction, and conversely, a 
contradictory labelling will probably lead to a decrease in predictive performance.
W hen training on the centroids, only the third case above can hold. Since the chiral pairs are more 
likely a priori to  be labelled the same (by the similar property principle) the repetitions should 
lead to a net increase in predictive performance in this case. This is what was observed. However, 
how much of this is due to the presence of chiral pairs and how much is due to an information gain 
from the clustering per se is impossible to  say without further analysis.
The remaining question is: what does the analyst do in light of this new information? For a 
given chiral pair, if both enantiomers are in the training set, an immediate response may be to 
remove the duplicates. There are two possibilities for a given pair:
1. If the enantiomers have the same label, then removing one of them  will skew the class priors
and the class densities.
2. If the enantiomers have contradictory labels, which one should be removed? Pragmatically, 
adjusting the activity threshold may reduce inconsistencies. Alternatively, manual inspection 
may lead a medicinal chemist to  treat them both as active or both as inactive, or remove
them  both. These approaches require valuable person time.
A more attractive alternative is to  leave both points in the training set, so as to  not disrupt the 
densities, with a prior ignorance about the label. This could be achieved by a transductive SVM 
(Vapnik, 1998; Joachims, 1999b). An approximation is to leave both  in with their opposing labels, 
and let the SVM determine which one falls on the wrong side of the hyperplane, according to  the 
distribution of the other points.
If one or both points are in the test set, then in a practical situation, we do not know whether 
the labels are inconsistent. Hence, the best we can do is leave them  both in and hope that the 
descriptors are sufficient to  discriminate between them. In this case, we have ground tru th  data, 
so we know th a t the descriptors are insufficient.
Thus, in the remainder, all of the available compounds are used when learning a classifier, and 
the test d a ta  are assumed a priori to  be consistent.
5.1.1.1 Performance Comparison
Since there are only 1415 compounds for which activity is known, comparing the performance of 
different predictive methods is compromised in this case. The two methods under consideration 
involve different selection criteria for the training data. In the case of random selection, the training
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Figure 5.1: pK^. The error (left) of the SVM (C  = 10) when training on the centroids is higher 
on five assays. However, the AUROC (right) is approximately the same or higher on ten assays, 
which suggests the operating point has not been set optimally.
and test data are i.i.d. from the same underlying distribution. Thus the error rate on the test set 
is an unbiased estimate of the true error rate. In the case of centroid selection, the training and 
test sets are not i.i.d. and have different distributions. The test error is thus a biased estimate of 
the true error rate. Since the average distance from a test to training point is greater in the case 
of centroid selection than in the case of random selection, we expect the test error to be biased 
upward. Moreover, since the test sets for the two methods are drawn from different distributions, 
the test error rates are not directly comparable. In the following, I report the test error and the 
AUROC and discuss the effects of this bias. Since the error rates are not comparable, standard 
errors and p-values are not reported. The results presented are merely suggestive. Note that the 
non-parametric McNemar test for comparing two classifiers is not applicable as the test sets differ.
If we were only interested in estimating the performance on this set of 1415 compounds, then 
the performance metric would be the overall error on the training and test sets. In this scenario, 
this measure would be directly comparable for the two methods.
There are two possibilities for obtaining a fair comparison under more general conditions. One 
would be to use a third set of compounds, drawn from the same distribution, as an independent test 
set. There are a few thousand compounds available whichh have been screened on assay 3 for which 
this is possible. Another would be to use cross-validation. For example, split the data into five 
folds of 283 compounds. For each fold, choose the training data  by clustering the remaining 1132 
compounds and selecting the centroids. Choose the random training set from the 1132 compounds 
to be of the same size. Train the SVM on each training set and test on the left-out fold. Repeat 
this for all five folds and average the error rates. This provides an unbiased estimate and makes use 
of all the data  in estimating the true error rate. However, it is time-consuming and was impractical 
for these data  given the available hardware.
5.1.1.2 R esu lts  an d  D iscussion
The misclassification rates on the test set are illustrated in the left of Figure 5.1, for C = 10. 
(The results for C = 1 are similar.) In the right of Figure 5.1 is illustrated the corresponding area 
under the ROC curve (AUROC, Chapter 3, Section 3.2.1)). When using the centroid training 
data, the test error is increased on five assays. However, on three of those assays the AUROC  
is increased. For only two assays (4 and 7) does the AUROC  decrease, although not by much.
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Figure 5.2: pK{. The relative differences between the (test) population priors, 7r+i, and the 
(training) sample priors, 7r^l5 are larger when the sample data are selected by clustering. This 
leads to the operating point being set sub-optimally (cf. Figure 5.1).
This suggests that the operating point b in the SVM solution has not been set optimally. The 
reason for this becomes evident when one considers the class priors. When the training data are 
randomly selected, the proportion of active compounds in the future will on average be the same 
as that in the training data. When the training data are selected by clustering, it is possible that 
the proportion of positives in the training data will differ from that in the population. This can be 
seen in Figure 5.2. The proportion of compounds in the population (i.e. the test set), 7r+i, deviates 
from that of the training set, 71+!, the most on assays 4,7,10 and 11. From Figure 5.1 we can see 
that on these assays the test error increased. However, on assays 10 and 11 the AUROC  increased 
and on assay 7 it remained approximately the same. On assay 4 A UROC only decreased slightly 
whereas the test error increased considerably. Thus it is probable that the ROC curve could be 
used post hoc to adjust the operating point to reduce the test error. Alternatively, if the true 
population proportions were known in advance then the correction to the regularization constants 
for the two classes, C + and C ~ , can be made (see Chapter 3, Section 3.1.4). On the two assays for 
which the proportion of positives in the analogues (test) set was within 5% of that of the centroids 
(training) set, viz. assays 3 and 9, there was a substantial reduction in error rate and increase 
in AUROC. This suggests that if the true priors were known and the corresponding correction 
made then training on the centroids would give superior predictive performance to training on the 
randomly selected data.
The relative advantage (R A , Chapter 3, Section 3.2.2) was on average 2% higher when using 
the randomly selected training data.
The number of support vectors was about 4% higher on average when training on the centroids, 
although the increase was as much as 20% in come cases. The number of iterations was about 5% 
higher on average when training on the centroids, although it varied considerably across assays.
Which method should be used to select the training data therefore depends on the properties 
desired of the learned decision rule. If one is designing a tool for screening set selection then the 
randomly selected training data would be better for two reasons. Firstly, the solutions are sparser, 
which leads to a shorter classification time. This is important when there are potentially millions 
of compounds in a virtual library. Secondly, RA  is slightly increased, i.e. there is an increased gain 
over randomly selecting compounds for in vitro screening.2 A further reason for preferring to use
2Random selection of training data for learning a rule should not be confused with randomly selecting compounds 
for in vitro screening.
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Random Centroid
C  = 1 C = 10° C  =  1
-OOIIO
AUROC — — — 1%
RA -4 % -2 % -1 % -2 %
N sv +4% +1% +5% +5%
Niter -8 % +32% -8 % +35%
“Assays 6 and 7 excluded. 
bAssays 1,3, and 7.
Table 5.1: pKi. Training the SVM with weighted misclassification costs leads to  a slight decrease 
in relative advantage (RA) and a slight increase in the number of support vectors (iVsv). The 
number of iterations was decreased when C  =  1 and increased when C  =  10. A UROC is almost 
unchanged.
the randomly selected training data  per se is th a t the assumption th a t the population is i.i.d. as 
the sample then holds. This is a key assumption underlying statistical learning theory and the 
corresponding algorithms and error bounds.
The effect of using clustering to select the training data  is reconsidered in the following section 
with respect to  a different loss function. The effect of using the fingerprints for clustering and 
MACCS keys for prediction is analysed in Section 5.3.1.1: Unless otherwise stated, the remainder 
of the results in this chapter are for randomly selected training data.
5.1.2 M isclassification Costs
In an effort to improve the relative advantage of the classifier, the SVM was retrained using the 
loss ratio A(—1, +1)/A (+1, —1) =  7rl1/7r^1. This is equivalent to  minimizing the false positive ra te 
plus the false negative rate, as opposed to minimizing the error rate. This was shown empirically 
in Chapter 3 (Section 3.1.5.3) to maximize the relative advantage. T hat is, the relative increase 
(over random selection) in the number of actives th a t would be found if the compounds predicted 
positive in silico were physically screened in vitro.
Since the SVM is now being trained to minimize the expected risk ra te as opposed to expected 
error, these are not sensible measures with which to  compare the two approaches. The RA  and 
the AU RO C  axe useful performance measures for the comparison.
In a strictly probabilistic setting the AU RO C  should not depend on the loss ratio, since the 
ROC curve would be generated by varying the loss ratio (Hand and Till, 2001). For an hyperplane 
classifier, such as an SVM, an ROC curve can be generated by varying the operating point b in 
/ (x )  =  sgn((0(x), w )w +  b). This does not give the same ROC curve as varying the loss ratio and 
retraining each time. Even if the A UROC is similar for two different loss ratios, the shape of the 
curve is likely to  be different. In practice, the AU RO C  was almost unchanged. The change in 
A U RO C , R A , number of support vectors (N sv) and number of iterations (Vjter) are presented in 
Table 5.1. The experiments with weighted costs chronologically preceeded those with equal costs. 
The maximum number of iterations for the former set was set at 5000, which was in some cases 
too few for the centroid data  when C  =  10. Results are averaged over those assays for which the 
SVM converged within 5000 iterations for both loss functionals.)
There was a slight deterioration in RA  and N sv- For C  =  1 the number of iterations was 
decreased. However, the case C  =  10 takes roughly four times as many iterations. Training with 
weighted costs increased this by about a third. Overall, there is a slight deterioriation in perfor­
mance, and time- and space-complexity when training the SVM with weighted misclassification 
costs on these data.
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Figure 5.3: pKi. When using weighted losses the risk is reduced by training on the centroids.
5.1.2.1 R an d o m  vs C en tro id s
When minimizing the error rate, training on centroids was found to result in a higher AUROC  
at the expense of a slight increase in the number of SVs and the number of iterations. However, 
the error rate was not always improved, possibly due to the skewing of the class priors and hence 
the operating point (Section 5.1.1.2). The comments of Section 5.1.1.1 concerning performance 
comparison also apply to the following discussion.
When minimizing the weighted loss functional, the results for C  =  1 axe as follows. (When 
C =  10, the SVM converged within 5000 iterations for both methods on only two assays.) A UROC 
was slightly increased by training on the centroids. The risk of using the SVM was correspondingly 
decreased on nine assays and was almost the same on the other two (Figure 5.3). Minimizing this 
risk functional was chosen to maximize RA. However, the RA  was almost the same for either 
method of selecting training data.
The number of SVs when training on the centroids was again on average 4% higher when C = l .  
It was unchanged when C  =  10 for those cases where the SVM converged within 5000 iterations. 
The number of iterations when training on the centroids was on average 12% lower when ( 7 = 1 .  
However, when C  =  10, the SVM trained on the centroids did not converge within 5000 iterations 
on eight assays, and was on average 27% slower on the others.
In terms of predictive performance, selecting the training data by clustering is preferable. For 
screening set selection, selecting data randomly is slightly preferable, as the solution is quicker to 
evaluate (less SVs) and has the same RA.
5.1.3 M et a-Analysis
In the preceding analysis, the SVM has been trained to minimize two loss functionals. The aim has 
been to maximize RA  and AUROC. In Section 5.1.3.1, the relation between these four measures 
is investigated. In Section 5.1.3.2, an estimator of the loss is compared to the losses incurred on 
the test data.
5.1.3.1 R e la tio n sh ip  B etw een  P erfo rm an ce  M easu res
The predictive performance of the SVM has been evaluated with a variety of measures. The 
A UROC summarizes in a single number the risk of using the SVM over a range of misclassification 
costs. The RA  is the enrichment of actives in a set selected for screening by the SVM, compared to
R a n d o m  
I 1 C e n tro id
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Measure Loss Random Centroid
C  = 1 C  = 10 C  =  1 C =  10
AURO C error -0 .80 -0 .77 -0 .83 -0 .7 7
AURO C risk -0 .99 —0.85a -0 .9 9 -0 .9 7 6
R A '1 error 0.74 0.74 0.70 0.42
R A '1 risk 0.83 0.83° 0.66 0.946
“Excluding assays 6 and 7.
bAssays 1,3 and 7.
Table 5.2: pK{. Correlations between performance measures, when minimizing the specified loss 
functional.
randomly selecting compounds for screening. The SVM is trained to  minimize a (regularized) loss 
functional. It is not possible to specify a loss functional th a t directly maximizes either AU RO C  
or RA. It would be hoped th a t a low error ra te  (or risk) corresponds to  a high A UROC  or RA. 
A loss functional was introduced in C hapter 3 (Section 3.1.5.3) th a t should vary approximately 
inversely with RA.
To give a rough idea of how these measures are interrelated, their linear correlations are given 
in Table 5.2. The error and risk (when each is respectively minimized) are highly correlated with 
AURO C. The risk is more strongly correlated. (Recall th a t the AU RO C  was almost the same 
for the two loss functionals.) The RA  was inversely correlated with error and risk. It was more 
strongly correlated with risk. However, minimizing error ra te  led to  higher R A  than minimizing 
risk. Since there are only 11 data  supporting each entry in the table, the correlations should not be 
taken too seriously. The patterns seem fairly consistent for the different values of C  and different 
training sets.
5.1.3.2 Behaviour of Error Estim ators
The main purpose of the work presented in this chapter is to  evaluate the effect of various methods 
for improving the solution of the SVM. However, given any one set-up, e.g. equal misclassification 
costs, randomly selected training data, SVM with Gaussian kernel, it is necessary to set the 
regularization param eter C. Although this problem is not discussed a t length in this work, it 
is useful to briefly consider some simple methods. Sollich (1999, 2000) presents a probabilistic 
argument th a t suggests C  should not be too small (C > 1, roughly). Cristianini and Shawe-Taylor 
(2000) also present a result th a t suggests C  = R ~ 2, where R  is the radius of the data. For a 
Gaussian kernel this implies C  > 1. The experiments reported here have used C  € {1,10} only, 
which seems a reasonable, if scanty, range.
One way to set a free param eter of a learning machine is to train  it for a range of values of 
th a t param eter and use th a t value minimizing some estimate of the performance. For the SVM, 
the expected error rate, or risk for the case of unequal misclassification costs, can be estimated 
in a number of ways. Since the SVM is a  regularized learning machine, one would hope th a t the 
training risk3 could be used as an estim ate of the expected risk. However, this is only the case for 
the optimal C, so this method is unlikely to succeed for selecting C. For the four set-ups reported 
above, the training risk was always smaller for C  =  10. This is as expected, since C — 10 imposes 
a higher penalty on training risk.
As noted in Chapter 3 (Section 3.1.5.2), the leave-one-out (LOO) risk is an almost unbiased 
estim ator of expected risk. This can be estimated by ela^. This estim ator is strictly valid only at 
the global optimum of the quadratic program. However, it was shown in Chapter 4 (Section 4.1.2),
3In the following ‘risk’ is any loss functional, including error rate.
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on some public domain d ata  sets, that before convergence ela  ^ is qualitatively the same as the test 
error. Thus it may be a useful estim ator of risk even when the SVM is term inated by HERMES or 
after a set number of iterations. For a given value of correlated well (p £ [0.90,0.94]) with
test error or test risk over the 11 assays when using randomly selected training data. It is also only 
valid if the test data  are i.i.d. as the training data, which is not the case when the training data  
axe selected by clustering. In this case, ela  ^ correlated less well (p £ [0.58,0.84]) with test error or 
test risk. However, for a given assay and set-up, ela  ^ was smaller for the better value of C  in only 
19 out of 44 cases (five out of 11 for the cases where the assumptions behind hold). Thus it 
seems th a t while, for a fixed C, ela  ^ is qualitatively the same as the test error, it is no better than 
random for choosing the better value of C. This is disappointing, given the results reported in the 
literature (Joachims, 2000; Duan et al., 2001).
5.1.4 Summ ary o f D ata M ining Considerations
The aim of this analysis has been to learn a decision rule to predict whether or not a compound 
is active. The quality of such a decision rule can be evaluated in term s of its predictive accuracy 
and its time- and space-complexity.
The predictive accuracy can be quantified by the relative advantage (RA) of using a learned 
decision rule to select compounds for synthesis and screening over random  selection of compounds. 
An alternative is to consider the misclassification rates over a range of costs, as summarized by 
the area under the ROC curve (AUROC). This latter measure is useful since the misclassification 
costs are subjective and difficult to quantify. It is not possible to directly maximize these quantities 
in the standard SVM framework. Minimizing a (possibly) weighted expected misclassification rate 
is a proxy for maximizing R A  or AURO C. Minimizing a specific expected risk (false negative 
ra te  plus false positive rate) was highly correlated with maximizing R A  and AUROC. However, 
minimizing the expected misclassification rate led to  the same A UROC  and a higher RA.
It should be noted th a t varying the operating point b in the SVM solution is not the same as 
varying the loss functional and retraining. For these data, the orientation of the hyperplane varied 
with the loss functional. Equal A UROC  does not imply the classifiers are the same.
A second performance criterion is classification speed. If the decision rule is to be used to select 
compounds for in vitro screening, then it should be quick to evaluate. There are generally many 
more compounds whose activity we would like to predict than  are screened. Thus, whilst training 
time should not be too long, classification time is more im portant. For an SVM, the classification 
speed is O (N sv). Solutions with few SVs axe therefore preferable.
Clustering the compounds in the space of fingerprints revealed th a t the properties used to 
describe the compounds did not have sufficient resolution to  identify them uniquely. This led to 
repetitions and inconsistencies from the viewpoint of hyperplane classification.
The AU RO C  of the SVM was slightly increased when the clustering was used to select the 
training data. However, random selection is preferred in this case, since it led to  slighty higher 
RA  and slightly spaxser solutions. This is a pragmatic decision.4 Note that when minimizing 
risk, training on the centroids always led to a lower risk. However, this did not translate into an 
increase in RA. The performance of any learning machine trained on data  selected by clustering 
will depend on the clustering algorithm, its parameters and the representation used.
Unless stated otherwise, in the remainder of this chapter, the results are reported for the case 
of equal misclassification costs and randomly selected training data. W ith this set-up, training
4Note that most of the results in the rest of this chapter are qualitatively the same for both methods of selecting 
training data.
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the SVM with the physicochemical and one-dimensional structural properties as descriptors led 
to solutions with many SVs, th a t did not perform much better than  a decision tree (Chapter 3, 
Section 3.3.2.2. In the remainder of this chapter, further attem pts to  improve the predictive 
performance and reduce the number of SVs are considered.
5.2 Evaluation of Heuristics
The heuristics STAR and LAIKA were introduced in the previous chapter. Their development was 
motivated in part by the results and analysis of the preceding sections. W hen classifying the pKi 
data, the SVM gave solutions with many SVs with poor predictive performance. STAR (Chapter 4, 
Section 4.3) was designed to  result in sparser solutions, without increasing training time or reducing 
predictive performance. LAIKA (Chapter 4, Section 4.2) was designed to automatically tune the 
‘w idth’ a  of the Gaussian kernel, which should lead to improved accuracy and a sparser solution. 
In Section 5.2.1, STAR is applied to the classification of the pKi data. In Section 5.2.2, LAIKA 
is applied to  the classification. The compound representation used is the same set of fourteen 
physicochemical and one-dimensional structural properties as before.
When using the heuristics, the SVM is not guaranteed to converge to the global optimum of 
the quadratic program. Hence, the HERMES criterion is used is the stopping criterion with a 
persistence of 1000. T hat is, unless the global optimum of the QP was attained first, training 
was halted if there had been no change in for 1000 iterations. For pragmatic reasons, the 
maximum number of iterations was set at 10000. The combination of STAR and LAIKA was not 
fully evaluated owing to excessively long training times.
5.2.1 STAR
The predictive accuracy of STAR was almost the same as the SVM across all assays, although 
it was very slightly lower on average when C = 1. The R A  and AU RO C  of STAR were almost 
identical to  th a t of the SVM across the assays. Thus, the predictive performance of STAR has not 
deteriorated from th a t of the SVM, under any of the three performance measures. The purpose of 
STAR though is to reduce the number of support vectors. The percentage change in the number 
of support vectors (N sv)  when using STAR is illustrated in Figure 5.4. N sv  is reduced on all 11 
assays by about one third when C =  1 and by about one eighth when C  =  10. The training time 
was also reduced in most cases.
In summary, STAR has predictive performance no worse than  the SVM, and results in a sparser 
solution than  the SVM, usually in a shorter runtime.
5.2.2 LAIKA
As noted in Chapter 4 (Section 4.2.3), on the pKi data, the original version (vl.0) of LAIKA 
did not improve the SVM solution and required longer training times. It was proposed th a t this 
was due to  the high number of support vectors (SVs) resulting in an underestimate of the kernel 
param eter a  (the ‘w idth’ of the RBF). On these data, LAIKA v l.0  actually led to  an estimate 
& <  <tjdh and an increase in the number of SVs. In Chapter 4 (Sections 4.2.3 and 4.2.4) the 
heuristic was developed to  overcome these problems in two ways. Firstly, by basing the calculation 
only on correctly classified SVs, the noise or overlap of the classes should not affect the estimate. 
Secondly, by only updating on points th a t have been correct SVs for a set number of iterations the
112
R untim e/s
cn -10
70
R u n tim e /s
E? 20
-10
-20
-30
-40
1 2 3 4 5 6 7 8 9  10 11PK,
Figure 5.4: pKi. STAR outputs a solution with fewer support vectors (iVsv) than the SVM both 
for C  =  1 (left) and C = 10 (right). The training time required by STAR is in general lower than 
for the SVM.
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Figure 5.5: pKi. The A UROC obtained by the new version of LAIKA is always lower when C  =  1 
(left) and approximately the same when C  =  10 (right).
estimate is not as affected by transient SVs. Thus the solution should be more stable and quicker 
to find.
The AUROC  obtained when using the previous version (i.e. vl.0), compared to using the new 
version (i.e. v2.2), is illustrated in Figure 5.5.
When C = 1 the A UROC obtained by the new version of LAIKA is always lower than that 
obtained previously. Note that training terminated at the global optimum on all assays except assay
2. Thus the deterioration in AUROC  is due to LAIKA v2.2 alone. When C = 10 the AUROC  
is approximately the same as that obtained previously. Note that only assay 3 terminated at the 
global optimum. LAIKA was halted after 10000 iterations on assays 6 and 7, and was terminated 
by the HERMES criterion on the other assays.5
LAIKA vl.0  gave solutions almost identical to the SVM. Thus the preceding argument carries 
over to comparing LAIKA v2.2 to the SVM. That is, when C = l ,  LAIKA v2.2 returns a solution 
with lower AUROC  than the SVM (by about 7% on average). The test error is correspondingly 
higher and the RA  slightly lower. On the three assays for which LAIKA required more iterations
5It is tempting to speculate that the solution did not deteriorate when C = 10 because LAIKA was halted early. 
That is, overfitting was prevented by early stopping (McLoone and Irwin, 2001). This is not the case, see below.
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Figure 5.6: pKi. The final value of a (left) for LAIKA v2.2 when C = 1 is much larger than the 
estimate <7jdh- This led to a high training error (underfitting). When C = 10, the final value of cr 
was about 50% higher, which resulted in similar predictive performance with fewer SVs (right).
(by a factor of three) the number of SVs was reduced the most. On the other assays, LAIKA 
required roughly half the training time of the SVM and the number of SVs was approximately the 
same. The number of iterations (and number of SVs) was not correlated with the test error. Note 
that the time per iteration of LAIKA was twice that of the SVM. Thus, even when the number of 
iterations was reduced, the training time was usually higher. As noted in Chapter 4 (Section 4.2.6), 
this could be improved by better algorithmics.
When C  =  10 the performance of LAIKA v2.2 is nearly the same as the SVM, in terms of 
AU RO C , RA  and test error. The number of iterations was doubled and the training time was 
trebled. The only gain was a slight (5%-14%) reduction in the number of SVs.
When C  =  10, on assays 1, 2, 4, 5, 9, 10 and 11, both the SVM and LAIKA were terminated 
by HERMES. Thus the speculation that early stopping prevented deterioration of the solution is 
unsupported. The question remains: why has the perfomance deteriorated when C  =  1 and not 
when C  =  10? The previous speculation for vl.0  was that LAIKA was overfitting. An inspection 
of the training and test errors shows that LAIKA was actually underfitting the training data. This 
is also apparent from the estimates of the width, d, obtained (Figure 5.6, left). When C  =  1, the 
estimate of cr is too high, thus the decision surface is too smooth to  capture the inherent complexity 
of the data. When C  =  10, the estimate of a  is about 50% higher than ctjdh> which results in 
similar predictive performance to the SVM (with ctjdh )> with fewer support vectors (Figure 5.6, 
right).
Why this would happen is unclear. When C  =  10, there are fewer SVs, so one would expect 
their median separation to be larger, which would result in a higher estimate of cr. On the other 
hand, there are fewer training errors when C = 10 (since errors are being penalized more heavily) 
and thus more of the SVs are free (oti < C). For these experiments it appears that the net result 
is more free SVs when C =  10 and a correspondingly lower cr. When C = l ,  the regularization 
is quite high, thus many points lie within the margin band. The few free SVs are spread out, 
which leads to a high estimate of cr. Thus the high explicit regularization (low C) has a knock-on 
effect (high cr) which increases the regularization further. The result is underfitting. Hence, it is 
likely that the optimal value of C , for a given data set and kernel, for LAIKA is higher than for 
the standard SVM (with ctjdh)- This is in agreement with the results of Chapter 4 (Tables 4.9 
and 4.10).
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When C  =  10, the new version of LAIKA had the desired effect of adapting a  to only the free 
SVs. This resulted in fewer SVs being required to  construct the decision boundary. The results are 
disappointing since the hope was th a t this would lead to  improved accuracy, whereas the accuracy 
was unchanged. The quality of the SVM solution is not as sensitive to the choice of C  as it is to 
the choice of <x. Hence LAIKA was developed as an attem pt to  autom ate the selection of cr. In 
doing so, it appears th a t LAIKA has become more sensitive to  the value of C  than is the SVM. 
Further experiments investigating the performance of LAIKA and the SVM for a larger number of 
values of C  would be required to confirm or refute this.
In summary, the new version of LAIKA underfitted the data  when the explicit regularization 
was high, owing to a knock-on effect. When the explicit regularization was lower, the new version 
of LAIKA gave the same predictive performance as the SVM. In the latter case, LAIKA reduced 
the number of SVs by 8% on average, a t the expense of a near trebling in training time.
5.2.3 Summary o f H euristics
The heuristics have been applied to the classification of compounds as active or inactive on eleven 
competitive binding assays, using fourteen properties as descriptors. W hen using the SVM with a 
Gaussian kernel, with width <tjdh> STAR led to SVM solutions with fewer support vectors, with 
no loss in predictive performance. Such solutions axe quicker to evaluate, and potentially easier 
to  interpret. An added bonus was th a t STAR was usually quicker to  tra in  than the SVM. The 
heuristic LAIKA did not improve the predictive performance and required excessive training time. 
It appeared to be more sensitive to the amount of regularization than  the SVM. Using STAR to 
reduce the number of SVs may lead to  a better results w ith LAIKA, but this was not possible 
owing to excessive training time.
5.3 Alternative Compound Representations
In Chapter 2 (Section 2.2), it was quoted from Kauvar et al. (1995) th a t ‘the way in which a 
compound is represented ultim ately limits the success of all subsequent procedures’. In particu­
lar, three possible representations of a  compound were described. In the following, variations of 
these three representations are used to  learn a decision function for classifying the competitive 
antagonists as active or inactive. In Section 5.3.1, the MACCS structural keys (Chapter 2, Sec­
tion 2.2.2) axe evaluated as a representation for these compounds. In Section 5.3.2, the reduced 
graph representation is used. This is a more sophisticated representation, similar to  the fingerprint 
described in Chapter 2 (Section 2.2.3). Finally, in Section 5.3.3, a new type of affinity fingerprint 
(see Chapter 2, Section 2.2.4) is presented and evaluated.
5.3.1 Predicting from Structural K eys
To recap: a structural key is a bitm ap in which each bit represents the presence or absence of a 
specific structural feature (James et al., 2000). Although structural keys were originally developed 
for database seaxching, they have proved to  be useful for distinguishing active compounds from 
inactive ones (Brown and M artin, 1996). The structural key used here is the MACCS key (MACCS- 
II, 1994). The MACCS key of a compound is a 166-dimensional binary vector, where each bit 
indicates presence or . absence of a  particular two-dimensional structural feature. The results of 
Brown and M artin (1996,1997) suggest th a t the MACCS key may be better for predicting biological 
activity than  the properties used above in Sections 5.1 and 5.2. In their work, the MACCS keys
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pK j Props MACCS t V
Test s.e. Test s.e.
1 0.22 0.01 0.19 0.01 1.24 0.11
2 0.27 0.01 0.21 0.01 3.54 0.00
3 0.26 0.01 0.21 0.01 2.76 0.00
4 0.25 0.01 0.21 0.01 2.38 0.01
5 0.33 0.01 0.29 0.01 2.26 0.01
6 0.37 0.01 0.31 0.01 2.92 0.00
7 0.30 0.01 0.28 0.01 1.20 0.11
8 0.27 0.01 0.19 0.01 4.47 0.00
9 0.31 0.01 0.19 0.01 6.92 0.00
10 0.24 0.01 0.19 0.01 2.45 0.01
11 0.24 0.01 0.21 0.01 1.71 0.04
Table 5.3: pK{. Test error rates for the SVM when using the properties (‘Props’) or MACCS keys. 
The error on the MACCS keys is significantly lower on nine assays (t-test at 95%).
were shown to accurately predict the values of various physicochemical properties. The MACCS 
keys thus contain a t least as much information about the compound as those physicochemical 
descriptors. W hether or not this extra information can be utilized for prediction depends on 
whether or not it is useful, and, if it is, whether or not a  learning machine can take advantage of 
it. The SVM seems well suited to take advantage of this extra information since it is robust to 
high-dimensional data.
The kernel used for these experiments was the linear kernel:
166
K (x ,  z) =  (x, z) =  =  (1 — Hamming(x, z)), (5.1)
p = l
where Hamming is the number of bits for which two bitmaps differ. This is a popular dissimilarity 
measure in chemoinformatics (see Chapter 2, Section 2.3.2). The resulting decision function is of 
the form:
/(x )  =  sgn
where wp is the pth component of the weight vector w  =  X)i=i Via ix i ’ T hat is, once the SVM has 
been trained, a new compound is classified as being active if (and only if) the sum of the weights 
assigned to structural features th a t are present in th a t compound is greater than  some threshold 
(—6). This is similar to  the approach of Gillet et al. (1998), where a genetic algorithm was used 
to assign weights to the structural features.
The predictive performance of the SVM when trained using a linear kernel on MACCS keys 
compared to using a Gaussian kernel on the properties is illustrated in Figure 5.7. The performance 
is reported in terms of test errors, R A , and A UROC for C  =  1. (The SVM did not converge within 
10000 iterations for C  =  10, no other values were tried.)
The test errors (Figure 5.7, top left) are represented in Table 5.3. On all 11 assays the test error 
when training on MACCS keys was decreased. The difference was significant on nine assays (t-test 
at 95%). AU RO C  (Figure 5.7, bottom left) was increased on all assays. R A  (Figure 5.7, top right) 
was increased on all but assay 1. ela  ^ correctly predicted th a t training on MACCS keys would lead 
to a lower test error than training on the physicochemical descriptors (Figure 5.7, bottom right). 
It should be noted th a t there is no reason to suppose th a t using C  =  1 with a Gaussian kernel has 
any relation to  using C  =  1 for a linear kernel. For the Gaussian kernel the radius, R, of the data
166
^  wpx p +  b
p = i
(5.2)
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Figure 5.7: pK{. Comparison of SVM performance when using the properties (‘Props’) or MACCS 
keys (C =  1): test error (top left), RA  (top right), AUROC  (bottom left). Note that ela  ^ (bottom 
right) correctly predicts that the structural keys will give better performance an all assays.
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Figure 5.8: pKi. When training on the MACCS keys, selecting the training data by clustering on 
fingerprints increases the AUROC  on six assays, but this does not correspond to an increase in 
accuracy (left). The training time and number of SVs were increased (right).
is upper bounded by 1, whereas for a linear kernel on these data R  «  5. If C = R ~ 2 (Cristianini 
and Shawe-Taylor, 2000), this suggests that better predictive performance could be attained with 
a smaller value of C  when using the MACCS keys.
On average, the proportion of the training data that became SVs was 46%, compared to 78% 
when training on the properties. Thus the classification time would be reduced by about two-fifths. 
This gain was at the expense of a roughly seven-fold increase in training time. The solutions 
provided by training on structural keys are unlikely to be useful unless there are only a few 
informative training data and many unlabelled data. Such a situation may occur in the early 
stages of lead discovery.
5.3.1.1 C lu ste rin g  S tru c tu ra l  K eys
In Section 5.1 above, the training data were selected by clustering the compounds in the space of 
fingerprints. The SVM was then trained on the centroids, using the properties as descriptors. This 
resulted in a slightly denser model with a slightly higher A UROC. We would a priori expect the 
number of SVs to be fewer, since the centroids should be more representative of the data. When 
the SVM is trained on the centroids using the MACCS keys the results are as follows (again, for 
C = 1 only).
The A UROC was increased on six assays and decreased on five. However, these changes did not 
result in corresponding changes in accuracy (Figure 5.8, left). This implies that, for some of the 
assays, the ROC curve could be used to adjust the operating point to achieve a higher accuracy.
Training on the centroids usually led to an increased training time. The number of SVs was 
always increased, contrary to expectations. The percentage changes in training time and number of 
SVs when training on the centroids, compared to training on randomly selected data, are illustrated 
in Figure 5.8 (right).
In summary, when learning a predictor of activity from MACCS keys, clustering the data in 
the space of fingerprints did not lead to an improvement in predictive performance, and led to an 
increase in training time and classification time.
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Figure 5.9: pKi. When using structural keys as descriptors, STAR reduces the number of SVs by 
roughly one third to one half. The cost incurred is no more than a 40% increase in runtime.
5 .3.1.2 S T A R  on  S tru c tu ra l  K eys
The predictive performance of STAR on these data was almost the same as that of the SVM on all 
three performance measures (with C = 1). The percentage difference in training time and number 
of SVs is illustrated in Figure 5.9.
STAR reduces the number of SVs by between a third and a half. The cost of this sparser 
solution is no more than an increase in runtime of about 40%. On average, the runtime of STAR is 
slightly lower than that of the SVM. The proportion of the training data that become SVs is about 
20%-30%. This is a significant improvement on training the SVM on physicochemical descriptors. 
However, training with STAR on the structural keys requires three to 13 times more time than 
training the SVM on the physicochemical properties.
5.3.2 Predicting from Reduced Graphs
The results in the previous section showed that a representation directly encoding structural fea­
tures, as opposed to derived physicochemical and structural properties, led to a sparser and more 
accurate solution. However, the training time was considerably increased. The MACCS keys were 
originally designed for searching for substructures in databases. There is no particular reason why 
the substructures encoded should be related to biological activity. Also, the topological relationship 
between the substructures is lost.
An alternative structural representation is the reduced graph (Gillet et al., 1991). A reduced 
graph is a simplification of the 2D chemical structure. As described in Gillet et al. (1999), the aim 
is to identify a level of simplification such that compounds with equivalent bioactivity are similar 
and those with different bioactivity are dissimilar. This is done by summarizing structural features 
that are likely to affect activity, whilst maintaining the topology between them. The reduced graph 
is then converted into a 2048-dimensional binary fingerprint.
The SVM was again trained with a linear kernel for C  G {1,10}. The solutions were almost 
identical for the two values of C, results are reported for C  =  1. The predictive performance when 
using reduced graphs was almost identical to that obtained when using MACCS keys on all three 
measures. However, the training error was always lower when using the reduced graphs, which 
may indicate that the SVM was overfitting in this case, in which case a lower value of C  should 
lead to improved performance. (Also, the radius 1 ? > 1 ,  which suggests C  <  1.)
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The main advantage in using the reduced graph representation, over using MACCS keys, for 
these compounds, was that the training time was reduced by a factor of between seven and 15. 
The number of SVs was 12%-28% higher than when using the structural keys. However, this is 
still 16%-41% lower than when using the properties.
It is noted by Gillet et al. (1999) th a t reduced graphs provide a complementary representation 
to standard 2D structural descriptors, and often identify active compounds th a t are missed when 
using the latter. Thus it may be possible to  improve the predictive performance by combining the 
SVM models trained on the different feature sets.
The effect of STAR was similar to the case of training on MACCS keys. The predictive per­
formance of STAR was almost identical to th a t of the SVM on all three measures. The training 
time was slightly (8%) longer. The number of SVs was reduced by 16%-42%, with 32%-46% of 
the training data  becoming SVs.
Note th a t the reduced graph representation has some similarities to the document representa­
tion used by Joachims in the development of £U : it is high-dimensional, sparse, and binary. For 
such data, Joachims (2000) suggests th a t using p =  1 in the calculation of (3.32) gives a tighter 
and more predictive bound, although this is not proved. On these data  however, selected the 
optimal value of C  in {1,10} for only seven of the 11 assays (p =  0.11). (Note that the SVM 
converged to the global optimum for all experiments when using the reduced graphs, so ela  ^ holds.)
In summary, the reduced graph representation led to  the same gains in accuracy over using 
properties as did the MACCS keys. Training on the reduced graphs was quicker than training on 
the properties (which was much quicker than  training on the MACCS keys). The reduced graphs 
also led to  solutions with fewer SVs than did the properties (although more than did the MACCS 
keys). It is likely th a t the SVM was overfitting the data, and th a t a lower value of C  would have led 
to improved performance. STAR reduced the number of SVs without deteriorating performance, 
a t the expense of a slight increase in training time.
5.3.3 Predicting from B ioactiv ity
The aim of the work reported in this chapter has been to  tra in  an SVM to predict accurately 
which compounds will be active when screened against various targets. The approach has been to 
learn a relationship between some descriptors of the compound and its bioactivity. The descriptors 
used have been physicochemical and structural. The general principle underlying QSAR is th a t 
there is a relationship between these descriptors and affinity for a certain biological target. An 
alternative is to use biological affinities themselves as descriptors. This approach has been called 
affinity fingerprinting by Dixon and Villax (1998), see Chapter 2 (Section 2.2.4) for a description 
of their work.
A novel approach is taken here: the actual pKi values themselves are taken as descriptors. 
T hat is, if the target is to predict whether or not a compound is active on assay 11 (say), then the 
descriptors are the pKi values on assays 1-10. Thus, the binding affinities of a compound to a set of 
receptors are used to  predict the affinity to another receptor. There are a number of advantages to 
this approach over the standard QSAR approach. Pharmaceuticals companies have a large amount 
of screening data. Thus when it desired to predict biological affinity for a new receptor, affinities for 
many other receptors are already known. Secondly, genome research has uncovered an enormous 
amount of receptor sequence data  and research has begun to  classify these receptors (Karchin 
et al., 2001). Decision rules relating affinities may aid this process. Receptors are categorized into 
families and superfamilies according to biological function. This existing domain knowledge may 
be drawn upon for selecting affinities as descriptors, thus guiding the process of feature selection,
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Actual pK[ SQ pK j 
<5.5 1
5.5-6.0 2
8.5-9.0 8
>9.0 9
Table 5.4: Rescaling of pK i values to  a semi-quantitative (SQ) ranking.
which remains a difficult problem in drug discovery (Dixon and Villar, 1998).
Note that, unlike IC50 or percentage inhibition, pKi values are directly comparable across 
screens since concentrations have been factored out. Thus the pKi value of a ligand for a receptor 
can be considered a constant, i.e. an inherent ‘property’ of the ligand.
Since compounds are screened a t only a limited range of concentrations, it is not always possible 
to  report an exact pKi value. The activity may be recorded els a number, or as less than or greater 
than  a certain value. For these data, the concentrations used led to  the data  being left-censored 
at pKi < 5.5 and right-censored at pKi > 9. The pK{ values were thus converted to a semi- 
quantitative (SQ) scale, as in Table 5.4. A bin size of 0.5 was used, as the pKi values are only 
accurate to approximately ±0.2 units. The threshold for ‘active’, as determined by the screening 
group, was a pKi of 6.0. Thus ‘inactive’ compounds have an SQ pKi in {1,2} and active compounds 
have an SQ pKi in { 3 ,.. .  ,9}. It would be preferable to  have bin sizes th a t better reflected the 
proportion of actives and inactives, but this was not possible owing to the precision and range of 
the assay.
An example thus comprises 10 integer-valued attributes in { 1 , .. . ,9 }  with a binary target 
(‘active’, or ‘inactive’). Note th a t this is the most compact of the four compound representations 
used in this work. The SVM was trained on these data  using a  Gaussian kernel, with C € {1,10}, 
as for the properties. The test errors are compared to those of the SVM trained with the properties 
and with the reduced graphs in Figure 5.10 {left) and Table 5.5. (Recall th a t with the MACCS 
keys the SVM performance was almost identical to  th a t th a t with the reduced graphs.) Results 
axe shown for C = 1. This value was the optimal for the affinity fingerprint on all assays, although 
ela£ selected it for only seven. Results axe qualitatively the same for C =  10. On ten assays the
pK j RG 
Test s.e.
pKi 
Test s.e.
t V
1 0.19 0.01 0.20 0.01 -1.13 0.13
2 0.21 0.01 0.16 0.01 3.22 0.00
3 0.21 0.01 0.13 0.01 5.33 0.00
4 0.21 0.01 0.15 0.01 3.75 0.00
5 0.28 0.01 0.21 0.01 3.85 0.00
6 0.31 0.01 0.21 0.01 5.03 0.00
7 0.27 0.01 0.16 0.01 6.86 0.00
8 0.19 0.01 0.14 0.01 2.55 0.01
9 0.21 0.01 0.16 0.01 3.33 0.00
10 0.16 0.01 0.13 0.01 2.11 0.02
11 0.22 0.01 0.12 0.01 6.23 0.00
Table 5.5: pK{. Test error rates for the SVM when using the reduced graphs (‘RG’) or affinity 
fingerprints (‘pKi ). The error on the affinity fingerprints is significantly lower on ten assays (£-test 
a t 95%). Results are shown for C  =  1.
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Figure 5.10: pK^. The test error (left) when using affinity fingerprints (‘p K i ) is lower than when 
using the properties (‘Props’) or reduced graphs (‘RG’). The training time is also lower (right). 
(The test error for the MACCS keys was the same as for the reduced graphs; the training time 
was an order of magnitude longer.) Results are shown for C = 1.
affinity fingerprints led to significantly lower test errors than the other representations (£-test at 
95%; for both values of C). On assay 1, no representation significantly outperformed the others. 
RA  and AUROC  were also highest with the affinity fingerprints, except for assay 1. The gains in 
RA  and A UROC were relatively small (roughly 17% increase on average over using the properties) 
compared to the gain in accuracy (39%).
The affinity fingerprints led to solutions with more SVs than did the reduced graphs when 
C  =  1 and fewer SVs when C  =  10 (although this latter was suboptimal for both representations). 
The number of SVs for both of these representations was in general lower than when training on 
the properties and higher than when training on the MACCS keys.
The training time was much lower when using the affinity fingerprints than when using any of 
the other three representations (Figure 5.10, right).
In summary, binding affinities provide a highly compact and informative representation of a 
compound. This facilitates rapid training of the SVM for prediction of other binding affinities. 
The solutions are sparse and the most accurate developed in this work.
5.3.3.1 ST A R  on A ffin ity  F in g e rp rin ts
The predictive performance of STAR, on all three measures, was fractionally poorer than the SVM, 
for both C  in {1,10}. AUROC  was one percentage point lower on nine assays when C  =  1 and on 
four assays when C = 10, and equal (to the nearest percentage point) on the remaining cases. The 
RA  of STAR was within four percentage points of that of the SVM, and was on average unchanged. 
The deterioration was slight but consistent.
The number of SVs was reduced on average by 20% at C  =  1 and by 8% at C = 10 (Figure 5.11). 
The corresponding training times were on average 32% and 37% longer. Thus, if the better value 
of C  could be selected, STAR would lead to a reduction in prediction time of one fifth, at the 
expense of an increase in training time of one third. If there are many more examples on which 
predictions are desired than for which activities are known, then STAR offers a reduction in overall 
computational time. This is usually the case when building decision rules in drug discovery.
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Figure 5.11: pK^. STAR reduces the number of SVs (Nsv)  a t the expense of longer runtime. The 
relative gain compared to the increased time is larger for C  =  1 (left) than for C — 10 (right)
5.3 .3 .2  L A IK A  on A ffinity  F in g e rp rin ts
Since the number of iterations required to train the SVM on these data when C  =  1 was low 
(<  300), LAIKA had no effect on most of the assays. LAIKA is only likely to have an effect if 
the update period, ha, is much smaller than the number of iterations. Since this is not known in 
advance ha was set at 100 for all experiments reported here. If the training is completed rapidly, 
one possibility is to estimate a  from the final set of SVs and retrain.
On the two assays where LAIKA had an effect when C  =  1, the estimate a  was approximately 
3<tjdh- This resulted in a slight increase in AUROC  and a substantial decrease in the number of 
SVs, at the expense of two to three times longer training time. However, the test error increased 
(by one percentage point) on these two assays. This is again indicative of the operating point b 
being suboptimally set for a heuristic.
When C = 10 the number of iterations to convergence of the SVM was 300-600, and LAIKA 
had some effect on the SVM. The predictive performance was consistenly but not significantly 
better than that of the SVM. The number of SVs was reduced, roughly in proportion to the 
increase in cr (Figure 5.12). Note that, as before (Section 5.2.2), a  is lower when C =  10 than 
when C  =  1 (for those assays where LAIKA had an effect). The cost of this is up to six times 
longer training time, which is moderately correlated (p = 0.68) with the reduction in the number 
of SVs. It seems unlikely that these results would be of any use in practice.
5 .3 .3 .3  S T A R + L A IK A  on A ffinity  F in g e rp rin ts
When C  =  1, the A UROC of STAR was slightly decreased on eight assays. The A UROC of LAIKA 
was increased slightly on two, and the solution remained the same on the others. STAR decreased 
the number of SVs, which should increase their separation, and hence the estimate of a. One 
might expect that LAIKA could recover the performance of STAR to that of the SVM (or better) 
whilst maintaining the sparsity conferred by STAR. This is what happened: the AUROC  of the 
combination was slightly increased in eight cases, decreased on one (assay 1) and was unchanged 
on the other three. (Comparisons are to within one percentage point.) The number of SVs was on 
average unchanged from that of STAR. On only one assay (again, assay 1) was the number of SVs 
of STAR+LAIKA higher than that of the SVM.
The RA  of STAR+LAIKA was correspondingly higher than the SVM or unchanged. The test
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Figure 5.12: pK{. When C = 10 LAIKA increases the estimate of a over its starting value (oo), 
leading to a reduction in the number of SVs {Nsv)
error was not always reduced (and was sometimes increased) when A UROC was increased. This 
is again indicative of a suboptimal operating point.
As expected, the sparsity induced by STAR led to increased separation of SVs and an increased 
LAIKA estimate of a. The number of SVs and the AUROC  were weakly correlated (|p| «  0.5) 
with the increase in cr.
The cost of this fractional increase in predictive performance, and reduction in number of SVs 
by a fifth on average, was nearly a doubling in training time. On the two assays (3 and 6) where 
LAIKA affected the solution, the combination was quicker than LAIKA. However, the combination 
was always slower than STAR. Thus on these data it would be preferable to use STAR+LAIKA 
over STAR alone only if the decrease in performance of STAR were unacceptable.
When C  = 10 the conclusions are similar. The A UROC was fractionally increased above that 
of the SVM, and STAR+LAIKA recovered the performance of the SVM on those assays where 
STAR deteriorated it. The reduction in the number of SVs was lower (15%). However, the training 
time was increased dramatically, by a factor of 27 over the SVM. (The largest increase in training 
time for the heuristics individually was a by factor of six.)
In summary, STAR+LAIKA provided the benefits of both heuristics, viz. reduced number of 
SVs with (slightly) improved performance. The effect was more pronounced when C  =  1, which 
required less than twice the training time of the SVM. W ith a higher value of C  the minor gains 
were rendered Pyrrhic by the extensive training time.
5.3.4 Summary of Alternative Representations
All three alternative compound representations — MACCS keys, reduced graphs (RG) and binding 
affinities (pKi) — offered improvements over the physicochemical and one-dimensional structural 
descriptors (‘properties’). The predictive performance was best for pK{. RG and MACCS gave 
the same predictive performance and were better than properties. MACCS gave the sparsest 
solutions, but at the expense of the longest training time. Thus MACCS keys would be preferable 
for learning a rough and ready filter from a few screened compounds. This could be used to 
select compounds for screening from a large (possibly virtual) library. Since training on MACCS 
keys is time consuming, a procedure to select informative training data is desired. Using Ward’s 
clustering to select the training data did not lead to improved performance. The characteristics of 
SVM training and solutions for the four compound representations are summarized in Table 5.6.
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P rops M A C C S RG A ffinities
Accuracy
Worst; SVM is over- Good Good Best
fitting so could be im­
proved
Training time
Slow Slowest Fast Fastest
Classification Speed 
Slowest Fastest Fast Fast
Properties are inter­
pretable but solutions 
were dense
Interpretability 
Common structural Very poor 
features amongst 
the few SVs can be 
identified
Open question; could 
provide a similarity 
metric for receptors
Table 5.6: pKi. Summary of SVM training and solutions for the four compound representations.
RG and pKi gave solutions sparser than did properties and were quicker to  train. pKi led to 
the shortest training times. Thus pKi would be preferable when high accuracy is needed and there 
are large number of screened compounds from which to  leaxn a decision rule.
These results suggest the following procedure.
1. Randomly select a small set of compounds, from a compound library.
2. Screen these in vitro, i.e. a low-throughput screen.
3. Using MACCS keys, learn a sparse classifier.
4. Predict the activities of the compounds in the library and rank them  in order of predicted 
activity, e.g. as ‘active’, ‘moderately active’, ‘inactive’.
5. Screen the ‘active’ compounds in vitro, i.e. a high-throughput screen.
6. Using other pKi values where available, or RG otherwise (or a combination), leaxn a more 
accurate classifier.
7. Use this a second, more accurate, virtual screen for the ‘moderately active’ compounds. The 
compact representation may also suggest relationships between the targets.
How many compounds are selected for the in vitro assays will depend on time and cost resources. 
Use of the classifiers should make the process of finding actives in the large compound library more 
efficient.
STAR always led to sparser solutions than did the standard SVM. The performance was the 
same as the SVM for RG and MACCS, and deteriorated slightly on pK{. The training time was 
never increased by more than  40%. In the above schema, STAR would be best employed when 
training with MACCS at Step 2, in order to  reduce classification time.
LAIKA slightly improved the performance of the SVM trained on pKi, and led to sparser 
solutions. However, the training time was increased considerably. LAIKA would not be useful in 
the above schema.
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5.4 Summary
In Chapter 3, the pKi data were described. An SVM was used to predict whether or not a com­
pound was active against various targets. The compound description used consisted of fourteen 
physicochemical and one-dimensional structural descriptors. The SVM solutions had a  high pro­
portion (>  50%) of support vectors and had poor predictive performance. This prompted the 
development of three heuristics, as described in Chapter 4. Three approaches to improving the 
SVMs performance have been presented in this chapter. These were: two general purpose data 
mining methods; the application of the heuristics.; and, the use of alternative compound represen­
tations. These approaches are not mutually exclusive. The main contributions presented in this 
chapter, and some ideas for future work, are summarized below.
Selecting Training Data Screening compounds against a target costs money and takes time. 
Also, the training time of the SVM is 0 ( l2) - 0 ( l3). Therefore, it is desirable to  select a 
subset of the available compounds to physically screen in order to train  an SVM. W ard’s 
clustering, a fast and popular algorithm in chemoinformatics, was applied to  this task. The 
clustering was performed in the space of Daylight fingerprints using the Tanimoto similarity 
measure.
•  The clustering revealed th a t the fourteen properties were insufficient to fully discrimi­
nate the compounds.
• On both properties and MACCS, the test accuracy was in general poorer. However, the 
AU RO C  increased. This suggests th a t the operating point was incorrectly set. This 
was probably because the class priors were different in the training and test sets.
•  Prior knowledge of the densities could be used to adjust the regularization constants 
for the two classes. Failing that, the ROC curve could be used post hoc to  correct the 
operating point.
•  Overall, whether minimizing expected error or expected risk, randomly selecting training 
data  was preferable. In this case, the number of SVs and training time were slightly 
lower, and RA  was slightly higher.
M inim izing W eighted Loss When using a classifier for screening set selection, one aim is to 
increase the number of active compounds found. This can be quantified by the relative 
advantage (RA), a measure similar to the global enhancement over random selection of 
compounds. A specific risk functional was minimized as a proxy for maximizing RA.
•  Although it is not guaranteed, AU RO C  was almost the same whether minimizing error 
or risk.
•  W hen minimizing the respective loss, risk was more highly correlated with 1 /R A  (and 
A UROC) than was error.
•  However, minimizing risk led to a decrease in RA, contrary to expectations. The risk 
functional is a first order approximation. A refined version is suggested in Chapter 6 
(Section 6.2.3.3).
•  The number of SVs was slightly higher. This may be because the hyperplane was pushed 
towards the over-represented class. Such an hyperplane would make less mistakes on 
the under-represented class, since it is further away. If the hyperplane lies in a  region 
where examples are denser, then, intuitively, there will be more SVs.
126
H E R M E S  This heuristic stopping criterion was used for all of the experiments reported in this 
chapter. The experiments with STAR and LAIKA would not have been possible without 
some sort of heuristic stopping criterion. A comparison of the solutions obtained with those 
obtained at the global optimum of the Q P would dem onstrate any advantages of HERMES.
S T A R  This heuristic for reducing the number of SVs was evaluated with all four compound 
representations. Overall, the behaviour was as expected: the number of SVs was reduced 
with little or no loss in predictive performance.
•  The number of SVs was reduced on all assays for all representations.
•  The predictive performance (w.r.t. all three measures) was almost the same as th a t of 
the SVM. It was slightly worse than the SVM on pKi.
•  The training time was usually reduced on pKi and MACCS. It was slightly longer on 
RG and about a third longer on pKi.
L A IK A  This heuristic for tuning the width of a  Gaussian kernel was evaluated with the proper­
ties and pKi representations. Overall, the performance, in terms of both time- and space- 
complexity, was disappointing.
•  On properties, the predictive performance deteriorated w.r.t. all three measures.
•  On pKi, the predictive performance was fractionally better than  the SVM. The operating 
point may have been set suboptimally on some assays.
• The number of SVs was slightly reduced for both representations.
•  The number of iterations and the training time were considerably increased.
•  It is postulated th a t the explicit regularization should be lower. However, this is achieved 
by increasing C, which would increase the already lengthy training time.
M A C C S  K ey s This representation is a 166-dimensional b it string encoding presence of prede­
fined substructures within a molecule.
•  The predictive performance was better than th a t of the properties on all three measures.
•  ela£ was within a factor of two of the test error, and correctly predicted th a t MACCS 
keys would give lower error than did properties.
•  The number of SVs was reduced, resulting in a 40% reduction in classification time.
•  These gains were at the expense of a seven-fold increase in training time.
•  The SVM was overfitting the training data. It is likely th a t a lower value of C  would 
lead to  lower error (and shorter training time).
R e d u c e d  G ra p h s  This representation is a 2048-dimensional bit string th a t aims to  encode struc­
tural features relevant to binding, whilst maintaining their topology.
•  The predictive performance was almost the same as th a t of the MACCS keys (i.e. better 
than that of properties).
•  The training time was much faster than that of MACCS and less than th a t of properties.
• The number of SVs, and hence classification time, was more than th a t of MACCS, but 
still lower than  when using properties.
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•  As for the MACCS keys, the SVM was overfitting. I t  is likely th a t a lower value of C  
would give better performance.
A ffin ities For a given receptor, this representation comprises the binding affinity of a compound 
to the other ten receptors. This is a novel representation, developed with Steven B arrett at 
GlaxoSmithKline.
•  On ten of the assays, this gave the best performance on all three measures.
•  The number of SVs was about the same as the reduced graphs, i.e. more than when 
using MACCS and less than when using properties.
•  The training time was less than  half of the next quickest, viz. reduced graphs.
HERMES and STAR are broadly successful and, when applied to the problems in drug discovery 
studied here, achieve the objectives for which they were developed. LAIKA, however, was not 
successful when applied to these problems. The use of alternative compound representations, such 
as the MACCS structural keys and reduced graphs which are more sophisticated than  chemical 
property data, was beneficial. The novel use of affinity data  which potentially provides a more 
direct source of information than the other representations, was even more beneficial.
The principal message of this chapter has been th a t there are numerous ways to tackle a data 
mining problem. Which method is preferable depends on the practical situation. Do we want a 
solution rapidly? How many data  are there? How accurate does it need to be? At what stage in the 
drug discovery process axe the predictions being made? The heuristics, compound representations, 
and data  mining methods presented here may help or hinder the data  miner depending on the 
answers to  these questions.
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Chapter 6
Critical A ssessm ent, Further 
Work, and Conclusions
The real question is not whether machines think but whether men 
do.
B .F . S k in n e r
The work presented in this thesis has been primarily concerned with the computer science field 
of supervised learning. Specifically, the classification of objects into one of two predetermined 
classes, or the ranking of objects in terms of some real-valued variable. Broadly, the field of 
supervised learning poses three questions: W hat is it theoretically possible to learn? How is this 
achieved? W hat actually happens when we apply learning algorithms to  practical problems? The 
first question is not addressed in this work. Statistical learning theory provides one answer to this 
question. This inspired the development of the support vector machine (SVM) in answer to  the 
second question. The motivation behind this work was to answer the third question, with respect 
to the learning problems th a t arise in the early stages of drug discovery.
The early stages of drug discovery have been described, as have some previous applications of 
machine learning. The aim of using such techniques is to improve the efficiency of drug discovery 
by saving time and money. It is also hoped th a t these autom ated techniques may contribute 
to pharmacological knowledge. The SVM was a promising new technique th a t had not previously 
been applied to predicting the biological activity of compounds. A common approach to  predicting 
activity is quantitative structure-activity relationship analysis (QSAR). This attem pts to relate 
physicochemical and structural descriptors to a real-valued activity. The obvious1 next step was to 
apply the SVM to a public domain QSAR problem and compare it to  other techniques (Burbidge 
et al., 2000, 2001a). The SVM proved to  be the favourable algorithm. However, this was a small (55 
compounds), well-characterized prepared data  set. SmithKline Beecham (now GlaxoSmithKline) 
were interested in predicting the activity of compounds from d ata  generated at the earliest stages 
of drug discovery. Standard QSAR was not designed with such d a ta  in mind. The SVM seemed 
well-suited to  the task.
Two problems were chosen. The first (‘HTS’) was to predict the activity of compounds from 
data generated from a single high-throughput screen. The second (lpKi ) was to predict the 
activity of compounds from data derived from several screens. The SVM was applied to each of 
these problems and was found to suffer from some problems not typically reported in the literature.
1 Obvious to M. TVotter, that is.
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A ccu racy  
U n b a la n ced  D a ta
C lassifica tio n
S p eed
In te rp re ta b i l i ty
R o b u s tn e s s
H ig h -d im en sio n a l
T ra in in g  t im e  a n d  
M o d e l S e lec tio n
M e m o ry  R e q u ire ­
m e n ts
C 5.0
Has proved poor here 
and in previous work 
at GSK
Can be tricky (e.g. on 
HTS, not presented 
here)
Fast
Easy
Poor
Not addressed 
Very fast
Low
N e u ra l N e tw o rk s
Poor without exten­
sive model selection
Poor on HTS
Reasonably fast
Very difficult 
Unreliable
Poor without exten­
sive model selection 
Tediously slow, espe­
cially with model se­
lection
Low for online learn­
ers used here
S V M
Not as good as ex­
pected; LAIKA gave 
little gain
Easy to implement; 
risk bounds become 
unreliable
Slow owing to dense 
solutions; STAR im­
proves
Open question 
Dependent on param­
eter selection 
Good
Reasonably fast, 
easy model selection; 
HERMES improves 
Can be large al­
though online algo­
rithm s available
Table 6.1: Method-to-criterion. A brief summary of my learnings for three algorithms, when 
applied to  pharmaceutical data  analysis.
Three heuristics were developed in an attem pt to  overcome these deficiencies.
L A IK A  The purpose of LAIKA (Burbidge, 2002a) is to autom atically tune one of the few free 
parameters of the SVM. The aims were (in order of importance): to  improve accuracy over 
using a predetermined heuristic; to reduce model selection time; and, to reduce the solution 
complexity and thus reduce classification time.
S T A R  The purpose of STAR (Burbidge et al., 2001b) was to autom atically remove noisy data 
points. The aims were (in order of importance): to reduce solution complexity and hence 
classification time; and, to reduce training time, without loss in performance.
H E R M E S  The purpose of HERMES (Burbidge, 2002b) was to  provide an alternative stopping 
criterion for SVM training. The aims were: to reduce training time without loss of perfor­
mance; and, to provide a stopping criterion when the other heuristics are used.
These heuristics were evaluated on public domain data  sets and shown to meet their various aims 
to  various degrees. They were then applied to the SVM classification of the pKi data.
In  Chapter 1, Section 1.2, some desirable properties of a machine learning algorithm in the 
context of drug discovery were outlined. In Table 6.1, I briefly summarize my learnings with 
respect to  these criteria for C5.0, neural networks and the SVM. The observations apply only to 
pharmaceutical data analysis of the kind presented in this thesis. The criteria ‘Chemical Sense’ 
and ‘Missingness’ have not been included as it is not possible to  infer anything regarding these 
from this work.
6.1 Critical Assessm ent
The contributions presented in this thesis are of two types: heuristics for the SVM: HERMES, 
LAIKA, and STAR; and, analysis of drug discovery data sets: QSAR, HTS, and pK{. In the
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following, the work pertaining to each of these six sub-topics is critically assessed and the main 
contributions, as italicized in the Synopsis (Chapter 1, Section 1.5), are restated.
6.1.1 General Criticism s
Before considering the contributions presented in this thesis, it is worthwhile to consider some 
generalities of data mining and SVMs. Various points have been glossed over during the analysis, 
and numerous claims of others have been left unsubstantiated w.r.t. drug discovery data.
•  In providing estimates of performance, e.g. the error rate, the various algorithms have been 
evaluated w.r.t. a test set disjoint from the training set. For a given d ata  set, say the 
standard SVM on the first of the 11 pKi assays with the MACCS representation, the error 
on the test set is an unbiassed estim ate of the true error. It is common practice, as here, 
to evaluate several heuristics, with various representations, and choose th a t combination 
with the lowest test error. We can reasonably expect this combination, call it Leaxner A, 
to perform well on further unseen data. However, the lowest test error of a collection of 
learners is not an unbiassed estim ator of the true error of Learner A. (Consider 10 random 
classifiers, over repeated trials, the lowest of the 10 test errors will always be <  0.5 but the 
true error of the particular classifier achieving th a t minimum each time is 0.5.) A sounder 
approach would have been to  ensure th a t there was a further set of data, from the same data 
generating process, on which to evaluate the algorithms. The practicalities of this for the 
pharmaceutical data  sets are dealt w ith in the relevant sections below.
•  It is claimed th a t the support vectors (SVs) are ‘in some sense the most im portant patterns 
in the d a ta ’ (Burges, 1998). The SVs found in the analysis of the drug discovery data  sets 
have not been analysed by chemists or pharmacologists.
•  SVM errors have been penalized linearly throughout this work (i.e. k =  1 in Eq. 3.15). 
Drug discovery data  are noisy, so this seems preferable to  quadratically penalizing errors (i.e. 
k  =  2). The latter has not been evaluated. If it led to comparable performance, then it may 
be preferable since the VC bound (3.28) could then be used for param eter selection.
•  The ‘unbiased’ hyperplane (the solution to  the QP (3.22) has been used throughout this work. 
This gives the same performance as the ‘biased’ hyperplane (the solution to the QP (3.15) 
on public domain data  sets. The difference has not been investigated on the pharmaceutical 
data  sets.
•  The estim ator ela  ^ was in general not reliable for param eter selection. The evaluation in 
Chapter 3 (Section 3.1.5.3) was not very thorough. Further, the suggestion th a t solutions 
where the SVM predicts all examples to be in the same class should be discarded was not 
implemented.
• The area under the ROC curve (AUROC) has been reported as a performance measure since 
misclassification costs are not known. However, it may be possible to obtain estimates of 
costs a t different stages. It may be th a t only the behaviour for a subsection of the ROC 
curve is of interest.
• The relative advantage (RA) has been reported as a performance measure. As noted, it is 
not very meaningful when the true positive ratio is very small, but this was not checked 
during the analysis of the results. GE  is a more reliable measure (and is used at GSK), but
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it requires a ranking of compounds. (Note th a t R A  =  GE when the operating point is such 
that the true positive rate is 0.5.) It would have been preferable to  calculate GE for all of 
the reported results.
•  The risk functional chosen to maximize R A  did not give as high R A  as minimizing the error 
rate, a t least on the pKi data. There was a high correlation between risk and R A ~ 1 for 
the public domain and pKi data  sets. There axe probably better ways, possibly iterative, to 
maximize RA.
•  All features were scaled to  lie in the range [—1,+1]. This is common practice for the SVM 
(Lee and Lin, 2000; Hsu and Lin, 2002). Theoretically, this should make no difference since 
there is a global optimum. W hat the effect is in practice remains unassessed. A common 
procedure in statistical pattern  recognition is to scale the features to have mean 0 and variance 
1 (Ripley, 1996).
•  The Adult d ata  sets were pre-processed as in P la tt (2000). Joachims (2000) suggests th a t 
this is a good idea. The SVM was not evaluated on the original data.
•  It is claimed th a t the parameters of the optimizer do not affect the quality of the solution 
(Chapter 3). Theoretically this is true. In practice, the results can differ slightly, particularly 
for the larger Adult data  sets (Chapter 4, Section 4.1.2).
•  The Adult data  sets axe subsets of a much larger data  set. Thus there it is possible to  evaluate 
the learned rules on a large unseen test set to  obtain better comparisons of performance.
• The M atlab implementations of the SVM and the heuristics run about 100 times more slowly 
than an equivalent implementation in C or C + + . This seriously limited the number of ex­
periments th a t could be carried out. In particular, it would have been preferable to  caxry 
out extensive characterization of the heuristics on artifical data  sets of different sizes, dimen­
sionalities and signal-noise ratios.
Overall, the various analyses have highlighted the benefits of deciding in advance what exactly 
it is th a t the data  mining exercise is supposed to achieve. This should then motivate the choice 
of performance measure and learning algorithm. Exploratory d a ta  analysis is also useful, bu t it 
should precede, not replace, a  systematic investigation.
6.1.2 Q SAR
The aim of this analysis was to predict the inhibition of dihydrofolate reductase by pyrimidines. 
The inhibition was reported as log (l/A i) (= pK i, but the symbol lpKi is used in this thesis as an 
abbreviation for the data  sets analysed in Chapter 5). This problem is typical of those encountered 
in standaxd QSAR analysis (Eriksson and Johansson, 1996; Hansch and Leo, 1995): there are a 
small number (55) of compounds whose real-valued acitivity we wish to predict. King et al. (1992) 
reformulated this as relational problem in order th a t inductive logic programming (ILP) could be 
applied. The aim is to learn the relationship great(). The advantages of this are th a t ILP can 
provide a few human-readable rules with high accuracy. They found th a t the learned rules could 
successfully rank compounds in the training set, but not compounds in the test set. The relational 
problem suffers from some disadvantages:
•  The relation greatQ is not defined for drugs of equal activity.
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•  The number of examples is increased from I to  0 ( l2), which is likely to increase training time.
• Converting relations to a ranking can lead to  the Condorcet (Escher staircase) paradox.
Also, when the work of Burbidge et al. (2000) was presented, doubts were raised about the suit­
ability of the compound representation used by King et al. (1992).
The relational problem can also be solved by a classifier such as the SVM. In hindsight, this 
seems rather pointless.
• SVM regression on 55 compounds with 27 features would be much quicker than  SVM classi­
fication on 2800 comparisons with 54 features.
•  The solutions would also be more readable.
•  As a classification problem the advantages of learning a relation have been lost.
• It is possible for the classifier to  predict th a t great(n, m) =  +1 and great(m ,n) =  +1.
•  Defining a threshold for ‘active’, as for the pKi and HTS data, would have been a better way 
to  frame this as a classification problem.
• The error on each test set was around 11%, which is the number of comparisons great(n, m) 
for which neither dn or dm appeared in any training comparison. The question is: Have we 
simply learnt a  ranking of training compounds and not of test compounds?
Overall, casting the relational problem as a classification one was ill-advised and did not lead to 
any new insight from the point of view of QSAR analysis.
From the point of view of machine learning the following points were highlighted by the analysis.
• Fast techniques such as a decision tree and automatically tuned neural nets did not perform 
well.
•  Extensive time and human effort was required to obtain good performance from the neural 
network.
• The SVM was fast and easy to tune, and gave optimal performance of the methods assessed. 
Some criticisms of the SVM methodology used axe as follows.
•  The estimator ela  ^ was used to select the param eters C  and <x. This gave good performance 
for these data, but results presented throughout the thesis suggest th a t ela  ^ is not reliable. 
It would have been preferable to use a validation set for param eter selection, as for the other 
techniques.
•  Nine param eter settings were tried, based on fixed heuristics. There is no evidence th a t these 
are optimal for these data. A more exhaustive search, e.g. by LOOMS, would show whether 
the heuristics were suitable.
The training errors were lower than the test errors, which suggests th a t the SVM was overfitting 
and th a t the above criticisms axe valid. However, the training and test sets were not i.i.d. so 
it is not possible to assert this. Further analysis is not waxranted, since the problem should be 
reformulated.
As a final, general point, this data set also highlighted the advantages of formulating the problem 
sensibly in the first place, as opposed to diving blindly in with the latest piece of technology.
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6.1.3 H TS
The aim of this analysis was to rank unscreened compounds from the compound library for high- 
throughput screening (HTS). Screening d ata  were made available by SmithKline Beecham (now 
GlaxoSmithKline, GSK) for five classes of receptor. Only the data  from the class ‘a ’ screens were 
used in the analysis. There were data  for eight specific receptors of class ‘a ’. Only seven of these 
were used as there were insufficient data  for receptor a4. For the purposes of evaluating the learned 
decision rules, a quarter of the screened compounds were treated as unlabelled. When learning 
the decision rules, the remaining three quarters were partitioned into training and test sets of 
equal sizes. The results reported in this thesis are the results on these test sets. Owing to  time 
constraints, the decision rules were not evaluated on the third set of ‘unlabelled’ compounds (see 
Section 6.1.1).
Several feature sets were provided for the compounds. Three of these, fs01-fs03, were used in 
this analysis. It would have been preferable to have used all of the feature sets, either singly or in 
combination, and use the test sets for feature selection. The ‘unscreened’ compounds could then 
have been used for a validation of the entire procedure. Further, once a procedure for screening 
set selection had been developed, the data  for the other four receptor classes could have been used 
for further validation.
A further aim, initially, was to identify which features were useful for prediction, for a given 
receptor, a given receptor class, and for all receptors in general. Initial attem pts (not reported 
here) proved this to  be a difficult problem. The analyses in Chapters 2 and 3 showed that no one 
feature set was optimal for receptor class ‘a ’.
Overall, the analysis of the HTS data, though far from exhaustive, was carried out well.
• Exploratory d ata  analysis, such as visualizing the distribution of the features, did not reveal 
anything particularly unusual.
• Techniques already used in drug discovery for classification and regression were evaluated. 
The linear techniques performed well.
•  The SVM for classification did not perform well, even w ith extensive model selection.
•  W hen the low proportion of hits was taken into account the SVM performed well, without 
extensive model selection.
These initial results suggest that the SVM, adjusted for the low hit rate, could be a more useful 
tool for screening set selection than the linear and neural net techniques currently used in QSAR. 
As it was set out to  show, techniques used for QSAR are not best-suited for the analysis of HTS 
data.
The following criticisms could be made of the analysis.
•  Only automatically tuned neural networks were used. The analysis of the QSAR data showed 
these to have poorer performance than  manually tuned networks. Since there were 21 prob­
lems with thousands of examples each, manually tuning the neural networks would have 
required much longer computational time and human effort.
•  The SVM was shown to  benefit from assigning a higher misclassification cost to  false nega­
tives. This may also lead to better performance for the other techniques.
• The results have not been assessed by the screening group a t GSK. It is not known how 
useful they are.
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• Domain knowledge was not incorporated. This was very difficult to obtain.
• Although the global enhancements (GE) are better than  random, i.e. GE >  1, it is not 
known whether these results are statistically significant. The A50 follows a negative binomial 
distribution, so it should be possible to develop a significance test.
•  The techniques of clustering and similarity-based prediction have been described for screening 
set selection. The SVM, and other techniques have not been compared to these.
There is plenty of scope for further work.
Analysis of these d ata  has highlighted th a t linear techniques can do better than their more 
sophisticated rivals, and th a t even the most recent advances in machine learning can fail without 
consideration of the characteristics of the data.
6.1.4 pKi
The aims of this analysis were exploratory. GSK provided screening data  for over a thousand 
compounds against 11 receptors. One broad aim was to assess the usefulness of various compound 
representations for learning from such data. A new representation was also proposed, whereby the 
aim was to relate affinities for different receptors. This would aid the process of characterizing the 
different receptor types and subtypes. Analysis of the hum an genome has led to  the discovery of 
many new receptors (Howard et al., 2001); any relationships between them could facilitate their 
categorization. Compact relationships are desired, since these are more easily interpretable in 
term s of biological and chemical sense. From a machine learning viewpoint then, the aims were to 
learn a compact predictor of activity for all of the receptors. Since the application remains open, 
the predictive performance was assessed w.r.t. a variety of measures. The error rate records the 
number of misclassified compounds, an obvious measure of accuracy (at least when the classes are 
not too unbalanced). The ROC curve gives a measure of the performance for a range of costs. This 
is more useful in a practical scenario. For example, the classifier may be used as a filter th a t flags 
unscreened compounds as ‘probably active’. The maximum allowed false positive rate (f.p.r.) will 
depend on screening costs, the ROC curve gives the hit ra te  for a specified f.p.r. The ROC curve 
on the training data  can also be used to alter the threshold above which compounds are deemed 
active. The f.p.r. and hit rate for all costs are summarized as the AURO C. If the classifier is used 
for screening set selection, then the global enhancement ( GE) over random selection is useful. A 
similar measure, the relative advantage (RA) is reported here. Note th a t the maximum this can 
attain  is 1/7T+1, which for these data  is a modest 1.4-3.6 gain over random selection of compounds. 
However, if the classifiers were used to  select compounds from a  company’s library then 7r+i would 
be lower and the potential gains much higher. In this case, care would have to be taken to adjust 
the misclassification costs to  take account of the different hit rates, and to ensure th a t the training 
data were representative of the library compounds.
Overall, the analysis of these data  led to a number of useful conclusions regarding: the feasibility 
of such learning; the discriminative power of the feature sets; the performance of the SVM; and, 
the usefulness of the heuristics; as summarized in Chapter 5. Here, I outline some aspects of the 
analysis which, in hindsight, could have been better carried out.
•  The compounds were deemed active if pKi > 6, if this is varied, then a different classifer 
results, with a different weight vector w. If the rankings obtained for different activity 
thresholds vary, then doubt would be cast on the validity of producing a ranking in such a 
way.
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•  If a ranking is desired, e.g. if the application is screening set selection, then a regression 
technique may be preferable. Particularly as the signal-noise ratio was high (about 30). The 
raw d ata  were left- and right-censored, and the preprocessed data  ordinal, so the regression 
approach would not be straightforward.
•  It would have been preferable to identify the best representation for the SVM first. The 
other techniques and heuristics could have then been evaluated against the SVM on just 
this representation, thus saving time and effort. As this work was primarily exploratory, the 
representations were suggested and calculated by Steven B arrett of GSK during the research 
in an attem pt to  improve the performance.
• A similar point is th a t all experiments were carried out using the randomly selected training 
data  and the centroid training data  simultaneously. The analysis was post hoc. Many of the 
results are not reported since they do not add anything, e.g. using STAR on reduced graphs 
with centroid training data. Had the experimentation been designed better initially, these 
unnecessary runs could have been avoided. This would have freed up time for investigations 
which are now consigned to ‘further work’.
• A more principled approach would also have identified th a t the data  initially supplied by GSK 
were not as supposed. Some compounds were duplicated and others were indistinguishable 
on the basis of the original set of features (properties). This is a potential pitfall in any 
applied research. In hindsight, the maxim is: ‘always check the data  before starting a data 
mining exercise’.
•  On the plus side, this did show unequivocally th a t the set of fourteen properties had poor 
discriminatory power.
•  The preliminary experiments on these data, which motivated the development of the heuris­
tics, were not well designed. Unequal misclassification costs were used which proved to be 
undesirable, even for maximizing RA. The maximum number of iterations was set at 5000, 
which proved too few in many cases. Thus a fair comparison between the original heuristics 
and the later ones was not possible.
•  Before applying the heuristics, it would have been preferable to have evaluated the SVM for 
a wide range of parameters C  and a. For example, by using the search of LOOMS. I was 
not aware of the LOOMS software when the analysis was commenced, at the time such an 
search seemed computationally infeasible. LOOMS was later used by Steven B arrett of GSK 
to classify these d ata  sets. Analysis of these results should indicate whether the restricted 
param eter sets affected the performance.
•  For the m ajority of the experiments reported in Chapter 5 the maximum number of iterations 
was set a t 10000. This was to  avoid excessively long training times. In some cases the SVM 
did not converge within this limit. It is not known whether this was due to  failure of the 
stopping criteria, or simply because the particular problems were complex. In any case, a 
maximum must be set when batch learning several classifiers.
• None of the examples made available were reserved as ‘unscreened’ compounds for the pur­
poses of a final validation. As the initial analysis used all of the compounds with the ‘prop­
erties’, the results reported here using this representation will be optimistically biased. Since 
this representation was the worst, this does not seriously affect the conclusions. This fortuity 
though, does not obviate th a t not holding out some examples is bad practice in data  mining.
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• There are a few thousand more compounds for which activity data  axe available for assay 
3. These could be used to validate the results, except for those which used the affinity 
representation. Unfortunately, this representation was optimal. The screening group a t GSK 
have expressed a willingness to set up assays of off-sample compounds if the results are 
convincing enough.
•  In practice, all pKi values would not be available for all of the compounds. Using only 
compounds for which pKi values were available for a given set of receptors would result in 
a small and biased data  set. A technique which allows missing values in the representation 
would be preferable. Ideally, the prediction of bioactivity profiles could be treated as a 
problem of multiple im putation of missing data.
•  W ith regards to  the previous point, using pKi values as descriptors relies on historical screen­
ing data. Such data  may have been generated under different conditions. Although the pKi 
value of a compound for a receptor is theoretically a constant, systematic and random errors 
will lead to  variation from screen to screen.
• The clustering used to select the training data was w.r.t. fingerprints. The compounds 
were not clustered using the same representations as used to  train  the classifiers. Also, 
the fingerprints were not used to  train  a classifier. The compounds were also clustered at 
Tanimoto thresholds of 0.90, 0.95, and 0.99, which led to respectively larger training sets 
(since there are more singletons). These clusterings were not used.
• The clustering was partly  inspired by Fung and Mangasarian (2000). In th a t work fc-medioid 
clustering was used. The clustering being done w.r.t. the same representation as was used 
for prediction. The methodology used here did not lead to similar conclusions.
•  W hen training data  are chosen by clustering they are not i.i.d. as the population. Further, 
the test d ata  are no longer i.i.d. as the population, since both  are chosen from the same 
finite d ata  set. This is most obvious in the difference in hit rates for the two sets. This 
could be corrected for. It is not known if the class-conditional densities were also altered. 
Visualization of the d ata  sets, and support vectors, may guide the data  mining process.
Finally, note th a t the m ajority of the analysis of the pKi d ata  is not intended to demonstrate 
the usefulness of the SVM per se. It is intended to dem onstrate the usefulness of the various 
different compound representations, the data mining method, and the SVM heuristics. A thorough 
evaluation of other techniques, such as decision trees, neural networks, clustering and similarity- 
based prediction, is required to  answer the first point.
6.1.5 H ERM ES
HERMES was developed as a stopping criterion for the SVM. Empirically, it was shown to reduce 
the training time without loss in accuracy. The evaluation was restricted to five publicly available 
data  sets w ith similar characteristics to  the pKi data  sets.
• The behaviour of £la  ^ was qualitatively the same as th a t of the test error during training. 
However, this was only demonstrated for two data sets. Use of artificial data sets would 
have allowed exact calculation of the generalization error and better characterization of the 
behaviour of ela
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• Results throughout the thesis cast doubt on the reliability of ela  ^ for param eter selection. The 
behaviour of other estimators could be investigated to provide alternative stopping criteria.
•  A completely fair comparison of the reduction in the number of iterations due to HERMES 
is only possible if the same QP solver is used. The M atlab implementation with HERMES 
used Hildreth and D’Espo, whereas BSVM uses TRON.
•  An im plementation of the SVM with HERMES in C or C + +  would allow a comparison of 
training times w ith state-of-the-art packages such as BSVM and SV M ll9ht.
•  The persistence was set at 100. This worked well, bu t was completely arbitrary. Extensive 
characterization on artificial data  sets could suggest a rule-of-thumb for this param eter, and 
reveal how sensitive the performance is to its value.
6.1.6 LAIKA
LAIKA was developed as a heuristic method for autom atically tuning the width a  of a Gaussian 
kernel for SVM classification. Some comments on the development and application of LAIKA are 
as follows.
•  LAIKA was developed on two public domain d ata  sets frequently used in the evaluation of 
SVMs. It was evaluated on one of these and four other data  sets, on which we would expect 
the intial heuristic to lead to  overfitting.
•  Visualization of the data  sets may have better illustrated the motivation behind LAIKA.
•  As noted above, a more extensive evaluation on artificial d ata  sets, would have led to a fuller 
characterization of its behaviour.
•  The model selection time was not reduced below th a t of some other methods for tuning a , 
as was intended.
•  Jaakkola et al. (2000) define ctjdh with the positive and negative points transposed from the 
definition used here. This was not initially realized. Tommi Jaakkola2 states th a t this is 
im portant when there are few positives. Fortunately, this wasn’t the case for any of the data 
sets on which LAIKA or ctjdh were evaluated.
•  Burbidge (2002a) reported good performance and a considerable decrease in training time 
for an early version of LAIKA. However, vl.O here, which is similar, had the longest training 
times. The version used in Burbidge (2002a) was affected by the same bugs th a t affected 
STAR in Burbidge et al. (2001b), i.e. the algorithm term inated too early. That this only 
deteriorated the performance on Diabetes suggests th a t a  looser stopping criterion for LAIKA 
v2.2 could be used.
•  The effect of using HERMES as a stopping criterion for LAIKA was not investigated in any 
detail. I t was shown to be useful for only two data sets, and one value of C.
•  Again, the choice of a persistence of 100 was arbitrary, other values were not tried.
• The initial value was taken as ctjdh for all experiments. Anecdotal evidence suggests that 
starting from ao =  1 or ao =  y /d /2  leads to similar final estimates. This has not been 
systematically investigated.
2Personal communication.
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•  The choice ha € { 2 0 , 4 0 , ,  100} was arbitrary.
•  In C hapter 4, it seemed th a t LAIKA tuned a  to  compensate for a poor choice of C. For those 
d ata  sets a low C  was optimal. A higher C  gives less explicit regularization; LAIKA increased 
<7, thus increasing the implicit regularization. In Chapter 5, it seemed th a t a higher C  was 
required, since a low C  had a knock-on effect which caused LAIKA to over-regularization. 
The interplay and causality between these has not been further investigated.
6.1.7 STA R
The heuristic STAR was developed to reduce the number of support vectors (SVs) in the SVM 
solution. Some comments on the heuristic are as follows.
•  There axe many SVs in the solutions obtained when classifying noisy and complex d ata  sets 
such as the pKi data.
•  STAR reduced the number of SVs as expected.
•  The SVM was trained to  a global optimum of the QP for the evaluation in Chapter 4. The 
algorithm failed to converge after 100000 iterations on Adult4 with C  =  1000.
•  HERMES was used as the stopping criterion on the pKi data. However, no evaluation of this 
criterion w ith STAR was made beforehand.
•  As for the other heuristics, a more exhaustive evaluation on artificial data  sets with various 
characteristics, and for other kernels and other param eter settings, would have provided a 
better characterization of the behaviour of STAR.
•  The update period, he =  100, was arbitrary. A characterization of the heuristic could lead 
to a rule-of-thumb.
Since the development of STAR, there have been a number of other attem pts to reduce the number 
of SVs. Scholkopf et al. (1998) solve a quadratic program to find a sparser representation of the 
SVM solution. This takes roughly as long again as training the SVM. Schohn and Cohn (2000) use 
a heuristic active learning approach to produce a sparse solution and compare this to a method 
similar to R aR  (Burbidge et al., 2001b). Downs et al. (2001) describe a method for identifying 
a subset of the support vectors which are linearly independent, the weights a* for these can be 
recalculated such th a t the hyperplane is expressible in term s of this subset only. A comparison 
between STAR and these three techniques is left as further work.
6.2 Further Work
The critical assessment in the previous section obviously suggests many avenues for further work. 
Any point of the form ‘it would have been preferable to do X ’ can be transformed into ‘further 
work on this should include X ’. Some of these statem ents can be made for the m ajority of the 
analyses presented in this thesis. These are summarized in Section 6.2.1 to avoid repetition. The 
remainder of the suggestions for further work falls into two categories: specific research on a topic 
already addressed, and general ideas for new data  mining projects and SVM heuristics. Most of 
the former type have already been mentioned, either in the respective chapter summaries or as 
suggested by the criticisms in the previous section. These are collected together in Section 6.2.2. 
The latter type axe fewer and require more explanation. These are sketched out in Section 6.2.3.
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6.2.1 General Comments
The drug discovery problems in this thesis have been formulated as classification problems. As 
noted above, this was not a good representation for the QSAR data. The dependent variable for 
all of the data  sets is a real-valued activity. It is common practive, especially for the noisier HTS 
data, to  threshold the activity and label compounds as ‘active’ or ‘inactive’. An immediate avenue 
for further work is to  ignore these thresholds and attem pt to predict the real-valued activity. T hat 
is, all of the three problems could be treated as regression problems. The SVM for regression has 
been shown to be competitive with other learning algorithms in a variety of domains (Mangasarian 
and Musicant, 1999; Smola and Scholkopf, 1997; Vapnik et al., 1997). The problems could also be 
treated as ones of ordinal regression. Recently, the SVM has recently been adapted to solving this 
directly (Herbrich et al., 2000).
It is of great interest to GSK to know which representations of a compound are most useful 
for prediction. Ideally, it is desired to know the best feature set for prediction of affinity to  a 
given receptor, a given group of receptors, and to receptors in general. Three feature sets were 
used for the HTS analysis and four representations for the pKi analysis. No definite conclusions 
can be drawn the HTS data. Further work could involve feature selection within the feature sets, 
including those not used. On the pKi data  the affinity fingerprint was found to  be optimal. Feature 
selection for each receptor would highlight relationships between the receptors.
An alternative to feature selection is model combination. W hen more than  one classifier has 
been learned for a given target, for example based on different representations, the learned classifiers 
can be combined. There are numerous methods for combining classifiers th a t could be used to 
aggregate the SVM solutions already found during this work (Scott et al., 1998; Roli and Kittler, 
2002).
It is not possible to assess every technique on every problem. However, in Chapter 2, the 
techniques of clustering and similarity-based prediction were described. It would be useful to 
apply these to the drug discovery data sets in order to  quantify the relative performance of the 
standard SVM. These techniqes do not seem to be much used in the field of supervised learning. 
They may exhibit good performance for other applications. Neural networks are also popular in 
QSAR. On the HTS and pKi data, only automatically tuned ‘dynamic’ nets were used. These 
performed poorly. A fuller evaluation of other algorithms should highlight the benefits of the SVM 
re param eter selection.
Regarding the SVM, there are numerous further experiments th a t could be run on all of the 
data sets. The number of values of C  and a  used was fairly small. Now th a t LOOMS is available, 
it is possible to perform a search over param eter space, at least for a Gaussian kernel. (The authors 
are developing the software to handle other kernels.) Very little work has been presented here on 
the problem of choosing C, or on assessing the sensitivity of the SVM to  its value. The limited 
results suggest th a t the estim ator ela  ^ is not reliable for selection of C. Other error estimators 
could be used, in particular, the VC bound when errors are penalized quadratically.
Only linear and Gaussian kernels have been used. These are very popular but there are numer­
ous other possibilities (Genton, 2001). Polynomial kernels and the sigmoid kernel were initially 
used during exploratory data  analysis and were found to suffer from very long training times.
Further ideas for the development of the heuristics are given below. A general point for all of 
the heuristics is the following. The heuristics all introduce an ex tra param eter, viz. the number 
of iterations before the heuristic criterion is checked. The effect of this on STAR was investigated 
briefly by Burbidge et al. (2001b). The effect on LAIKA was investigated in Chapter 4. For 
all of the heuristics, a thorough characterization should involve evaluation on artificial data sets.
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Variables of interest include:
• I, the number of training examples;
•  d, the dimensionality;
•  the signal-noise ratio;
•  q, the working set size;
•  the kernel and its parameters; and,
• C, the regularization constant.
Ideally, a rule-of-thumb would be developed, with the SVM being fairly insensitive to  the value 
calculated.
6.2.2 Specific Ideas
In this section, various suggestions for further work on each of the data  sets and heuristics are 
collected.
6.2.2.1 QSAR
The QSAR data were analysed in Chapters 2 (Section 2.4.1) and 3 (Section 3.3.1). Some avenues 
for further work include the following.
•  Use the support vectors as centres for a Gaussian RBF network. This should show whether 
the improved performance of the SVM was due to  the location of the centers (Scholkopf 
et al., 1997b).
•  Use a sigmoid kernel for the SVM. An improved performance over the Gaussian kernel would 
suggest th a t the sigmoid is a better model for the data  than  the Gaussian.
•  The representation was six blocks of nine features: one block for each of three substitution 
sites for each of the two compounds. This information is lost when using an off-the-shelf ker­
nel. An alternative would be to design a kernel th a t incorporates this additional knowledge.
•  The classifications obtained could be converted to a ranking in order to compare the perfor­
mance with the ILP approach (King et al., 1992).
6.2.2.2 HTS
The HTS data were analysed in Chapters 2 (Section 2.4.2) and 3 (Section 3.3.3). Further work on 
this problem could include the following.
• A potential application of this work is to identifying false positives and negatives in the HTS 
screening data. If an accurate and reliable classifier could be learned, then training errors 
could be flagged as possibly mislabelled. In order to validate such an approach, compounds 
would have to be screened a t least in duplicate. Such data have been generated at GSK.
•  The two best techniques for this problem were logistic regression and the SVM. This suggests 
combining the two, i.e. regularized kernel logistic regression (P latt, 2000; Zhu and Hastie, 
2002).
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•  Isolated hits are not considered progressible. This suggests learning a predictor of the ac­
tivities of a group of similar compounds. A combination of clustering and prediction is one 
possibility.
• The results already obtained could be investigated to determine if there is any relationship 
between the performance, the hit rate, the feature sets, and the nuumber of examples.
• Thresholding the feature weights in the linear models would be a first step towards feature 
selection. Sensitivity analysis could be used for feature selection with any of the learning 
machines, including the SVM (Evgeniou et al., 2000).
6 .2 .2 .3 pKi
The pKi data were analysed in Chapters 3 (Section 3.3.2) and 5. The analysis of these has been the 
most extensive. Since a whole chapter has been devoted to  the analysis of these data, the future 
work suggested in the various summaries (Sections 5.1.4, 5.2.3, 5.3.4, and 5.4) is not repeated here. 
O ther possibilities for further analysis include the following.
•  The 2048-bit reduced graph (RG) representation should have more discriminative power than 
the 166-bit MACCS structural keys (Chapter 2, Section 2.2.2). The predictive performance 
of the SVM was the same with either representation when C  =  1. A search for the optimal 
C  for each representation is required to  confirm or refute the claim.
•  The RG and MACCS representations are high-dimensional, sparse and binary. They may 
thus have similar statistical properties to documents represented as a bag-of-words. Joachims 
(2001) constructs an idealized document and proves th a t an SVM classifier with a linear 
kernel should perform well on such data. Can we analyse these compound representations in 
a similar manner?
•  The Euclidean metric is not the most suitable for fingerprints and structural keys (Chapter 2, 
Section 2.3.2). The Tanimoto similarity measure could be used instead, i.e. define AT(x, z) =  
Tanimoto(x, z).
•  Although the analysis has been treated as 11 separate classification problems, it could be 
treated as a single multi-label problem. For example, a  chemist may desire compounds 
th a t are active against all 5-HT receptors and inactive against all histamine receptors. The 
precision-recall break-even point (Chapter 3, Section 3.2.1) is often used as a performance 
measure in this case (Joachims, 1998).
6.2.3 N ew  Directions
Suggestions for further analysis of the heuristics and modifications have been made above and 
in the summary to Chapter 4. In the following some other heuristics for the SVM are briefly 
described. These were also motivated in part by the analysis of various pharmaceutical data  sets.
6.2.3.1 Transduction
The transductive approach to  classification is to perform inductive and deductive steps simulta­
neously (Vapnik, 1998). We axe given a training set and the test set 3 in advance. The aim is to 
classify the test set with minimum error. Therefore, instead of searching over the space of decision
3Also called the working set by some authors.
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rules, we search over the space of labellings. Note th a t the predicted labelling may not correspond 
to the output of any one decision rule in our hypothesis space. If there are k unlabelled examples, 
then there are 2k binary classifications. The optimization requires learning an hyperplane for each 
of the 2k possible labellings. The transductive SVM solution is the labelling of the test set that 
leads to  the largest margin. This search is combinatorial, a  heuristic search is given by Joachims 
(1999b). M athematical programming techniques have also been applied to  the problem (Fung and 
Mangasarian, 2000; Bennett, 1999).
An alternative is to cluster the test data, as suggested by Vapnik (1998), and perform a heuristic 
search over labellings of the clusters, possibly allowing points to move cluster if they are repeatedly 
mislabelled during the search. Further, only test points classified with low confidence by the 
inductive SVM need be included in the search. This approach was presented at NIPS’99 (Burbidge, 
1999), but not investigated further.
The advantage of the transductive approach is th a t the decision function is only learned in the 
region of interest. This may be beneficial in drug discovery. A group of unscreened compounds 
may be of interest for different reasons than those already screened and may not be in the same 
region of chemical space. To attem pt to learn a classifier for the whole of chemical space from 
a sample drawn from one region of it is unreasonable. To learn a classifier for a subregion is a 
modest aim. Strictly, the theory behind the transductive approach only holds if the test data  are 
i.i.d. as the test data. Yet, it seems as though transduction would be most useful when this is not 
the case (Klinkenberg and Joachims, 2000).
6.2.3.2 Im putation of M issing Data
Multiple missing attribu te values can be imputed independently or collectively. When there are 
many complete data  records it is feasible to learn a predictive model for each feature. If most of 
the data  records have some entries missing this is not feasible. In this case one desires to  leaxn 
multiple imputations simultaneously. One approach is to train  a  neural network with multiple 
outputs and a network structure that maintains consistency in the imputation. Neural networks 
can be difficult to tune and slow to train. The SVM has only a  single output and cannot be 
used directly for multiple imputation. A committe of SVMs could be trained th a t can perform 
multiple imputation. Starting from an initial random guess of all of the missing values, one SVM 
is trained to predict each feature, based on the other features. The collective predictions are then 
used as a first approximation for the missing values and the process is repeated until a stable set 
of predictions is reached for the missing values.
W ith binary SVM classifiers, this approach is only possible when all of the features axe binary. 
This is case for the pKi d ata  if the features axe taken not be the SQ pKi values, but these affinities 
thresholded as ‘active’ or ‘inactive’. For multi-valued features, a network of SVM regressors could 
be used. The pKi data  inspired this idea, since in practice, there are many compounds th a t have 
been screened against some targets, but few th a t have been screened against all. The problem 
of predicting binding affinity from binding affinity is therefore more naturally framed as one of 
multiple imputation of missing data, rather than  a  straightforward classification (or regression) 
problem.
W hen predicting the missing values, the examples on which we wish to  predict are known. This 
step could be treated as one of transductive inference.
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6.2.3.3 M axim ixing Relative Advantage
In Chapter 3 (Section 3.2.2), the following was proposed as a first order approximation to maxi­
mizing the relative advantage (RA):
Minimize FP F N
w,6 N  P  ’
where A =  F P /N  is unknown. This risk functional has been used with A =  1, which errs in favour 
of correctly classifying positive points (e.g. active compounds). An alternative is an iterative 
approach. Starting with Ao =  0.5, say, solve the optimization. Calculate Ai =  F P q/ N , where F P 0 
is the number of mislabelled negative training examples. Iterate until the change in A falls below 
some tolerance. To speed this up, A could be updated after every, say, 100 iterations, as for the 
heuristics described in Chapter 4.
For the SVM, changing A amounts to  changing the ratio  of the misclassification costs, which is 
equivalent to changing the ratio of the regularization param eters C + , C ~ . Retraining of the SVM 
with a new A should therefore be fairly rapid. The iterative maximization could be applied to any 
classification algorithm which minimizes a risk.
6.2.3.4 Aggregating SVM s
The training time of the SVM scales empirically as 0(Z2) (P latt, 1999; Joachims, 1999a). This can 
become computationally infeasible for very large data  sets. Bradley and M angasarian (2000) have 
proposed linear programming methods for fast training on massive data  sets. Another possibility is 
to  segment the training data, either randomly or by clustering, and train  an SVM for each segment 
of data. The learned classifiers must then be combined in some way. Evgeniou (2000) proposes 
combining the solutions by learning a linear relationship between the individual outputs and the 
labels of the training data. An alternative is to  treat the SVMs as preprocessors. T hat is, the 
support vectors (SVs) within each segment are considered as candidate SVs for the SVM trained 
on the whole data. Points which are not SVs of the SVMs trained on the segments are discarded. 
A single SVM can then be trained on the subset of points th a t are SVs from the individual SVMs. 
Other refinements include discarding SVs th a t are training errors (cf. STAR), and partitioning the 
data  several times, and retaining only those points which are SVs for the m ajority of partitions.
6.3 Conclusions
The scientific contributions presented in this thesis are to the field of data mining. A number of 
general points have been raised and methodologies presented and evaluated. The chief contributions 
are to the domain of support vector classification. These are the three heuristics HERMES, LAIKA 
and STAR. To the respective authors’ knowledge, these heuristics have not yet been used in 
the SVM community. Work introducing these algorithms has been published or accepted for 
publication. In particular, the stopping criterion HERMES has been accepted for publication by
C.-W. Hsu, one of the coauthors of BSVM (Hsu and Lin, 2002) which is among the fastest SVM 
implementations. T. Joachims4 has also expressed an interest in incorporating the heuristic into his 
state-of-the-art SVM package SV M h9ht (Joachims, 1999a). The heuristic STAR has also received 
interest from the authors of the first SVM book Cristianini and Shawe-Taylor (2000)5.
4Personal communication.
5 Chris Watkins, personal communication
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The application of these heuristics to problems in drug discovery was broadly successful. Each 
of the algorithms achieved the aims for which it was designed to  some extent. The shortcomings 
and possible solutions have been discussed. It should be noted th a t the aim of GlaxoSmithKline 
in providing the various data  sets was to find out if anything at all could be said. The criterion 
for success was essentially: Can we do better than random in predicting activity? The answer 
provided by the research presented here is yes, with characterizations of the heuristics and the 
data  sets and proposals for use in practice.
This leads to the question of: W hat next? Ideally, I would like to  take what I have learned 
about data  analysis, in particular classification, and formulate a well-defined, statistically rigorous 
set of experiments to validate the claims made. In practice, this is impossible, as the commercial 
environment is not a purely research one. The numerous data sets and problems tackled have well- 
prepared me for aiming for a second best. Approaching industrial and commercial problems with 
the mindset of a pragmatic theorist is an almost oxymoronic balance, but one th a t must be held 
as an ideal to ensure th a t the results obtained can be meaningfully interpreted. A balance must 
also be found between exploratory work and the more rigorous experiments such work suggests 
and the actual implementation of the techniques developed. As noted in the introduction, there is 
not much point doing applied science unless it is applied.
145
Bibliography
Abraham , M., 2001. Prediction of physical chemical and biological processes from structure using 
LFER methodology. Presentation.
Aizerman, M., Braverman, E., Rozonoer, L., 1964. Theoretical foundations of the potential function 
m ethod in pattern  recognition learning. Automations and Remote Control 25, 821-837.
Arabie, P., H ubert, L., Soete, G. (Eds.), 1996. Clustering and Classification. World Scientific, 
Singapore.
Arunlakshana, O., Schild, H., 1959. Some quantitative uses of drug antagonists. British Journal of 
Pharmacology 14, 48-58.
Ash, R., 1990. Information Theory. Dover.
Bellman, R., 1961. Adaptive Control Processes: A Guided Tour. Princeton University Press, NJ.
Bennett, K., 1999. M athematical programming methods for support vector machines. In: Scholkopf 
et al. (1999a), pp. 293-326.
Bennett, K., Mangasarian, O., 1992. Robust linear programming discrimination of two linearly 
inseparable sets. Optimization Methods and Software 1, 23-34.
Bevan, C., Hill, A., Reynolds, D., Valko, K., 2001. Rapid physicochemical profiling. Presentation.
Bishop, C., 1995. Neural Networks for P attern  Recognition. Clarendon Press.
Blake, C. L., Merz, C. J., 1998. UCI repository of machine learning databases .
URL h t t p : //www. i c s . u c i . edu/~m learn/M LR epository. htm l
Bdhm, H.-J., Schneider, G. (Eds.), 2000. V irtual Screening for Bioactive Molecules. Vol. 10 of 
M ethods and Principles in Medicinal Chemistry. Wiley-VCH, Weinheim, Germany.
Borman, S., 1990. New QSAR techniques eyed for environmental assessments. Chemical Engineer­
ing News 68, 20-23.
Bradley, P., M angasarian, O., 2000. Massive data  discrimination via linear support vector machines. 
Optimization M ethods and Software 13 (1), 1-10.
Bravi, G., Gancia, E., Green, D., Hann, M., 2000. Virtual Screening for Bioactive Molecules, Ch. 
Modelling Structure-Activity Relationships. Vol. 10 of Bohm and Schneider (2000), pp. 81-116.
Breiman, L., 1994. Bagging predictors. Tech. Rep. 421, Department of Statistics, University of 
California, Berkeley, CA.
146
Breiman, L., Friedman, J., Olshen, R., Stone, C., 1984. Classification and Regression Trees. 
Wadsworth International Group, Belmont, CA.
Brown, M., Grundy, W., Lin, D., Cristianini, N., Sugnet, C., Furey, T., M. Ares, J., Haussler,
D., 2000. Knowledge-based analysis of microarray gene expression d ata  using support vector 
machines. Proceedings of the National Academy of Sciences 97 (1), 262-267.
Brown, R., M artin, Y., 1996. Use of structure-activity data to compare structure-based clustering 
methods and descriptors for use in compound selection. Journal of Chemical Information and 
Computer Science 36, 572-584.
Brown, R., M artin, Y., 1997. The information content of 2D and 3D structural descriptors relevant 
to  ligand-receptor binding. Journal of Chemical Information and Com puter Science 37, 1-9.
Burbidge, R., December 1999. Making transductive classification feasible. Presentation. N IPS’99 
Workshop on Using Unlabelled D ata for Supervised Learning. Breckenridge, Co.
URL h t t p : / / s t a t s . m a . i c . a c .u k / rd b /p re s e n ta t io n s /n ip s 9 9 - tra n s d u c tio n .p p s
Burbidge, R., Maxch 2002a. Adaptive kernels for support vector classification. In: Proceedings of 
the MSRI Workshop on Non-Linear Estimation and Classification. Lecture Notes in Computer 
Science. Springer-Verlag, Berkeley, Ca., to  appear.
Burbidge, R., February 2002b. Stopping criteria for SVMs. Tech. rep., Statistics Section, Imperial 
College, 180 Queen’s Gate, London, SW7 2BZ, submitted to Special Session on Support Vector 
Machines and Kernel Methods, ICON IP’02.
Burbidge, R., Buxton, B., March 2001. An introduction to support vector machines for data  
mining. In: Sheppee, M. (Ed.), Keynote Papers, Young OR12. Operational Research Society, 
Operational Research Society, University of Nottingham, pp. 3-15.
Burbidge, R., Trotter, M., B.Buxton, S.Holden, 2000. Drug design by machine learning: support 
vector machines for pharmaceutical data  analysis. In: Maxtin, A., Come, D. (Eds.), Proceedings 
of the AISB’00 Symposium on Artificial Intelligence in Bioinformatics symposium, AISB00, 
17th-20th April, 2000. University of Birmingham, pp. 1-4.
Burbidge, R., Trotter, M., B.Buxton, S.Holden, December 2001a. Drug design by machine learning: 
support vector machines for pharmaceutical data  analysis. Computers and Chemistry 26 (1), 4 - 
15.
Burbidge, R., Trotter, M., B.Buxton, S.Holden, 2001b. STAR — sparsity through autom ated 
rejection. In: Connectionist Models of Neurons, Learning Processes, and Artificial Intelligence: 
6th International Work-Conference On Artificial and Natural Neural Networks, IWANN 2001, 
Proceedings, P art 1. Granada, Spain, June 2001, pp. 653-660.
Burges, C., Crisp, D., 2000. Uniqueness of the SVM solution. In: Solla et al. (2000), pp. 223-229.
Burges, C. J. C., 1998. A tutorial on support vector machines for pattern  recognition. D ata Mining 
and Knowledge Discovery 2 (2), 1-47.
Butina, D., 1999. Unsupervised d ata  base clustering based on Daylight’s fingerprint and Tanimoto 
similarity: a fast and autom ated way to  cluster small and large d a ta  sets. Journal of Chemical 
Information and Computer Science 39, 747-750.
147
Chapelle, O., Vapnik, V., 2000. Model selection for support vector machines. In: Solla et al. (2000), 
pp. 230-236.
Chapelle, O., Vapnik, V., Bousquet, O., Mukherjee, S., 2002. Choosing multiple parameters for 
support vector machines. Machine Learning 46, 131-160.
Cheng, Y.-C., Prusoff, W., 1973. Relationship between the inhibition constant (hi) and the con­
centration of inhibitor which causes 50 per cent inhibition («50) of an enzymatic reaction. Bio­
chemical Pharmacology 22, 3099-3108.
Clementine 6.0, 2001. SPSS Inc. Headquarters, 233 S. Wacker Drive, 11th floor, Chicago, Illinois 
60606.
Cortes, C., Vapnik, V., 1995. Support vector networks. Machine Learning 20, 273-297.
Cristianini, N., Shawe-Taylor, J., 2000. An Introduction to  Support Vector Machines and Other 
Kernel-based Learning Methods. Cambridge University Press.
Cristianini, N., Shawe-Taylor, J., Campbell, C., 1998. Dynamically adapting kernels in support 
vector machines. In: Kearns, M., Solla, S., Cohn, D. (Eds.), Advances in Neural Information 
Processing Systems, 11. The MIT Press, Denver, CO.
Curran, C., April 2001. Novartis tackles rise in respiratory diseases. Chemistry and Industry 7, 
205.
Devijer, P., K ittler, J., 1982. Pattern  Recognition: A Statistical Approach. Prentice-Hall.
Dixon, S., Villar, H., 1998. Bioactive diversity and screening library selection via affinity finger­
printing. Journal of Chemical Information and Computer Science 38, 1192-1203.
Downs, T., Gates, K., Masters, A., 2001. Exact simplification of support vector machine solutions. 
Journal of Machine Learning Research 2, 293-297.
Drucker, H., Schapire, R., Simard., P., 1993. Improving performance in neural networks using a 
boosting algorithm. In: Hanson, S., Cowan, J., Giles, C. (Eds.), Neural Information Processing 
Systems 5. Morgan Kaufmann, Denver, CO, pp. 42-49.
Duan, K., Keerthi, S., Poo, A., 2001. Evaluation of simple performance measures for tuning SVM 
hyper parameters. Tech. Rep. CD-01-11, Department of Mechanical Engineering, National Uni­
versity of Singapore, 10, Kent Ridge Crescent, 119260, Singapore.
Duda, R., Hart, P., 1973. P attern  Classification and Scene Analysis. John Wiley & Sons.
Eglen, R., Schneider, G., Bohm, H.-J., 2000. High-throughput screening and virtual screening: 
E ntry points to drug discovery. In: Bohm and Schneider (2000), pp. 1-14.
Eriksson, L., Johansson, E., 1996. M ultivariate design and modeling in QSAR. Chemometrics and 
Intelligent Laboratory Systems 34, 1-19.
Evgeniou, T., June 2000. Learning with kernel machine architectures. Ph.D. thesis, MIT.
Evgeniou, T., Pontil, M., Papageorgiou, C., Poggio, T., 2000. Image representations for object 
detection using kernel classifiers. In: Proceedings of ACCV2000 The Fourth Asian Conference 
on Computer Vision January 8 th - l l th  2000. Lecture Notes in Computer Science. Springer, The 
Grand Hotel, Taipei, Taiwan, to appear.
148
Fellenz, W., June 2001. Reduced support vector selection by linear programs. In: Mira and Prieto 
(2001), pp. 677-684.
Feng, J., June 2001. Non-symmetric support vector machines. In: Mira and Prieto (2001), pp. 
418-426.
Freund, Y., Schapire, R., 1999. Large margin classification using the perceptron algorithm. Machine 
Learning 37 (3), 277-296.
Friedman, J ., 1997. On bias, variance, 0 /1—loss, and the curse-of-dimensionality. D ata Mining and 
Knowledge Discovery 1, 55-77.
Friefi T .-T ., Cristianini, N., Campbell, C., 1998. The kernel-adatron: a fast and simple learning 
procedure for support vector machines. In: Shavlik, J. (Ed.), Machine Learning Proceedings of 
the Fifteenth International Conference (ICML ’98). Morgan Kaufmann, San Francisco, CA, pp. 
188-196.
Fukunaga, K., 1972. Introduction to Statistical Pattern  Recognition, 1st Edition. Academic Press.
Fung, G., M angasarian, O., October 1999. Semi-supervised support vector machines for unlabelled 
data  classification. Tech. Rep. 99-05, D ata Mining Institute, Computer Sciences Department, 
University of Wisconsin.
Fung, G., Mangasarian, O., 2000. D ata selection for support vector machine classifiers. In: Ramakr- 
ishnan, R., Stolfo, S. (Eds.), KDD-2000, Proceedings of the Sixth ACM SIGKDD International 
Conference on Knowledge Discovery and D ata Mining, August 20-23, 2000, Boston, MA. ACM, 
pp. 20-23.
Gentile, C., 2001. A new approximate maximal margin classification algorithm. In: Leen, T., 
Dietterich, T., Tresp, V. (Eds.), Advances in Neural Information Processing Systems 13. The 
MIT Press, Denver, CO.
Genton, M., 2001. Classes of kernels for machine learning: A statistics perspective. Journal of 
Machine Learning Research 2, 299-312.
Gillet, V., Downs, G., Holliday, J., Lynch, M., Dethlefsen, W., 1991. Computer storage and retrieval 
of generic chemical structures in patents. 13. reduced graph generation. Journal of Chemical 
Information and Computer Science 31, 260-270.
Gillet, V., W illett, P., Bradshaw, J., 1998. Identification of biological activity profiles using sub- 
structural analysis and genetic algorithms. Journal of Chemical Informatics and Computer Sci­
ence 38, 165-179.
Gillet, V., W illett, P., Bradshaw, J., 28th-29th October 1999. Reduced graphs as descriptors of 
bioactivity. Presentation.
URL h t tp : / / www. d a y lig h t . com /m eetings/em ug99/G illet/
Guenoche, A., Hansen, P., Jaum ard, B., 1991. Efficient algorithms for divisive hierarchical cluster­
ing. Journal of Classification 8, 5-30.
Hammett, L., 1970. Physical Organic Chemistry, 2nd Edition. McGraw-Hill, New York.
Hand, D., Till, R., 2001. A simple generalisation of the area under the roc curve for multiple class 
classification problems. Machine Learning 45, 171-186.
149
Hanley, J., McNeil, B., 1982. The meaning and use of the area under a receiver operating charac­
teristic (ROC) curve. Radiology 143, 29-36.
Hann, M., Green, R., 1999. Chemoinformatics — a new name for an old problem? Current Opinion 
in Chemical Biology 3, 379-383.
Hansch, C., 1969. A quantitative approach to biochemical structure-activity relationships. Acct. 
Chem. Res. 2, 232-239.
Hansch, C., Leo, A., 1995. Exploring QSAR Fundamentals and Applications in Chemistry and 
Biology. Vol. 1. American Chemical Society, Washington, D.C.
Herbrich, R., Graepel, T., Obermayer, K., 2000. Large margin rank boundaries for ordinal regres­
sion. In: Smola et al. (2000), pp. 115-132.
Herbrich, R., Graepel, T ., Williamson, R., 2002. The structure of version space, personal commu­
nication.
Hertz, J., Krogh, A., Palmer, R., 1991. Introduction to  the Theory of Neural Computation. 
Addison-Wesley, Redwood City, CA.
Hijfte, L. V., Marciniak, G., Froloff, N., 1999. Combinatorial chemistry, autom ation and molecular 
diversity: new trends in the pharmaceutical industry. Journal of Chromatography B 725, 3-15.
Hildreth, C., 1957. A quadratic programming procedure. Naval Research Logistics Quarterly 4, 
79-85.
Hollinger, M., 1997. Inroduction to Pharmacology. Taylor & Francis, Washington, D.C.
Howard, A., McAllister, G., Feighner, A., Liu, Q., Nargund, R., der Ploeg, L. V., Patchett, A., 
March 2001. Orphan G-protein-coupled receptors and natural ligand discovery. TRENDS in 
Pharmacological Sciences 22 (3), 132-140.
Hsu, C.-W., Lin, C.-J., 2002. A simple decomposition method for support vector machines. Machine 
Learning 46, 291-314.
Huber, P., 1981. Robust Statistics. John Wiley & Sons.
Jaakkola, T., Diekhans, M., Haussler, D., 1999. Using the fisher kernel method to  detect remote 
protein homologies. In: Lengauer, T., Schneider, R., Bork, P., Brutlag, D., Glasgow, J., Mewes, 
H.-W., Zimmer, R. (Eds.), Proceedings of the Seventh International Conference on Intelligent 
Systems for Molecular Biology. AAAI Press, Heidelberg, Germany, pp. 149-158.
Jaakkola, T., Diekhans, M., Haussler, D., 2000. A discriminative framework for detecting remote 
protein homologies. Journal of Computational Biology 7, 95-114.
James, C., Weininger, D., Delaney, J., July 2000. Daylight Theory M anual Daylight 4.71. Daylight 
Chemical Information Systems, Inc., 27401 Los Altos, Suite #360, Mission Viejo, CA 92691.
Jarvis, E., Patrick, E., 1973. Clustering using a similarity measure based on shared nearest neigh­
bours. IEEE Transactions on Computing C 22, 1025-1034.
Joachims, T., April 1998. Text categorization with support vector machines: learning with many 
relevant features. In: Nedellec, C., Rouveirol, C. (Eds.), Machine Learning: ECML-98, 10th 
European Conference on Machine Learning. Vol. 1398 of Lecture Notes in Artificial Intelligence. 
Springer, Chemnitz, Germany.
150
Joachims, T., 1999a. Making large-scale SVM learning practical. In: Scholkopf et al. (1999a), pp. 
169-184.
Joachims, T ., 1999b. Transductive inference for text classification using support vector machines. 
In: International Conference on Machine Learning.
Joachims, T., 2000. Estimating the generalization performance of a SVM efficiently. In: Langley 
(2000), pp. 431-438.
Joachims, T., 2001. Support vector machines and document classification. Ph.D. thesis, GMD 
First, check this.
Karchin, R., Karplus, K., Haussler, D., 2001. Classifying G-protein coupled receptors with support 
vector machines. Bioinformatics .
Kauvar, L., Higgins, D., Villar, H., Sportsman, J., Engvist-Goldstein, A., Bukar, R., Bauer, K., 
Dilley, H., Rocke, D., 1995. Predicting ligand binding to  proteins by affinity fingerprinting. 
Chemistry and Biology 2, 107-118.
King, R. D., Muggleton, S., Lewis, R. A., Sternberg, M. J. E., 1992. Drug design by machine 
learning: the use of inductive logic programming to  model the structure-activity relationships 
of trim ethoprim  analogues binding to dihydrofolate reductase. Proc. Natl. Acad. Sci. USA 89, 
11322-11326.
Klinkenberg, R., Joachims, T., 2000. Detecting concept drift with support vector machines. In: 
Langley (2000).
Kohavi, R., 1996. Scaling up the accuracy of naive-bayes classifiers: a decision-tree hybrid. In: 
Simoudis, E., Han, J., Fayyad, U. (Eds.), Proceedings of the Second International Conference 
on Knowledge Discovery and D ata Mining, pp. 202-207.
Kovesdi, I., Dominguez, M., Orfi, L., Naray-Szabo, G., Varro, A., Papp, J., Matyus, P., 1999. 
Application of neural networks in structure-activity relationships. Medicinal Research Reviews 
19 (3), 249-269.
Labute, P., 1999. Binary QSAR: A new method for the determ ination of quantitative structure 
activity relationships. In: Pacific Symposium on Biocomputing 4. pp. 444-445.
Lang, K., Waibel, A., Hinton, G., 1990. A time delay neural network architecture for isolated word 
recognition. Neural Networks 3, 33-43.
Langley, P. (Ed.), 2000. Machine Learning Proceedings of the Seventeenth International Conference 
(ICML ’00). Morgan Kaufmann, Stanford, CA.
LeCun, Y., Boser, B., Denker, J., Henderson, D., Howard, R., Hubbard, W., Jackel, L., 1989. 
Backpropagation applied to handw ritten zip code recognition. Neural Computation 1 (4), 541- 
551.
Lee, J.-H., Lin, C.-J., November 2000. Automatic model selection for support vector machines. 
Tech. rep., Department of Computer Science and Information Engineering, National Taiwan 
University, Taipei 106, Taiwan.
Leo, A., Weininger, D., August 2000. CLOGP Reference Manual. Daylight Chemical Information 
Systems, Mission Viejo, CA.
151
Li, Y., Long, P., 2001. The relaxed online maximum margin algorithm. Machine Learning 46, 
361-387.
Lin, C.-J., More, J., 1999. Newton’s m ethod for large-scale bound constrained
problems. SIAM Journal of Optimization 9, 1100-1127, software available at
h t t p : / /www. m cs. a n l . gov/~m ore/tron.
Lin, Y., Lee, Y., Wahba, G., March 2000. Support vector machines for classification in nonstan­
dard situations. Tech. Rep. 1016, Department of Statistics, University of Wisconsin, 1210, West 
Dayton St., Madison, W I 53706.
Lipinski, C., Lombardo, F., Dominy, B., Feeney, P., 1997. Experimental and computational ap­
proaches to estim ate solubility and permeability in drug discovery and development settings. 
Advanced Drug Delivery Reviews 23, 3-25.
Lipnick, R., 1986. Charles Earnest Overton: Narcosis studies and a contribution to general phar­
macology. Trends in Pharmacological Science 7, 161-164.
Littlestone, N., W armuth, M., 1986. Relating data compression and learnability. Tech. rep., Uni­
versity of California, Santa Cruz.
Lunts, A., Brailovskiy, V., 1967. Evaluation of attributes obtained in statistical decision rules. 
Engineering Cybernetics 3, 98-109.
MACCS-II, 1994. MACCS-II Menu Reference Manual version 2.2. MDL Information Systems, San 
Leandro, CA.
Manallack, D., Livingstone, D., 1999. Neural networks in drug discovery: have they lived up to 
their promise? Eur. J. Med. Chem. 34, 95-208.
M angasarian, O., 2000. Generalized support vector machines. In: Smola et al. (2000), pp. 135-146.
Mangasarian, O., Musicant, D., November 1999. Robust linear and support vector regression. Tech. 
Rep. 99-09, D ata Mining Institute, Computer Sciences Department, University of Wisconsin.
Mangasarian, O., Musicant, D., June 2000. Lagrangian support vector machines. Tech. Rep. 00- 
06, D ata Mining Institute, Computer Sciences Department, University of Wisconsin, Madison, 
Wisconsin.
M angasarian, O., Wolberg, W., September 1990. Cancer diagnosis via linear programming. SIAM 
News 23 (5), 1&18.
M atlab 6.0, 2001. The Mathworks, Inc., 3, Apple Hill Drive, Natick, MA 01760-2098.
McGregor, M., Pallai, P., 1997. Clustering of large databases of compounds: using the MDL “keys” 
as structural descriptors. Journal of Chemical Information and Computer Science 37, 443-448.
McLoone, S., Irwin, G., 2001. Improving neural network training solutions using regularisation. 
Neurocomputing 37, 71-90.
Menard, P., Lewis, R., Mason, J., 1998. Rational screening set design and compound selection: 
cascaded clustering. Journal of Chemical Information and Computer Science 38, 497-505.
Mercer, J., 1909. Functions of positive and negative type and their connection with the theory of 
integral equations. Philosophical Transactions Royal Society London A 209, 415-446.
152
Michie, D., Spiegelhalter, D., Taylor, C., 1994. Machine Learning, Neural and Statisti­
cal Classification. Prentice Hall, Englewood Cliffs, N.J., data  available at anonymous ftp: 
f t p .n c c .u p .p t /p u b /s ta t lo g / .
Mira, J., Prieto, A. (Eds.), June 2001. Connectionist Models of Neurons, Learning Processes, 
and Artificial Intelligence: 6th International Work-Conference On Artificial and N atural Neural 
Networks, IWANN 2001, Proceedings, P art 1. Vol. 2084 of Lecture Notes in Computer Science. 
Springer-Verlag, Granada, Spain.
Mitchell, T ., 1997. Machine Learning. McGraw-Hill International.
Morris, J., Bruneau, P., 2000. Prediction of physicochemical properties. In: Bohm and Schneider 
(2000), pp. 33-58.
Muggleton, S., B ryant, C., Srinivasan, A., M ay/June 2000. Measuring performance when pos­
itives are rate: Relative advantage versus predictive accuracy — a biological case-study. In: 
de M antaras, R. L., E.Plaza (Eds.), Machine Learning: ECML 2000 11th European Confer­
ence on Machine Learning. Vol. 1810 of Lecture Notes in Artificial Intelligence. Springer-Verlag, 
Barcelona, Catalonia, Spain.
M urthy, S. K., Kasif, S., Salzberg, S., 1994. A system for oblique induction of decision trees. 
Journal of Artificial Intelligence Research 2, 1-32.
Neal, R., 1996. Bayesian Learning for Neural Networks. Springer.
Ng, A., 1997. Preventing overfitting of cross-validation data. In: Proceedings of the Fourteenth 
International Conference on Machine Learning. Morgan Kaufmann, pp. 245-253.
Osuna, E., Freund, R., Girosi, F., 1997a. An improved training algorithm for support vector 
machines. In: Principe, J., Giles, L., Morgan, N., Wilson, E. (Eds.), Proceedings of the 1997 
IEEE Workshop on Neural Networks for Signal Processing. Amelia Island, FL., pp. 276-285.
Osuna, E., Freund, R., Girosi, F., May 1997b. Support vector machines: training and applications. 
AI Memo 1602, MIT.
P la tt, J., 1999. Fast training of support vector machines using sequential minimal optimization. 
In: Scholkopf et al. (1999a), pp. 185-208.
P la tt, J., 2000. Probabilities for SV machines. In: Smola et al. (2000), pp. 61-74.
Pomerleau, D., 1993. Knowledge-based training of artificial neural networks for autonomous robot 
driving. In: Connell, J., Mahadevan, S. (Eds.), Robot Learning. Kluwer Academic, pp. 19-43.
Popper, K., 1968. The Logic of Scientific Discovery, 2nd Edition. Harper Torch Books, New York.
Provost, F., Fawcett, T ., 2000. Robust classification systems for imprecise environments. Machine 
Learning To appear.
QSAR, U., Group, C., 2001. Spring meeting.
Quinlan, J., 1992. C4.5: Programs for Machine Learning. Morgan Kaufmann.
Quinlan, R., 1987. Simplifying decision trees. International Journal of Man-Machine Studies 27, 
221-234.
153
Ratsch, G., Onoda, T., Muller, K.-R., 2001. Soft margins for AdaBoost. Machine Learning 42 (3), 
287-320.
Ripley, B., 1996. P attern  Recognition and Neural Networks. Cambridge University Press.
Roli, F., Kittler, J. (Eds.), 2002. Multiple Classifier Systems, Third International Workshop, 
MCS 2002, Cagliari, Italy, June 24-26, 2002. Proceedings. Lecture Notes in Computer Science. 
Springer-Verlag.
Rosenblatt, F., 1958. The perceptron: a probabilistic model for information storage and organiza­
tion in the brain. Psychological Review 65, 386-408.
Sadowski, J., 2000. Optimization of chemical libraries by neural networks. Current Opinion in 
Chemical Biology 4, 280-282.
Schneider, G., 2000. Neural networks axe useful tools for drug design. Neural Networks 13, 15-16.
Schohn, G., Cohn, D., 2000. Less is more: Active learning with support vector machines,. In: 
Langley (2000).
Scholkopf, B., Burges, C., Smola, A. (Eds.), 1999a. Advances in Kernel Methods: Support Vector 
Learning. The MIT Press.
Scholkopf, B., Knirsch, P., Smola, A., Burges, C., 1998. Fast approximation of support vector 
kernel expansions, and an interpretation of clustering as approximation in feature spaces. In: 
DAGM Symposium Mustererkennung. LNCS. Springer-Verlag.
Scholkopf, B., Shawe-Taylor, J., Smola, A., Williamson, R., 1999b. Kernel-dependent support 
vector error bounds. In: Ninth International Conference on Artificial Neural Networks. Institute 
of Electrical Engineers, University of Edinburgh, UK, 7th-1 0 th September, 1999, pp. 304-309.
Scholkopf, B., Smola, A., Muller, K.-R., 1997a. Kernel principal components analysis. In: Gerstner, 
W., Germond, A., Hasler, M., Nicoud, J.-D. (Eds.), Artificial Neural Networks — ICANN’97. 
Vol. 1327 of Lecture Notes in Computer Science. Springer, pp. 583-588.
Scholkopf, B., Sung, K.-K., Burges, C., Girosi, F., Niyogi, P., Poggio, T., Vapnik, V., 1997b. 
Comparing support vector machines with Gaussian kernels to  radial basis function classifiers. 
IEEE Transactions on Signal Processing 45 (11).
Scott, M., Niranjan, M., Prager, R., May 1998. Parcel: feature subset selection in variable cost do­
mains. Tech. Rep. CUED/F-INFENG /TR.323, Cambridge University Engineering Department.
Seydel, J ., 1966. Prediction of in vitro activity of sulfonamides, using Hammett constants or 
spectrophotometric d ata  of the basic amines for calculation. Molecular Pharmacology 2, 259- 
265.
Shawe-Taylor, J., B artlett, P., Williamson, R., Anthony, M., October 1996. S tructural risk mini­
mization over data-dependent hierarchies. Tech. Rep. NC-TR-96053, Department of Computer 
Science, Royal Holloway, University of London, Egham, Surrey TW20 0EX, UK.
Sigillito, V., Wing, S., Hutton, L., Baker, K., 1989. Classification of radar returns from the iono­
sphere using neural networks. Johns Hopkins APL Technical Digest 10, 262-266.
Smith, H., Draper, N., 1998. Applied Regression Analysis, 2nd Edition. John Wiley & Sons.
154
Smith, J., Everhart, J., Dickson, W., Knowler, W., Johannes, R., 1998. Using the ADAP learning 
algorithm to forecast the onset of diabetes mellitus. In: Greenes, R. (Ed.), Proceedings of the 
Symposium on Computer Applications in Medical Care. Los Alamitos, CA: IEEE Computer 
Society Press, Washington, pp. 261-265.
Smola, A., B artlett, P., Scholkopf, B., Schuurmans, D. (Eds.), 2000. Advances in Large Margin 
Classifiers. The MIT Press.
Smola, A., Scholkopf, B., 1997. On a kernel-based m ethod for pattern  recognition, regression, 
approximation and operator inversion. Tech. Rep. 1064, GMD First, Kekulestrafie 7, 12489 
Berlin.
Smola, A., Scholkopf, B., Muller, K.-R., 1998. The connection between regularization operators 
and support vector kernels. Neural Networks 11, 637-649.
Solla, S., Leen, T., Muller, K.-R. (Eds.), 2000. Advances in Neural Information Processing Systems 
12 .
Sollich, P., 1999. Probabilistic interpretation and Bayesian methods for support vector machines. 
In: Ninth International Conference on Artificial Neural Networks. The Institute of Electrical 
Engineers, London, UK, pp. 91-96.
Sollich, P., 2000. Probabilistic methods for support vector machines. In: Solla et al. (2000), pp. 
349-355.
SPSS, 1999. Clementine 5.1.
URL h t tp : //www. s p s s . com
Stead, P., 2000. High throughput screening of natu re’s diversity: successes, issues and future 
directions. In: Dixon, G., Major, J., Rice, M. (Eds.), High Throughput Screening: The Next 
Generation. Society of Chemical Industry, BIOS Scientific Publishers Ltd., Oxford, University 
of Surrey, Guildford, UK, pp. 75-82.
Terstappen, G., Reggiani, A., January 2001. In silico research in drug discovery. TRENDS in 
Pharmacological Sciences 22 (1), 23-26.
Valler, M., Green, D., July 2000. Diversity screening versus focussed screening in drug discovery. 
Drug Discovery Today 5 (7), 286-293.
Vapnik, V., 1995. The Nature of Statistical Learning Theory. Springer-Verlag.
Vapnik, V., 1998. Statistical Learning Theory. John Wiley & Sons.
Vapnik, V., Chapelle, O., 2000. Bounds on error expectation for support vector machines. Neural 
Com putation 12 (9), 2013-2036.
Vapnik, V., Chervonenkis, A., 1974. Theory of P attern  Recognition. Nauka, Moscow.
Vapnik, V., Golowich, S., Smola, A., 1997. Support vector method for function approximation, 
regression estimation and signal processing. In: Mozer, M., Jordan, M., Petsche, T. (Eds.), 
Neural Information Processing Systems. Vol. 9. The MIT Press, Denver, CO.
Vapnik, V., Lerner, A., 1963. P attern  recognition using generalized portra it method. Automation 
and Remote Control 24.
155
Wahba, G., Lin, Y., Zhang, H., 2000. GACV for support vector machines. In: Smola et al. (2000), 
p p .297-310.
Walters, W., Stahl, M., Murcko, M., April 1998. Virtual screening — an overview. Drug Discovery 
Today 3 (4), 160-178.
Ward, J., March 1963. Hierarchical grouping to optimize an objective function. Journal of the 
American Statistical Association 58 (301), 236-244.
Williamson, R., Smola, A., Scholkopf, B., 1999. Entropy numbers, operators and support vector 
kernels. In: Scholkopf et al. (1999a), pp. 127-144.
Zhang, J.-H., Chung, T., Oldenburg, K., 1999. A simple statistical param eter for use in evaluation 
and validation of high throughput screening assays. Journal of Biomolecular Screening 4 (2).
Zhang, J.-H., Chung, T ., Oldenburg, K., 2000. Confirmation of primary active substances from 
high throughput screening of chemical and biological populations: a statistical approach and 
practical considerations. Journal of Combinatorial Chemistry 2, 258-265.
Zhu, J., Hastie, T., 2002. Kernel logistic regression and the im port vector machine. In: Advances 
in Neural Information Processing Systems 14. The MIT Press, Denver, CO, to  appear.
Zien, A., Ratsch, G., Mika, S., Scholkopf, B., Lengauer, T., Muller, K.-R., 2000. Engineering 
support vector machine kernels th a t recognize translation initiation sites. Bioinformatics 16 (9), 
799-807.
156
